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Résumé 
Ce travail concerne l'étude de la dégradation enzymatique de micropolluants 
pharmaceutiques récalcitrants présents dans l'eau. Tout d’abord, les efficacités de trois 
laccases différentes issues respectivement de : Pycnoporus sanguineus CS43, Trametes 
versicolor (Tv) et Myceliophtora thermophila ont été comparées lors d’essais de dépollution 
de solutions modèles renfermant trois antibiotiques (amoxicilline, ciprofloxacine et 
sulfaméthoxazole) et un antiépileptique (carbamazépine). Les essais ont été réalisés avec les 
laccases libres en présence ou non de médiateurs redox. L'impact de plusieurs paramètres 
opératoires sur les performances des enzymes a également été étudié. Puis, une nouvelle 
méthode d’immobilisation des laccases impliquant l’activation du support (microparticules à 
base de silice commerciales) par du glutaraldéhyde en phase vapeur a été mise au point et 
optimisée en utilisant la méthodologie de plans d’expériences. Après immobilisation, la 
laccase Tv s’est avérée être la plus active. Des essais de dégradation en présence de 
médiateurs redox ont confirmé l’efficacité de l’enzyme immobilisée et sa possible 
réutilisation lors de cycles successifs. La toxicité des solutions après traitement a été évaluée 
par des tests Microtox®. La laccase Tv a également été immobilisée sur des nanoparticules 
non commerciales à base de silice ou d’argile ainsi que sur des composites à base de silice et 
d’argile. La laccase Tv immobilisée sur les supports composites riches en silice a montré une 
plus grande réactivité et de meilleures performances pour l'élimination des composés cibles.  
Mots-clés :  Laccase, Enzymes immobilisées, Médiateurs redox, Micropolluants 
pharmaceutiques, Biodégradation. 
 
Abstract 
This work is focused on the study of the enzymatic depletion of recalcitrant pharmaceutical 
micropollutants in water. The potential degradation of three antibiotics (amoxicillin, 
ciprofloxacin and sulfamethoxazole) and one anti-epileptic (carbamazepine) was studied 
with three laccases: Pycnoporus sanguineus CS43, Trametes versicolor (Tv) and 
Myceliophtora thermophila. Free laccase systems were evaluated for pharmaceuticals 
depletion on model solutions in the presence or absence of redox mediators and the impact 
of several parameters on the performance of laccases for degradation were studied. The 
enzymes were then immobilized on different solid supports: commercial silica, laboratory 
synthetized nano-silica and clay based composite nanomaterials and used for degradation 
tests. A novel methodology for the covalent binding of laccases onto carriers was developed 
by using glutaraldehyde in vapour phase and the best immobilization conditions were 
determined through a 23 full factorial design. The immobilized Tv shown the highest activity 
and was tested in presence of redox mediators. Moreover, the reusability was evaluated in 
several degradation cycles and the toxicity of the solutions after treatment was assessed 
with the Microtox® test. In comparison to laccase immobilized on commercial silica, the Tv 
supported on laboratory synthetized materials showed higher activity and a better 
performance for the removal of target compounds. 
Keywords: Laccase, Enzyme immobilization, Redox mediators, Pharmaceutical 
micropollutants, Biodegradation. 
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Synthèse des travaux en français 
 
 
I. Contexte 
Une eau de bonne qualité est essentielle à la santé humaine et à l'équilibre 
écologique et à la santé des écosystèmes. Toutefois, ces dernières années, le 
développement des techniques analytiques a permis la détection de polluants présents à de 
très faibles concentrations dans les eaux. Ces micropolluants, de par leur accumulation due à 
leur persistance, présentent une nouvelle menace pour les ressources en eau. Ces composés 
sont en effet difficilement biodégradables et peuvent avoir des effets potentiellement 
négatifs sur la santé humaine et l'environnement. Parmi les grandes catégories de 
contaminants émergents, les composés d’origine pharmaceutiques sont parmi les plus 
souvent retrouvés dans les eaux en raison leur consommation toujours plus importante en 
raison de la croissance et du vieillissement de la population. Des quantités importantes de 
molécules pharmaceutiques non utilisées, ainsi que leurs sous-produits métabolisés, sont 
continuellement rejetés dans la nature via ou non les effluents des stations d'épuration des 
eaux usées (STEP). Les effluents des hôpitaux et des industries pharmaceutiques qui 
présentent des concentrations de l’ordre µg L-1 sont évidemment aussi des contributeurs 
importants à cette pollution. 
Ainsi, des résidus de différents types de composés pharmaceutiques (antibiotiques, 
analgésiques, anti-inflammatoires, antidépresseurs, etc.) ont été détectés dans les eaux 
usées, les eaux de surface et souterraines, adsorbés sur les sédiments et même dans l'eau 
potable dans le monde entier (Sui et al., 2015; Tran et al., 2018; Yang et al., 2017). Les 
concentrations retrouvées dans les plans d’eau varient de quelques ng à plusieurs µg L-1. 
Dans l'eau des rivières, on trouve couramment des concentrations de l’ordre de la dizaine à 
la centaine de ng L-1, ces valeurs étant généralement plus faibles que celles observées dans 
les effluents des stations d'épuration des eaux usées. En outre, les niveaux de contamination 
des eaux souterraines sont plus faibles que ceux observés dans les eaux de surface ; les 
concentrations rapportées sont inférieures à 10 ng L-1.  
A l'échelle mondiale, la présence de ces micropolluants pharmaceutiques dans 
l'environnement est préoccupante même si l'ampleur de leurs effets sur la santé des 
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organismes aquatiques et terrestres est encore largement inconnue. Bien que les niveaux de 
contamination trouvés soient relativement faibles, ces molécules sont biologiquement 
actives même à de très faibles concentrations et peuvent ainsi engendrer des effets 
chroniques suite à une exposition continue et prolongée. Ces effets chroniques 
comprennent entre autre la perturbation ou l'altération du système endocrinien, 
l'augmentation des cas de certains types de cancer, le développement d'une résistance aux 
antibiotiques.  Par ailleurs, l'exposition aux produits pharmaceutiques sur les communautés 
microbiennes naturelles a aussi des effets néfastes qui ont été récemment rapportés (Barra 
Caracciolo et al., 2015; Gogoi et al., 2018). 
La présence de ces molécules pharmaceutiques et de leurs métabolites dans les eaux 
indique que les traitements classiques des effluents réalisés dans les STEPs sont inefficaces 
sur ce type de pollution. En effet, ces composés pharmaceutiques de par leur structure 
complexe et généralement polycyclique sont difficilement biodégradables. Bien que certains 
d’entre eux puissent être transférés, principalement par adsorption sur les solides en 
suspension dans les effluents, la grande majorité reste néanmoins présente dans les 
effluents traités. Il est donc nécessaire de trouver des options de traitement efficaces 
permettant l'élimination efficace et complète de ces polluants.  
Au cours de la dernière décennie, de nombreuses études ont porté sur l'élimination 
de produits pharmaceutiques dans des eaux et des effluents contaminés via des procédés 
physico-chimiques, microbiologiques ou d'oxydation avancée. Même si ces études ont 
donné des résultats prometteurs, ces différents procédés se sont révélés efficaces 
uniquement pour l'élimination de certains groupes de composés pharmaceutiques. De plus, 
les coûts d'exploitation élevés, la variabilité des rendements obtenus et la formation dans 
certains cas de sous-produits toxiques constituent également un obstacle à l'application de 
ces nouvelles technologies (Luo et al., 2014). 
L'utilisation d'enzymes peut être une envisagée comme une alternative intéressante 
pour la résolution de ce problème. En général, les enzymes sont capables de catalyser des 
réactions spécifiques, le plus souvent dans des conditions opérationnelles modérées (pH, 
température, force ionique), ce qui permet de réduire la consommation d'énergie et de 
rendre le procédé plus écologique. Ces biocatalyseurs peuvent transformer efficacement et 
rapidement les polluants de l'environnement à des concentrations très diverses ; 
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contrairement aux microorganismes, leur action n’est pas gênée par la toxicité des 
molécules traitées. Différents types d'enzymes extraites de bactéries et de champignons ont 
été utilisées avec succès pour l’élimination de micropolluants toxiques (Demarche et al., 
2012). En particulier, les enzymes issues de cultures de champignons de pourriture blanche 
ou fibreuse (White rote fungi WRF) et impliquées dans le processus de dégradation de la 
lignine (lignine peroxydase (LiP), peroxydase de manganèse (MnP), peroxydase versatile (VP) 
et laccase) sont également capables d’éliminer une large gamme de xénobiotiques (Cabana 
et al., 2007; Cruz-Morató et al., 2014). 
Parmi la famille des oxydo-reductases, les laccases, grâce à la présence de quatre 
atomes de cuivre dans leur site actif, sont capables de catalyser l'oxydation de substrats en 
présence simplement d’oxygène dissous (Fig. 1) (Giardina et al., 2010). Ainsi, les laccases 
peuvent catalyser l'oxydation d'une large gamme de composés phénoliques et aromatiques, 
ceci dans une large gamme de températures et de pH. De plus, le fait que cette enzyme ne 
nécessite que de l'oxygène comme co-substrat représente un avantage supplémentaire pour 
l'application des laccases par rapport aux peroxydases qui utilisent le peroxyde d’hydrogène 
comme co-substrat. De nombreuses études ont mis en évidence le potentiel des laccases vis-
à-vis de la bioremédiation d'effluents contaminés par différents types de polluants 
organiques (Jin et al., 2016; Salazar-López et al., 2017; Suda et al., 2012; Tran et al., 2010) 
 
 
Fig. 1. Représentation schématique du centre active de cuivre dans la laccase (Adapté avec 
permission de Barrios-Estrada et al., 2018) 
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Cependant, l'efficacité du traitement dépend des propriétés physico-chimiques des 
micropolluants et de la souche fongique dont la laccase a été extraite. Par ailleurs, la plupart 
des polluants pharmaceutiques présents dans l’eau présentent des structures non 
phénoliques pour lesquels les laccases ne présentent qu’une affinité limitée. Néanmoins, 
l’utilisation de médiateurs redox qui agissent comme une "navette électronique" entre 
l'enzyme et le substrat permet d’étendre les capacités d’oxydation des laccases à une 
gamme plus large de substrats. Ainsi, il est possible d'oxyder des composés chimiques qui en 
principe ne sont pas des substrats naturels des laccases (Fig. 2) (Cañas and Camarero, 2010). 
 
 
Fig. 2. Schéma du système médiateur laccase. 
 
 
Généralement, les procédés de traitement enzymatique sont mis en œuvre dans des 
réacteurs discontinus en présence d’enzymes libres (sous forme de solutions brutes ou 
purifiées). Toutefois, ce mode de fonctionnement n’est pas adapté aux applications à plus 
grande échelle, comme dans une STEP, où le procédé doit fonctionner en mode continu. Afin 
que le biocatalyseur ne soit emporté avec les effluents traités et ne les contamine, il est 
indispensable de prévoir un moyen de le retenir au sein du réacteur. De plus, l'utilisation de 
laccases libres présente d’autres inconvénients : leur stabilité en solution est limitée, leur 
récupération et réutilisation est difficile voire impossible, ce qui entraîne des coûts 
d'exploitation élevés. Ces inconvénients peuvent être surmontés par l’emploi d’enzymes 
immobilisées. L'immobilisation des enzymes peut être réalisée sur une grande variété de 
supports solides à base de matériaux d'origine inorganique, organique et hybride ou 
composite. Le choix du bon support d’immobilisation est important car ses caractéristiques 
physico-chimiques influencent fortement les propriétés finales de l'enzyme immobilisée. 
Ainsi, plusieurs aspects tels que la présence de nombreux groupes fonctionnels et une bonne 
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résistance chimique et mécanique doivent être pris en compte (Zdarta et al., 2018). D’après 
la littérature, les supports inorganiques, tels que la silice et les argiles, représentent une 
excellente option pour l'immobilisation des enzymes en raison de leur grande 
biocompatibilité, leur grande surface spécifique, la présence de nombreux groupes 
fonctionnels différents, leur stabilité exceptionnelle, leur faible coût et leur réutilisation 
potentielle (Zucca and Sanjust, 2014). 
Le choix de la méthode d'immobilisation est également extrêmement important ; il 
dépend des caractéristiques du support choisi, des propriétés de l'enzyme à immobiliser et 
du procédé auquel le biocatalyseur immobilisé sera appliqué. Parmi les différentes 
méthodes d'immobilisation disponibles, la liaison covalente semble être la technique la plus 
appropriée pour les applications dans le domaine de l'eau et des eaux usées puisque cette 
approche implique l'attachement multipoint d'enzymes au support, ce qui améliore 
considérablement la stabilité et la réutilisabilité des enzymes et réduit leur lixiviation (Gasser 
et al., 2014). Des laccases immobilisées par covalence sur différents supports solides ont été 
appliquées pour l'élimination de polluants pharmaceutiques dans l'eau avec des résultats 
encourageants (Barrios-Estrada et al., 2018b; De Cazes et al., 2014; Ji et al., 2016; Kumar and 
Cabana, 2016). Néanmoins, la recherche de nouveaux matériaux et de protocoles 
d'immobilisation pour le développement de nouveaux biocatalyseurs répondant aux besoins 
des applications industrielles et environnementales reste d'une importance capitale. 
 
 
II. Objectifs de recherche 
Les principaux objectifs de cette thèse sont d’une part l’étude des potentialités de 
différentes laccases (2 laccases commerciales et 1 mélange de laccases de Pycnoporus 
sanguineus CS43 préparé à la School of Engineering and Sciences of the Tecnológico de 
Monterrey au Mexique) vis-à-vis de l'élimination de différents micropolluants 
pharmaceutiques, à savoir trois antibiotiques (amoxicilline, ciprofloxacine et 
sulfaméthoxazole) et un anti-épileptique (carbamazépine) en présence ou non de 
médiateurs redox et d’autre part le développement d’une méthode immobilisation adaptée 
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à de nouveaux supports, à savoir des nanoparticules à base de silice et d’argile développés 
dans le cadre de l’ANR POLPHARMA. 
Les principales étapes de l’étude seront : 
 L’étude de la réactivité des différentes enzymes (sous forme libre) vis-à-vis de 
différents substrats en réacteur batch 
 La mise au point de la méthode d’immobilisation sur des particules de silice 
commerciales 
 Le greffage de l’enzyme la plus réactive sur les nouveaux matériaux et l’étude des 
potentialités du support actif vis-à-vis de l’élimination des micropolluants. 
 
 
III. Présentation du manuscrit 
Les résultats expérimentaux des travaux réalisés sont rassemblés dans le présent manuscrit 
qui se compose de six chapitres. 
 Le chapitre 1 présente brièvement le contexte et les objectifs de recherche de 
l’étude.  
 
 Le chapitre 2 présente l'état de l'art sur la problématique des micropolluants 
présents dans les effluents et l’environnement, leur toxicité et la difficulté de leur 
élimination. Différentes technologies de traitement conventionnelles et émergentes 
sont décrites avant de focaliser sur les potentialités du traitement par voie 
enzymatique. L'objectif est de donner un aperçu des connaissances actuelles 
relatives à l’élimination de micropolluants par les laccases (libre et immobilisées). 
 
 Le chapitre 3 est la transcription d'un article de recherche publié dans la revue 
« Process Biochemistry ». Cette partie regroupe les résultats des essais de 
dégradation par les différentes laccases sous forme libre en présence ou non de 
médiateurs redox, l’objectif de ces expériences étant de voir si et comment les 
enzymes dégradent les différents substrats afin de mieux comprendre les 
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mécanismes impliqués dans la biotransformation des composés pharmaceutiques. 
Ainsi, les performances des trois enzymes sélectionnées ont été comparées, les effets 
des conditions opératoires (pH et température) et des médiateurs redox (type) sur 
l'efficacité d'élimination des micropolluants ciblés ont été étudiés.  
 
 Le chapitre 4 présente la méthode d’immobilisation développée pour permettre un 
greffage optimum des laccases sur des particules de taille nanométrique. Cette 
méthode implique l’activation du support (particules de silice commerciale) par du 
glutaraldéhyde en phase vapeur. L’identification des paramètres influençant le 
rendement d’immobilisation et l’efficacité du biocatalyseur après immobilisation a 
été réalisée grâce à un plan d'expériences. Les performances catalytiques de 
l’enzyme immobilisée ont été comparées à celle de l’enzyme libre avec le substrat 
modèle (ABTS) et avec le mélange de micropolluants ciblés en présence de 
médiateurs redox. La réutilisation de l'enzyme immobilisée a été évaluée au cours de 
plusieurs cycles consécutifs de dégradation.  
 
 Le chapitre 5 présente d’une part l'immobilisation de la laccase commerciale issue de 
Trametes versicolor sur les différents nanomatériaux (nanoparticules de silice, 
microparticules d'argile et nanocomposites de silice et d'argile) développés dans le 
cadre du projet ANR POLPHARMA et d’autre part leur utilisation de ces supports 
activés pour l'élimination des composés pharmaceutiques. L'étude compare dans un 
premier temps, les potentialités de ces différents supports vis-à-vis de 
l’immobilisation d’enzyme en termes de rendement d'immobilisation des protéines 
et d’activité spécifique du solide activé. Puis ces supports actifs ont été utilisés pour 
le traitement de solutions modèles de micropolluants en présence d’un médiateur 
redox et les résultats obtenus sont discutés en reliant l’efficacité d’épuration et les 
propriétés du support d’immobilisation. 
 
 Enfin, le mémoire se termine par le chapitre 6 qui résume les conclusions générales 
de l'étude et présente les perspectives pour les travaux futurs. 
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IV. Résultats et Conclusions 
Pour répondre à l’objectif de notre étude à savoir : l’évaluation des potentialités des 
laccases pour la dépollution des eaux renfermant des micropolluants pharmaceutiques, deux 
approches différentes ont été suivies : le traitement enzymatique au moyen de systèmes de 
laccases libres et l'utilisation d'enzymes immobilisées sur différents supports solides. Pour 
les systèmes à laccase libre, le potentiel oxydant d'un extrait brut d'une souche native du 
champignon de pourriture blanche Pycnoporus sanguineus (PSL) a été comparé à ceux 
d’enzymes commerciales : la laccase de Myceliophthora thermophila (MTL) et la laccase de 
Trametes versicolor (TVL) commercialisées respectivement par les sociétés Novozymes et 
Sigma. 
Comme cela a été décrit au chapitre 3, le traitement enzymatique en présence 
d’enzymes libres seules s'est révélé inefficace pour la biotransformation des composés 
pharmaceutiques. Seule l'amoxicilline (AMX), un antibiotique, a été partiellement éliminée. 
Mais les résultats obtenus montrent que l’importance de l’élimination dépend de la laccase 
utilisée et des conditions de réaction étudiées. En particulier, des conditions légèrement 
acides (pH 5-6) permettent d’améliorer la dégradation. Les contre-performances observées 
ont été attribuées aux propriétés physico-chimiques des produits pharmaceutiques testés, 
les rendant ainsi résistants à l'attaque des laccases. En effet les structures chimiques de ces 
micropolluants sont assez différentes de celles des substrats habituels des laccases. Afin 
d'essayer d'élargir le spectre d’action des laccases étudiées, des médiateurs redox ont été 
ajoutés au milieu réactionnel. Les résultats obtenus ont mis en évidence l’effet positif de 
l'addition d’un des 3 médiateurs testés à savoir : les médiateurs naturels syringaldéhyde 
(SYR) et acide p-coumarique (PCA) et du médiateur synthétique 2,2’-azino-bis-(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS). Cependant, il a été observé que 
l’amélioration des performances dépend du système laccase-médiateur utilisé. Des 
pourcentages de dégradation intéressants ont été observés en présence d’ABTS et de SYR. 
Mais les meilleurs rendements de dégradation des molécules non phénoliques ont été 
obtenus en présence de SYR ; ces bonnes performances sont à mettre en relation avec la 
formation de radicaux très réactifs et stables lors de l’oxydation du SYR par les laccases. Par 
ailleurs, il faut noter que les laccases commerciales ont montré de meilleures performances 
que l'extrait brut de P. sanguineus. Dans l'ensemble, le pouvoir oxydant des laccases a été 
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augmenté suite à l'ajout de médiateurs, mais aucun des médiateurs testés n’a rendu 
possible la dégradation de la carbamazépine (CBZ). Quoi qu'il en soit, le potentiel de 
dégradation des systèmes de laccases libres-médiateurs pour le traitement de certains 
produits pharmaceutiques récalcitrants a été démontré. 
Dans un second temps, une méthode d’immobilisation des laccases sur des supports 
solides de taille micrométrique (microparticules commerciales de gel de silice 
fonctionnalisées) a été développée et les résultats obtenus ont été présentés dans le 
chapitre quatre. Compte tenu de la taille du solide (100 µm), l’activation des billes de silice 
par le glutaraldéhyde (GLU) a été réalisée en phase vapeur de façon à limiter les risques 
d’agrégation. A notre connaissance, c’est la première fois que cette technique d'activation 
est utilisée pour l'immobilisation de laccase en vue de procédés de remédiation. Un plan 
expérimental complet (23) a été utilisé pour étudier l'effet des différents paramètres 
opératoires (temps d’activation, concentration en enzymes, temps de contact, pH) sur 
l’efficacité de l’immobilisation. Selon le modèle obtenu, les conditions permettant d’obtenir 
les billes les plus intéressantes en termes d’activité (14±2 U g-1 de billes) et de rendement 
d'immobilisation des protéines (35%) sont : une durée d’activation de 18 h et un temps de 
contact de 2 h en présence d’une solution enzymatique renfermant 107 U à pH 7. 
Il a ensuite été démontré que l’immobilisation covalente de la laccase sur les billes de 
silice permet d'améliorer sa stabilité sur une gamme de valeurs de pH (pH de 4 à 7) et de 
températures (de 25 à 55 °C) mais surtout d'améliorer sa stabilité lors du stockage à long 
terme par rapport à la forme libre. Néanmoins, après immobilisation, les laccases ne sont 
toujours pas capables d’oxyder des produits pharmaceutiques ciblés. Cependant, tout 
comme lors des essais avec l'enzyme libre, l'ajout de médiateurs redox a rendu possible la 
biotransformation des produits pharmaceutiques. Après 3h de réaction, les pourcentages 
d'élimination sont compris entre 40-100% selon le substrat et le médiateur considéré. De 
plus, il a été observé que la disparition des produits pharmaceutiques analysés résultait de 
l'action combinée de mécanismes de dégradation enzymatique et d’adsorption sur le 
support, l’importance de l'un ou l'autre de ces mécanismes étant fonction du composé 
pharmaceutique considéré. En particulier, on a mis en évidence que l’élimination de l'AMX 
et du SMX est principalement due à la biodégradation, même s’il est possible que 
l'adsorption de ces composés ait pu jouer un rôle important dans le processus oxydatif en 
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améliorant le transfert d'électrons entre la laccase et le substrat. Dans le cas de la 
ciprofloxacine (CIP) et de la CBZ, la disparition de ces composés du milieu réactionnel résulte 
uniquement de phénomènes d’adsorption. Cela a été attribué à leur affinité pour être 
adsorbé sur les solides. Dans l'ensemble, les médiateurs redox générant des radicaux 
phénoxylés (SYR et PCA) semblent plus efficaces pour la biotransformation des produits 
pharmaceutiques, le SYR étant le plus efficace. Néanmoins, les résultats de tests Microtox®, 
ont montré que l'utilisation du SYR entraine une augmentation de la toxicité de l'effluent 
après traitement contrairement à l’ajout d’ABTS, ce dernier médiateur étant en outre le 
moins toxique des 3 médiateurs testés. Enfin, il a été montré qu’après immobilisation, le 
biocatalyseur pouvait être réutilisé efficacement pendant sept cycles consécutifs en 
présence de SYR. Compte tenu de l’intérêt de ce médiateur, des recherches devront être 
faites pour trouver une solution à l’augmentation de la toxicité engendrée lors de son 
utilisation.  
Le cinquième chapitre de cette thèse a été consacré à l'étude de l'immobilisation de 
la laccase sur différents supports inorganiques. Des nano-composites de silice (SiNPs), 
d'argiles (argile Y et SWy-3) et de silice/argile (95/5 et 50/50) présentant des caractéristiques 
différentes en termes de composition chimique, de taille et de surface spécifique ont été 
utilisés pour réaliser l'immobilisation covalente de la laccase de T. versicolor selon la 
méthode développée au chapitre 4. Les résultats obtenus ont montré que les cinq supports 
présentaient des capacités d'immobilisation différentes. La surface spécifique, le type et la 
composition du matériau semblent donc avoir une influence sur l’immobilisation. Il a été 
observé que les matériaux à base de silice permettent de greffer de plus grandes quantités 
de protéines sous forme actives. Ceci est particulièrement évident lorsque l’on compare les 
performances des nano-composites. Le biocatalyseur est d’autant plus actif que la 
concentration en silice est plus élevée dans le composite. Ainsi, le nanocomposite 50/50 est 
le meilleur support en termes d'activité spécifique élevée (185 U mg-1) et de rendement 
d'immobilisation des protéines (30%), respectivement. Les particules à base de silice seule 
sont également intéressantes puisqu’elle présente également une activité spécifique élevée 
(110 U mg-1).  
Ces 2 supports ont donc été retenus et les performances des 2 biocatalyseurs 
obtenus ont été comparées lors d’essais de dégradation du mélange des micropolluants 
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pharmaceutiques en présence de SYR. Quel que soit le biocatalyseur testé, des rendements 
de dégradation élevés (50-100%) ont été atteints pour les quatre produits pharmaceutiques 
étudiés ; ceci en raison de l'action synergique de l'oxydation catalysée par laccase et de la 
remarquable capacité de sorption des supports. Il est intéressant de noter que même 
lorsque les deux biocatalyseurs ont montré des efficacités de dépollution similaires, les 
mécanismes impliqués dans l’élimination des micropolluants du milieu réactionnel sont 
différents. En raison de la capacité de sorption modérée du support des particules de SiNPs, 
l’élimination des micropolluants est vraisemblablement à attribuer à la laccase mais il est 
possible que l’adsorption des substrats sur la silice ait contribué à accélérer et à intensifier la 
dégradation catalysée par laccase immobilisée. Par contre, alors que le nanocomposite 
50/50 présente une capacité de sorption remarquable, cela ne permet pas d’améliorer la 
biotransformation des micropolluants. En d'autres termes, la seule adsorption des produits 
pharmaceutiques ne permet pas d’améliorer la dégradation de composés récalcitrants. A 
notre connaissance, c'est la première fois que des matériaux composites silice/argile sont 
utilisés comme supports d’immobilisation des laccases pour le traitement des polluants 
pharmaceutiques et les résultats semblent encourageants. Les résultats présentés ici 
soulignent le rôle important des propriétés des matériaux supports dans le processus 
d'immobilisation ainsi que dans la performance du biocatalyseur. En ce sens, nous avons 
démontré l'avantage d'utiliser des matériaux polyvalents permettant à la fois le greffage de 
l’enzyme et l’adsorption des composés à éliminer. Leur mise en œuvre au sein des procédés 
de dépollution permet ainsi, de réaliser en une seule étape, l’élimination d’un mélange de 
composés dont certains sont non biodégradables mais ont la possibilité de s’adsorber et 
d’autres qui au contraire ne sont pas capables de s’adsorber mais qui peuvent être 
biodégradés. 
Les travaux réalisés ici démontrent le potentiel d'utilisation des laccases pour le 
traitement enzymatique des micropolluants pharmaceutiques dans l'eau, mais il est 
important de considérer certains aspects pour le développement futur de cette recherche. 
La performance des laccases dans cette thèse a été étudiée principalement à l'aide d'eaux 
usées synthétiques. Il est important d'évaluer la performance des systèmes libres et des 
systèmes immobilisés dans des conditions réelles d'eaux usées. En ce sens, les essais avec 
des systèmes enzymes-médiateurs dans les eaux usées réelles à très faibles concentrations 
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de micropolluants, comme on les rencontre habituellement dans ces eaux, devraient être 
fondamentaux pour évaluer l’impact des conditions réelles sur l’efficacité du traitement. Un 
autre aspect important à considérer est l'extension du traitement, puisque toutes les 
expériences réalisées dans le cadre de ce travail sont à l'échelle du laboratoire. En ce sens, la 
conception d'un réacteur (p. ex. bioréacteur enzymatique à membrane, lit garni) serait la 
meilleure option puisqu'elle permettrait également d'évaluer l'efficacité du traitement en 
fonctionnement continu.  
L'immobilisation de la laccase a permis d'augmenter la stabilité et la réutilisabilité de 
l'enzyme qui est cruciale pour les applications à grande échelle. Par conséquent, la méthode 
d'immobilisation proposée devrait être optimisée afin de maximiser les rendements 
d'immobilisation et la charge d'activité sur les porteurs pour rendre le processus plus 
rentable. De plus, d'autres essais devraient être effectués avec des SiNP et des 
nanocomposites 50/50 pour caractériser complètement ces biocatalyseurs et évaluer leur 
éventuelle réutilisation. 
Dans cette étude, il a été démontré que l'ajout de médiateurs a amélioré la 
dégradation et a élargi le spectre des composés dégradés par la laccase. Cependant, l'ajout 
continu de ces composés à la réaction entraîne une augmentation des coûts et de la toxicité 
de l'effluent traité. Il est recommandé d'étudier l'effet du type du médiateur et de sa 
concentration sur les rendements de dégradation et la toxicité afin de mettre au point un 
processus de traitement vraiment efficace et efficient. De plus, à la fin de la thèse, une 
nouvelle approche pour la réutilisation du SYR a été étudiée en immobilisant le médiateur 
sur des supports solides. Comme les résultats préliminaires semblaient prometteurs, nous 
croyons qu'il vaut la peine d'étudier en profondeur cette technologie. 
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1. Introduction 
 
 
1.1 Background 
Good quality water is essential to sustain human well-being and ecological balance of 
ecosystems. However, in the recent years the detection of new and emerging pollutants, 
presenting persistent and accumulative characteristics has highlighted a new threat to water 
resources due to their potentially negative impacts to human health and the environment. 
Among the large categories of emerging contaminants, pharmaceutical compounds are 
among the most commonly present in waters due to their universal use as a consequence of 
an aging and growing population, and their non-biodegradable and pseudo persistence 
nature. Significant amounts of un-metabolized and un-used pharmaceuticals as well as their 
by-products are continuously discharged into water bodies, together with untreated 
wastewater and effluents from wastewater treatment plants (WWTPs). Thus, residues of 
different types of pharmaceutical compounds (e.g. antibiotics, analgesics, anti-
inflammatories, antidepressants, etc.) have been detected in sewage, surface and 
groundwater compartments, adsorbed on sediments and even in drinking water all over the 
world (Sui et al., 2015; Tran et al., 2018; Yang et al., 2017). 
The occurrence of pharmaceutical compounds in the environment is of global 
concern and the extent of their impacts on the health of aquatic and terrestrial organisms is 
widely unknown. Pharmaceutical pollutants have been found in water bodies at 
concentrations from ng to several µg L-1, hospital and drug manufacturing effluents are 
obviously the major contributors with concentrations in the higher µg L-1 range. In river 
water are commonly found in the range of tens to hundreds of ng L-1, which are usually 
lower than WWTP effluent. In comparison to surface water, lower contamination levels in 
ground water were reported with less than tens ng L-1. These concentration levels are 
relatively low but some of these molecules are biologically active even at very low 
concentrations and can produce chronic effects as the consequence of a continuous and 
prolonged exposure. Such chronic effects include disruption or alteration of the endocrine 
system. Moreover, increased incidents of some types of cancer, development of antibiotic 
resistance and detrimental effects on natural microbial communities have been also 
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documented as potential effects of pharmaceuticals exposure (Barra Caracciolo et al., 2015; 
Gogoi et al., 2018). 
The constant detection of pharmaceutical products and their metabolites in water 
bodies indicates that conventional WWTPs are ineffective for the removal of these types of 
substances. Indeed, the degradation of pharmaceutical compounds implies an important 
challenge due to their low bioavailability and complex structure. Although some 
pharmaceutical compounds can be removed from water during conventional wastewaters 
treatment, mainly by adsorption on suspended solids and/or biodegradation, still a large 
proportion remains in treated effluents. It is therefore necessary to find effective treatment 
options allowing the efficient and complete removal of these pollutants. Over the last 
decade, many studies have investigated the removal of pharmaceuticals from water and 
wastewater using physicochemical, microbiological or advanced oxidation processes. Even if 
these studies led to promising results, the treatment processes evaluated showed to be 
effective only for the removal of certain groups of pharmaceutical compounds. In addition, 
the high cost of operation, the variable efficiencies obtained and the possible formation of 
hazardous by-products also poses as an obstacle for the successful application of these 
technologies (Luo et al., 2014). 
A potential alternative to the application of conventional treatment processes is the 
use of enzymes. Generally, enzymes are able to catalyze specific reactions, mostly under 
moderate operational conditions (i.e. pH, temperature, ionic strength) which results in lower 
energy consumption and a more environmentally friendly process. These biocatalysts can 
effectively transform environmental pollutants over a wide range of concentrations at a 
rapid rate without the risk of being withdrawn by the effect of these compounds as 
observed in conventional wastewater treatment plants or bioreactors based on activated 
sludge processes. Different types of enzymes extracted from organisms such as bacteria and 
fungi have been described to potentially oxidize hazardous pollutants (Demarche et al., 
2012). In this sense, the use of white rot fungi cultures (WRF) and their lignin modifying 
enzymes (lignin peroxidase (LiP), manganese peroxidase (MnP), versatile peroxidase (VP) 
and laccase) have attracted a lot of attention in recent years for their ability to remove a 
wide range of xenobiotics (Cabana et al., 2007; Cruz-Morató et al., 2014). 
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Particularly interesting, laccases are oxidative enzymes containing four cupper atoms 
in the active site which enable them to catalyze single electron oxidation of substrates with 
the concomitant reduction of molecular oxygen to water (Giardina et al., 2010). In this way, 
laccases can catalyze the oxidization of a broad range of phenolic and aromatic compounds. 
The use of laccases is attractive since they can carry out the oxidation of substrates over a 
wide range of temperatures and pH values. Moreover, the fact that this enzyme only 
requieres oxygen as co-substrate represent an additional advantage for the application of 
laccases in comparison to peroxidases. Thus, numerous studies have indicated that laccases 
present a great potential in the bioremediation of contaminated effluents with different 
types of organic pollutants (Jin et al., 2016; Salazar-López et al., 2017; Suda et al., 2012; Tran 
et al., 2010). However, the removal efficiency of these pollutants depends on their 
physicochemical properties and the fungal strain from which the laccase has been extracted. 
Most of the pharmaceutical pollutants found in water bodies present non-phenolic 
structures which are not always suitable for laccase oxidation. The substrate range of 
laccases can be extended by redox mediators that act as an “electron shuttle” between the 
enzyme and substrate. In this way, it is possible to oxidize chemical compounds that in 
principle are not laccase substrates (Cañas and Camarero, 2010). 
Generally, enzymatic treatment processes are implemented in batch reactors with 
free enzymes (either in crude or purified form). However, larger scale applications such as in 
a WWTP need to be operated in continuous mode. Thus, the retention of the enzyme in the 
reactor is necessary in order to avoid the laccase being washout with the treated effluent. 
Furthermore, the use of free laccases present some drawbacks related to their limited 
stability in solution, difficult recovery and reusability which results in high operational costs. 
These disadvantages can be overcome by the immobilization of enzymes on different 
supports. To date, immobilization of enzymes has been carried out on a broad variety of 
support materials from inorganic, organic and hybrid/composite origin. The proper selection 
of a support material is of important matter since its physicochemical characteristics strongly 
influence the final properties of the immobilized enzyme. Thus, several aspects such as the 
presence of numerous functional groups and good chemical and mechanical resistance need 
to be considered (Zdarta et al., 2018). In this sense, inorganic support materials, such as 
silica and clays, represent an excellent option for enzyme immobilization due to their great 
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biocompatibility, large specific surface area, presence of many different functional groups, 
exceptional stability, low cost and reusability (Zucca and Sanjust, 2014).  
The selection of the immobilization method is also extremely important and depends 
on the characteristics of the support chosen, the properties of the enzyme to immobilize and 
the process to which the immobilized biocatalyst will be applied. Among the different 
immobilization methodologies available, covalent binding seems to be the most suitable 
technique for water and wastewater applications since this approach involves the multipoint 
attachment of enzymes to the support which significantly enhance enzyme stability, 
reusability and reduce enzyme leaching (Gasser et al., 2014). Laccases covalently 
immobilized on different solid carriers have been applied for the removal of pharmaceutical 
pollutants in water with encouraging results (Barrios-Estrada et al., 2018b; De Cazes et al., 
2014; Ji et al., 2016; Kumar and Cabana, 2016). Therefore, a continuous searching of new 
materials and immobilization protocols for the development of new biocatalysts meeting the 
needs of industrial and environmental applications is of important matter. 
 
1.2 Research objectives 
The main objectives of this thesis are, on one hand, the study of the potentialities of 
different laccases (two commercial laccases and a laccase cocktail from Pycnoporus 
sanguineus CS43 prepared at the School of Engineering and Sciences of Tecnologico de 
Monterrey, Mexico) for the elimination of pharmaceutical micropollutants in the presence 
or absence of redox mediators; and on the other hand, the development of an 
immobilization method adapted to new supports, namely nanoparticles based on silica and 
clay materials developed within the framework of the ANR Polpharma project. The study will 
be focused on the conversion of antibiotics (amoxicillin, ciprofloxacin and sulfamethoxazole) 
and anti-epileptic (carbamazepine) compounds as laccase substrates.  
 
The specific objectives that will be accomplished are: 
 The study of the reactivity of different enzymes (in free form) towards different 
substrates in a batch reactor. 
 The development of the immobilization method on commercial silica particles. 
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 The immobilization of the most active enzyme on the new materials and the study of 
the potentiality of the active supports for the elimination of the pharmaceuticals. 
 
 
1.3 Thesis outline 
This thesis describes the potentiality of three different laccases, in free and 
immobilized form, for the degradation of recalcitrant pharmaceutical micropollutants. The 
manuscript consists of six chapters. Chapter 1 introduces the background and research 
objectives of this study.  
Chapter 2 presents the state of the art regarding the occurrence, fate and elimination 
of pharmaceutical micropollutants in water. Different conventional treatment technologies 
are described before focusing in enzymatic treatment of these compounds. The objective is 
to provide an overview of the current knowledge regarding the application of laccases in 
both free and immobilized forms. 
Chapter 3 is composed of a published research article in the Process Biochemistry 
Journal. This section presents the use of free laccases as well as laccase-mediator systems in 
batch test conditions. The aim of this work is to investigate if, and how enzymes carry out 
the degradation process of the different substrates in order to establish the groundwork for 
the laccase catalyzed transformation of pharmaceutical compounds. Thus, three different 
enzymes have been evaluated as well as the effects of operational conditions (pH and 
temperature) and redox mediators (type) on the removal efficiency of target 
micropollutants.  
Chapter 4 presents the immobilization of laccases onto silica gel carriers and the use 
of the biocatalyst for the degradation of a mixture of pharmaceuticals. A novel protocol for 
the covalent immobilization of laccases involving the activation of the amino-functionalized 
support with glutaraldehyde in vapor phase is proposed. In this sense, a statistical 
experimental design was generated in order to study the parameters affecting the 
immobilization process. The novel biocatalyst has been completely characterized to properly 
compare its performance with the free counterpart and applied for the degradation of the 
target pharmaceuticals in multi-compound solutions in presence of redox mediators. The 
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reusability of the immobilized enzyme has been evaluated during several consecutive 
degradation cycles. Additionally, the effectiveness of the enzymatic treatment is also 
assessed by studying the toxicity of the biotransformation products generated from the 
enzymatic reactions by Microtox® assays. 
Chapter 5 introduces the use of different novel inorganic support nanomaterials for 
the immobilization of the commercial Trametes versicolor laccase and its use for the removal 
of the target pharmaceutical compounds in batch reactions. This work has been done in the 
framework of the ANR project POLPHARMA involving the collaboration with different French 
research laboratories (LCMP-UPMC, BRGM, CEREGE and CIRSEE from SUEZ) which kindly 
provided the different supports materials to be tested. The study compares the capability of 
silica nanoparticles, clay microparticles and silica/clay nanocomposites to covalently 
immobilize laccase based in the protein immobilization yield and the specific activity of each 
bio-catalytic formulation. The best biocatalysts have been investigated for the simultaneous 
removal of the target pharmaceuticals with the aid of syringaldehyde as redox mediator. The 
results obtained are discussed by comparing the different properties of the support 
materials in order to explain the removal efficiencies observed by each immobilized enzyme.  
Finally, the dissertation ends with chapter 6 which summarizes the overall conclusion 
of the investigation and the perspectives for future works. 
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2. Literature review 
 
 
2.1. Pharmaceutical compounds as emerging contaminants 
In recent decades, studies on the quality assessment of water resources have 
attracted attention towards a critical problem of contamination due to the occurrence of a 
variety of newly identified compounds presenting persistent, bioactive and bio-accumulative 
characteristics (Gogoi et al., 2018; Rodriguez-Delgado and Ornelas-Soto, 2017). This group of 
substances known as emerging contaminants (ECs) are defined as any synthetic or naturally-
occurring chemical or any microorganism that is not routinely monitored or regulated in the 
environment and has known or suspected potential adverse ecological and human health 
effects (UNESCO, 2014). Therefore, management of pollution due to ECs presents a new 
global water quality challenge. 
Among ECs, pharmaceuticals are probably one of the most relevant compounds due 
to their universal use, their physicochemical properties and their capacity to be incompletely 
removed by conventional wastewater treatment processes (Zenker et al., 2014). They have 
been detected in several environmental compartments such as surface water, ground water, 
urban wastewater and even in drinking water (Kanakaraju et al., 2018). Pharmaceuticals 
represent more than 4000 different molecules with a total consumption of several thousand 
tons per year for the treatment of human and animal diseases as well as in livestock an 
aquaculture (de Cazes et al., 2014). 
Pharmaceuticals enter the environment through various stages of the product 
lifecycle from their production and consumption to disposal (Fig. 2.1). In the aquatic 
environment these compounds are continually introduced via various pathways, such as 
direct discharges of untreated and treated wastewaters from industries, hospitals, animal 
husbandry, households and wastewater treatment plants (WWTPs) (Wang and Wang, 2016; 
Y. Yang et al., 2017). After administration, human pharmaceuticals are excreted as parent 
forms or as active metabolites and enters the sewage system to reach WWTPs (Klatte et al., 
2017). Unfortunately, conventional wastewater treatment processes do not allow the 
effective elimination of pharmaceuticals from treated water (Bu et al., 2013; Halling-
Sorensen et al., 1998). In addition, during treatment pharmaceuticals can be adsorbed on 
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sewage sludge. Thus, they can reach soils if the sludge is used as fertilizer or if treated water 
is used for land irrigation (Ebele et al., 2017; Klatte et al., 2017). Similarly, veterinary drugs 
can be released when animal wastes both solid and liquid are spread on agricultural fields as 
fertilizers (Ebele et al., 2017). Moreover, pharmaceuticals present in soils can leach from soil 
into surface and ground waters (Gavrilescu et al., 2015; Heberer, 2002) and/or enter the 
food chain by crops uptake (Klatte et al., 2017; Rivera-Utrilla et al., 2013). 
 
 
Fig. 2.1. Potential sources and pathways of pharmaceuticals pollution in the environment. 
 
 
Although pharmaceuticals have been entering the environment for many years, 
investigation on their occurrence is recent. Since the first detection in the aquatic 
environment in 1978, the rapid development of high sensitive analytical instruments has 
allowed to identify more than 275 different pharmaceutical compounds previously 
undetectable as they usually are present in sewage, surface and groundwater at levels of µg 
L-1 (Zenker et al., 2014). Antibiotics, steroids, antidepressants, beta-blockers, analgesics, anti-
inflammatories, lipid-lowering drugs, tranquilizers and stimulants have been detected in 
surface and ground water bodies in different countries around the world including Germany 
(Ternes, 1998), Greece (Kosma et al., 2014), Italy (Castiglioni et al., 2004), Spain (Ortiz de 
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Garcia et al., 2013), South Africa (Archer et al., 2017), United States (Kolpin et al., 2002), 
China (Bu et al., 2013) Canada and Brazil (Ternes et al., 1999). 
The occurrence of pharmaceutical compounds in the environment - due to their non-
biodegradable and pseudo persistence nature - is of global concern and the extent of their 
impacts on aquatic and terrestrial organisms is widely unknown. Short term studies suggest 
that acute toxic effects of pharmaceutical pollutants are insignificant, but their continuous 
release and exposure may produce chronic effects (Barra Caracciolo et al., 2015). Potential 
concerns from prolonged exposure include disruption or alteration of the endocrine system 
by mimicking, blocking or hampering hormonal functions. Increased incidents of some types 
of cancer, development of antibiotic resistance and detrimental effects on natural microbial 
communities have been also documented as potential effects of pharmaceuticals exposure 
(Barra Caracciolo et al., 2015; Gogoi et al., 2018). 
As a result of the insufficient knowledge in terms of toxicity, impacts and behaviours 
of pharmaceuticals, only few are regularly monitored in the environment and many remain 
unregulated. At present, different organizations have established directives and legal 
frameworks to protect and improve the quality of water resources. The United States 
Environmental Protection Agency (USEPA) has included three pharmaceuticals 
(erythromycin, 17α-ethinylestradiol (EE2) and nitroglycerin) in their recent contaminant 
candidate list (CCL-3) together with eight synthetic hormones (Kanakaraju et al., 2018). The 
European Union released a set of directives including the directive 2000/60/EC which 
established a strategy to define high risk substances to be prioritized. Then, a set of 33 
priority substances and their respective environmental quality standards were ratified by the 
directive 2008/105/EC. In 2013, the directive 2013/39/EU recommended attention for the 
monitoring and treatment options for a group of 45 priority substances including two 
pharmaceuticals (diclofenac and EE2) and a natural hormone estradiol (E2). Finally, in 2015 
the watch list of substances for European Union wide monitoring was amended to include 
three macrolide antibiotics and the natural hormone estrone (E1) (Barbosa et al., 2016). 
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2.1.1. Antibiotics 
Antibiotics are organic molecules that inhibit the growth of bacteria, most of them 
have microbial origin but they are also semi or totally synthetic (Michael et al., 2013). 
Currently, about 250 different antibiotics are available for use in veterinary and human 
medicine which are classified in different classes according to their chemical structure or 
mechanism of action (Table 2.1) (Barra Caracciolo et al., 2015; Kümmerer, 2009).The impact 
of antibiotics in the environment is highly dependent on their consumption habits and their 
strong intrinsic persistence. For example, antibiotics such as β-lactams are the most used for 
human therapy (Li, 2014), but sulfonamides, fluoroquinolones, macrolides and trimethoprim 
are the most frequently detected in both influent and effluent samples worldwide (Tran et 
al., 2018). Therefore, a representative antibiotic belonging to the β-lactam (amoxicillin), 
sulfonamide (sulfamethoxazole) and fluoroquinolone (ciprofloxacin) groups were chosen as 
model substrates to be eliminated in the present research. The structures of these selected 
antibiotic compounds are presented in Table 2.1. 
Amoxicillin (AMX), is a penicillin-type antibiotic which is distinguished by the presence 
of an extra amino group on its side chain. These antibiotics are of the most important groups 
in medicinal and veterinary therapy with a consumption reaching 50-70% of the total 
amount of antibiotic applied in human medicine. AMX and its presence in the environment, 
have been widely investigated despite its extensive hydrolysis which leads to instability and 
its rapid degradation to various degradation products (Gozlan et al., 2013). 
Sulfamethoxazole (SMX) is an antibiotic which belongs to the family of sulfonamides; 
these compounds limit bacterial growth by preventing the synthesis of folic acid which is 
essential for the synthesis of bacterial DNA (Barra Caracciolo et al., 2015). SMX is considered 
as an emerging contaminant of concern due to its potential adverse effects on ecosystems 
and human health (Avisar et al., 2009). 
Ciprofloxacin (CIP) belongs to a class of synthetic antibiotic agents with a broad range 
of activity against gram-negative and gram-positive organisms. CIP can inhibit essential 
enzymes involved for DNA production and it is used for the treatment of severe infections 
(Le-Minh et al., 2010). 
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Table 2.1. Classes, consumption and main uses of antibiotics (Adapted from Grenni et al., 2018; with permission). 
Class Antimicrobial effect Main use 
Consumption EU 
(tons year-1) 
Example Chemical structure 
β-lactams 
Synthesis inhibition of 
cell wall 
Human, 
veterinary 
1779.8-2110.9 Amoxicillin 
 
Tetracyclines 
Inhibition of protein 
synthesis 
Human, 
veterinary 
5.9-2942.6 Tetracycline 
 
Fluoroquinolones 
Synthesis inhibition of 
nucleic acids 
Human 186.1-231.5 Ciprofloxacin 
 
Aminoglycosides 
Inhibition of protein 
synthesis 
Human, 
veterinary, 
plants 
4.7-290.8 Gentamicinc 
 
Macrolides 
Inhibition of protein 
synthesis 
Human, 
veterinary, food 
additive 
252.3-638 Erythromycin A 
 
Glycopeptides 
Synthesis inhibition of 
cell wall 
Human, 
veterinary 
n.r. Vancomycin 
 
Sulfonamides 
Synthesis inhibition of 
nucleic acids 
Human, 
veterinary 
121.5-826.3 Sulfamethoxazole 
 
Nitroimidazoles 
Inhibition of protein 
synthesis 
Human n.r. Metronidazole 
 
n.r.: Not reported. Data of consumption in 1997 from Cars et al. (2001). 
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The occurrence of these three antibiotics in different environmental matrices has 
been investigated and some examples are summarized in Table 2.2. In general antibiotics are 
detected in water bodies at concentrations from ng to several µg L-1, hospital and drug 
manufacturing effluents are the major contributors with concentrations in the higher µg L-1 
range (Kümmerer, 2009). For example, CIP has been typically quantified in hospital effluents 
with concentrations up to 101 µg L-1 (Lindberg et al., 2014). Antibiotics in river water are 
commonly found in the range of tens to hundreds of ng L-1, which are usually lower than 
WWTP effluent. In comparison to surface water, lower contamination levels in ground water 
were reported with less than tens ng L-1. Anyway, high concentration of SMX has been 
quantified in ground water (Table 2.2). Probably due to its weak sorption to soil, reaching 
ground water by leaching or running off (Carvalho and Santos, 2016). Nonetheless, WWTPs 
are believed to be one of the main hotspots for the releasing of antibiotic pollutants into the 
environment as they usually are the final destination of urban and, in some cases, hospital 
effluents as well as due to their limited efficiency for the removal of these compounds.  
The relatively high concentrations of SMX and especially of CIP in WWTP effluents 
could be related to their high consumption and resistance to biological degradation. 
However, CIP can conjugate with metal cations present in wastewater to form complex 
compounds becoming more abundant in sewage sludge (Tiwari et al., 2017). In contrast, 
despite AMX extensive consumption its occurrence has not been covered frequently. 
Probably the fast hydrolysis and rapid degradation of the antibiotic in addition to analytical 
limitations contribute to low detection in aquatic systems as evidenced in the lack of reports 
for its presence in ground water. 
 
Table 2.2. Occurrence and concentration of antibiotics found in different water bodies. 
Compound 
Range of concentration (ng L-1) 
Surface water WWTP effluent Ground water 
AMX BLQ-662 BLQ-190 - 
SMX BLQ-4330 BLQ-1800 BLQ-458 
CIP 80 BLQ-5692 0.28-40 
Reference 
Gibs et al. (2013) 
Kasprzyk-Hordern et al. 
(2008) 
Phuong Hoa et al. (2011) 
Guerra et al. (2014) 
Minh et al. (2009) 
Rosal et al. (2010) 
Tran et al. (2016) 
López-Serna et al. (2013) 
Van Stempvoort et al. 
(2013) 
BLQ: below limit of quantification 
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The continuous input and partial elimination of antibiotics has raised concern about 
the ecological risk of these compounds in the environment. Antibiotics and their degradation 
products have the potential to disrupt vital ecosystem processes due to their anti-microbial 
characteristics being bacteria, fungi and microalgae the organisms more vulnerable. Hence, 
chronic toxicity and the prevalence of resistance to antibiotics in bacterial species have been 
associated to the presence of antibiotics in the environment (Michael et al., 2013). Toxic 
effects of CIP in aquatic organisms was studied by Ebert et al. (2011) in photo autotrophic 
Anabaena flos-aquae (cyanobacteria), Desmodesmus subspicatus (green algae) and Lemna 
minor (macrophyte) finding that the antibiotic was more toxic to the cyanobacteria and the 
macrophyte at the predicted environmental concentration. In other study, cyanobacteria 
were more vulnerable than green algae to SMX when photosynthetic efficiency was 
evaluated (van der Grinten et al., 2010). Gonzalez-Pleiter et al. (2013) evaluated the toxicity 
of different antibiotics both in single and mixture solutions on cyanobacteria and green algae 
finding that the toxic effects of antibiotics increased when they were in combination with 
other antibiotics. Exposure to antibiotics may have adverse effects on reproductive systems 
of different organisms like the freshwater flea Daphnia magna and the crustacean Artemia 
salina. In fact, Kim et al. (2007) studied the effect of sulfonamides and trimethoprim on the 
acute toxicity by employing D. magna, V. fisheri and the Japanese medaka fish where the 
freshwater flea resulted as the most susceptible organism in terms of effect/lethal 
concentrations. 
The potential development of antibiotic resistance in natural bacterial strains is of 
especial concern. Extensive use of both human and animal antibiotics has led to the 
emergence and spread of antibiotic resistance bacteria resulting in the reduced therapeutic 
potential of these compounds against human and animal pathogens. The consequences are 
particularly worrying for bacteria in the aquatic environment since they are continuously 
exposed to antibiotic residues. For example, Zhang et al. (2009) observed higher prevalence 
of antibiotic resistance in Acinetobacter spp. in downstream samples from a WWTP in 
comparison to upstream samples, especially for trimethoprim. Additionally, the presence of 
antibiotics in WWTP can influence the microbial activities and in consequence the 
performance of the treatment. Gonzalez-Martinez et al. (2014) reported that CIP induced 
deterioration of the nitrification process even at relatively low concentrations. 
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2.1.2. Antiepileptic 
Carbamazepine (CBZ) is probably the most common anti-seizure drug used worldwide 
for the control of grand mal and psychomotor epilepsy. Additionally, it is also prescribed for 
the treatment of bipolar depression and trigeminal neuralgia (Clara et al., 2004). Even when 
only 2 to 3% of the drug is excreted as the parent compound, CBZ has been frequently 
detected in natural waters, ground water, soil and sediments in ground water recharging 
areas (Clara et al., 2004; Sui et al., 2015; Tran et al., 2018). Due to its poor removal in 
conventional WWTPs and persistence in the environment CBZ was suggested as a marker for 
anthropogenic contamination (Barra Caracciolo et al., 2015). For this reason, CBZ was also 
chosen to be part of the pharmaceuticals studied in the present investigation. 
Concentration of CBZ detected in influents and effluents of WWTPs around the world 
varied significantly reaching few µg L-1 (Table 2.3). As mentioned before, conventional 
WWTPs are ineffective for CBZ removal as it presents low biotransformation and limited 
adsorption to sludge (Naghdi et al., 2018a). Thus, CBZ has been detected at concentrations 
up to 1075 ng L-1 in surface water samples in Berlin (Heberer et al., 2002). In ground water 
CBZ was detected in 42% of samples collected in 23 European countries with a maximum 
concentration of 390 ng L-1 (Loos et al., 2010). Moreover, ground water studies suggested 
that CBZ could survive intact after 8 to 10 years of residence in the subsurface (Sui et al., 
2015). It was not attenuated during bank filtration which may be one of the reasons for their 
prevalence in the groundwater (Clara et al., 2004). In fact, soil studies found CBZ tends to 
accumulate and to be recalcitrant to microbial degradation (Barra Caracciolo et al., 2015). 
The potential effects of CBZ have been documented in various recent studies. CBZ 
was found to reduce bacterial biomass of riverine biofilm (Lawrence et al., 2005), to be toxic 
to Hydra attenuata organism (Quinn et al., 2008) and to decrease the health of Mytilus 
galloprovincialis mussel (Martin-Diaz et al., 2009). Jos et al. (2003) carried out an 
ecotoxicological evaluation of CBZ using different model systems including daphnia magna, 
vibrio ficheri, chlorella bulgaris, the plant allium cepa and the Vero monkey kidney cells. 
Although results demonstrated that CBZ did not produced acute toxicity in aquatic biota 
assayed, chronic and synergistic effects with other chemicals should not be excluded.  
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Table 2.3. Concentration range of CBZ in effluents from WWTPs. 
Country Effluent concentration (ng L-1) Reference 
Spain 69-173 Rosal et al. (2010) 
South Africa 279.5 Archer et al. (2017) 
Austria 940-1510 Clara et al. (2004) 
Greece 28-416.8 Kosma et al. (2014) 
Germany 6300 Ternes (1998) 
Germany 1630 Heberer et al. (2002) 
France 157.3-293.4 Togola and Budzinski. (2008) 
 
 
2.1.3. Physicochemical properties of the selected pharmaceuticals 
Table 2.4 shows the main physicochemical properties of the selected antibiotic and 
antiepileptic compounds. Some parameters such as water solubility or the coefficient of 
partition octanol-water (Log Kow) are important values to observe in order to estimate the 
fate of the pollutants in the environment and during water treatment. In general, 
compounds presenting lower water solubility and high Log Kow values are expected to show 
high sorption potential. In this sense, from the selected pharmaceuticals only CBZ could be 
expected for potential sorption. The acidity constant (pKa) is also an important parameter 
since the neutral ionic forms of the target pollutants usually behave differently. 
 
Table 2.4. Physicochemical properties of selected pharmaceutical compounds. 
Compound 
Molecular weight 
(g mol-1)a 
Solubility in water 
(mg L-1) 
pKab Log Kowa 
AMX 365.4 3400e 
2.4 
7.4 
9.6 
0.87 
SMX 253.3 610c 
1.83 
5.57 
0.89 
CIP 331.3 ~0* 
5.9-6.1 
8.7-8.9 
0.28 
CBZ 236.3 78d 13.9 2.45 
*soluble in diluted aqueous acid solution. 
a: Wang and Wang, (2016); b: Ternes and Joss, (2006); c: Suárez et al., (2008); d: Celiz et al., (2009); e: DRUGBANK 
(https://www.drugbank.ca/). 
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2.2. Treatment technologies for pharmaceuticals removal 
As mentioned above, most conventional water and WWTPs were not designed for the 
treatment of wastewater containing pharmaceutical and other emerging contaminants. 
Typically, WWTPs comprise a primary system of physicochemical treatment and a secondary 
system that consists of a biological reactor formed by activated sludge. Although some 
micropollutants can be removed from water during conventional treatment, still a variable 
proportion remain in the effluent to be discharged to the environment. It is therefore 
imperative to find effective treatment options not only from a practical point of view, but 
also from an economical aspect. Over the past few decades, a variety of different physical, 
chemical and biological technologies have been evaluated for the removal or degradation of 
pharmaceutical compounds in water. In this section, an overview of the most relevant 
treatment technologies available for each category is presented. The advantages and 
drawbacks of the different processes are resumed in Table 2.5. 
 
2.2.1 Physical treatment processes 
2.2.1.1 Adsorption  
Adsorption is one of the most prevalent physical processes for the removal of 
contaminants in water and one of the main processes for pharmaceuticals treatment (Wang 
and Wang, 2016). It is a simple process that enables to transfer molecules in liquid phase to 
a solid surface thus allowing the removal of pollutants instead of producing more dangerous 
by-products (Homem and Santos, 2011; Rivera-Utrilla et al., 2013). Overall, the effectiveness 
of adsorption process depends on both the nature of the pollutant and the type of 
adsorbent material. Thereby, in order to enhance the removal of pharmaceutical 
micropollutants different adsorbents have been investigated and developed.  
Activated carbon is probably the most traditional adsorbent used in water treatment. 
It can be used in two different presentations: powdered activated carbon (PCA) and granular 
activated carbon (GAC). PAC tends to be more efficient due to its higher specific surface and 
is usually added in contact basins, while GAC is packed in a “column” (Snyder et al., 2007). 
The performance of activated carbon adsorption mainly depends on the properties of the 
activated carbon sorbent (i.e. specific surface area, porosity) and on the hydrophobicity and 
charge of the target compounds (Michael et al., 2013). Moreover, reaction conditions such 
Chapter 2 
 
36 
 
as, temperature, pH or contact time can also significantly influence the process. 
Unfortunately, activated carbon lacks selectivity and when used in complex water matrices 
competition for adsorption sites between the target pharmaceuticals and other compounds 
in water (i.e. organic matter) may occur leading to efficiency loss (Mailler et al., 2015). 
 
Table 2.5. Advantages and drawbacks of different technologies in the removal of pharmaceutical 
micropollutants in wastewater (Adapted from Ahmed et al., 2017; with permission). 
Treatment process Advantages Drawbacks 
Adsorption Removal of a wide variety of 
micropollutants 
Difficult regeneration of 
adsorbent materials 
High costs related to the 
consumption and disposal of used 
adsorbents 
Membrane filtration Removal of a number of 
micropollutants including some 
pharmaceuticals 
High costs of operation 
Membrane fouling 
Disposal issue of concentrated 
sludge 
Low removal of hydrophobic 
compounds 
Coagulation-Flocculation High removal of turbidity and 
colour 
Increased sedimentation rate 
Ineffective removal of 
pharmaceutical compounds 
Large generation of sludge 
Introduction of coagulant slats in 
the aqueous phase 
Advanced oxidation 
processes (AOP) 
High removal efficiency  
Selective oxidation favouring 
disinfection properties 
Short degradation rate 
Allows degradation and 
mineralization of pollutants 
High energy consumption 
Formation of toxic by-products 
Interference of free radical 
scavengers 
Activated sludge Low capital and operational costs Low removal efficiency  
Generation of large amounts of 
sludge  
Membrane bioreactor Effective removal of hydrophobic 
compounds 
High quality effluent  
Small foot print 
High energy consumption 
Membrane fouling 
Inefficient removal of hydrophilic 
and persistent compounds 
Post-treatment may be required 
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Although activated carbon is the most used adsorbent, new materials like graphene 
and carbon nanotubes have also been tested as a possible option for the adsorption of 
pharmaceutical micropollutants. Graphene presents higher specific surface area than 
activated carbon and has been proved to remove pharmaceutical compounds (Wang and 
Wang, 2016). Similarly, the excellent properties of carbon nanotubes led to several studies 
to investigate their potential for the adsorption of pharmaceuticals like carbamazepine (Ji et 
al., 2016b) and sulfamethoxazole (Ji et al., 2016a). As in the case of activated carbon, the 
adsorption capacity of these two materials also depends on the properties on the pollutants. 
Although these materials are considered as a promising technique for the removal of 
pharmaceutical compounds, research has to be done in order to investigate the feasibility of 
the technology at large scale application in continuous processes as well as with real 
wastewater (Wang and Wang, 2016). Table 2.6 summarizes the removal efficiency of 
selected pharmaceutical micropollutants via adsorption on different materials. 
 
Table 2.6. Removal of selected pharmaceuticals through adsorption by different materials. 
Compound 
Type of 
adsorbent, 
dose adsorbent 
Type of water 
Influent 
concentration 
(µg L-1) 
Removal 
(%) 
Reference 
AMX GAC, 30 g L-1 
Real 
wastewater 
317 000  95 Putra et al. (2009) 
SMX PAC, 1-20 mg L-1 River water na 20 Westerhoff et al. (2005) 
 
PAC, 5 mg L-1 Surface water 0.1 35 Snyder et al. (2007) 
 
PAC, 50 mg L-1 
Real 
wastewater 
0.6 60 Altmann et al. (2014) 
 
Graphene,  
100 mg L-1 
Synthetic water  100 34 Yang and Tang (2016) 
CIP PAC, 8-43 mg L-1 
Hospital 
wastewater 
15.7 >99 Michael et al. (2013) 
CBZ PAC, 5 mg L-1 Surface water 0.1 70 Snyder et al. (2007) 
 
GAC, 10 mg L-1 Synthetic water  0.5 100 Yu et al. (2008) 
 
Graphene Synthetic water  10 000 97 Rizzo et al. (2015) 
na : not available. GAC: granular activated carbon. PAC: powdered activated carbon 
 
 
2.2.1.2 Membrane filtration  
The use of membrane separation processes for water treatment has increased in the 
last decades. Among the different type of membranes available in the market, ultrafiltration 
(UF, pore size 10 nm), nanofiltration (NF, pore size 1 nm) and reverse osmosis (RO, pore size 
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<1 nm) membranes have been proved to effectively remove small size pollutants such as 
pharmaceutical compounds (Ganiyu et al., 2015). Removal of pharmaceuticals 
micropollutants in membrane separation can occur through various mechanisms 
(adsorption, steady state rejection, electrostatic effects) which are dependent on the 
physicochemical properties of the compound, the feeding solution and the membrane 
characteristics (Michael et al., 2013). 
Overall, studies showed excellent removal yields for all the target pollutants (Košutić 
et al., 2007; Radjenović et al., 2008; Zhang et al., 2006). Several antibiotics including β-
lactams, quinolones, tetracyclines and sulfonamides were highly removed (<90%) after 
combined treatment with micro filtration (MF) and RO (Watkinson et al., 2007). Kimura et al. 
(2004) tested two different RO membranes for the treatment of endocrine disrupting 
compounds and pharmaceutical active compounds obtaining high retention of SMX (70-82%) 
and CBZ (85-91%). Similarly, Morse and Jackson (2004) reported complete removal for AMX 
from wastewater by RO. 
Despite the good removal reported for the target pharmaceuticals is important to 
remark that as in adsorption, this treatment process produces a new effluent (i.e. the 
retentate) where the contaminants are concentrated. Moreover the sensitivity of the 
membranes to temperature and the presence of organic compounds and dissolved salts in 
the feeding medium can cause membrane deterioration and fouling which usually decrease 
the effectivity of the process (Homem and Santos, 2011). 
 
2.2.1.3 Coagulation and flocculation 
Coagulation and flocculation represent an important part of conventional water and 
wastewater treatment plants and are typically applied before sedimentation and filtration in 
a process better known as clarification. Coagulation involves the addition of chemicals, 
usually aluminium and iron salts, which react with suspended and colloidal particles to form 
micro-particles by reducing their repulsive charges (Matilainen et al., 2010). Then, during the 
flocculation these micro-particles collide and form larger aggregates or flocs that are easily 
removed by sedimentation (Matilainen et al., 2010; Verma et al., 2012).  
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The combined process of coagulation-flocculation is usually used in water treatment 
to decrease turbidity and colour as well as for the removal of pathogens. However, this 
technology has been found inefficient for the removal of pharmaceutical pollutants. Poor 
removal could be related to the use of conventional coagulants which were not specifically 
designed to remove emerging organic micropollutants (Alexander et al., 2012). Nonetheless, 
partial removal of antibiotics in the range from 20 to 90% depending on the nature of the 
compound has been achieved using different coagulants (Choi et al., 2008; Stackelberg et al., 
2007). For example, Stackelberg et al. (2007) reported that the addition of ferric chloride 
during the clarification process led to an average reduction of 15% in the concentration of 32 
organic compounds, including nine pharmaceuticals. According to these authors, the 
moderate SMX removal observed could be attributed to hydrolysis reaction with the 
coagulant and the very low elimination of CBZ resulted of its sorption on suspended particle 
matter. 
 
2.2.2 Advanced oxidation processes 
Advanced oxidation processes (AOPs) represent a very effective alternative for the 
treatment of recalcitrant pharmaceutical micropollutants that are not removed by 
conventional water and wastewater treatment technologies. AOPs are oxidative methods 
based on the generation of radicals (OH•, O2•-., HO2•), mainly hydroxyl radicals (OH•) 
(Kanakaraju et al., 2018). These radicals are extremely reactive species that can successfully 
attack a broad range of organic and inorganic molecules leading to the oxidation or even 
mineralization of the pollutants (Ahmed et al., 2017; Rivera-Utrilla et al., 2013). Hydroxyl 
radicals can be generated from oxidizing agents such as ozone (O3) or hydrogen peroxide 
(H2O2), often combined with metallic or semiconductor catalysts or UV radiation (Homem 
and Santos, 2011; Rivera-Utrilla et al., 2013). AOPs commonly applied for pharmaceutical 
water/wastewater treatment could be classified into three categories: photochemical 
processes, non-photochemical processes and hybrid or combined processes. Examples of the 
application of some of these processes for the treatment of the target pharmaceuticals are 
presented hereafter (Fig. 2.2). 
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Fig. 2.2. AOPs technologies for removal of pharmaceutical micropollutants in wastewater. 
 
Ozonation and combinations of O3, with H2O2 (O3/H2O2), and O3 with UV (O3/UV) have 
been applied to pharmaceuticals in water as single oxidation method, peroxidation or 
disinfection step before other treatments. For example, a study carried out by Alharbi et al. 
(2016) suggested that different doses of ozone could be required for the effective oxidation 
of four different pharmaceuticals (diclofenac, CBZ, SMX and trimethoprim). The treatment of 
pharmaceuticals including different classes of antibiotics (β-lactam, sulphonamides) with 
ozonation led to high removal yields (>50%); however, low mineralization of the pollutants 
was observed probably due to the presence of persistent by-products formed during the 
process (Akmehmet Balcıoğlu and Ötker, 2003; Almomani et al., 2013; Andreozzi et al., 
2005). Ozonation process could be improved by the addition of H2O2 or UV irradiation as 
demonstrated by Drewes et al. (2008) who used a lab-scale and full-scale O3/H2O2 systems 
for the removal of several pharmaceuticals including SMX obtaining more than 90% 
degradation after 2 min contact time. 
The application of UV radiation during disinfection step in water treatment processes 
can lead also to the degradation of pharmaceutical micropollutants. In this method removal 
efficiencies will depend on the chemical structure and the UV absorption sensitivity of the 
pharmaceuticals (Kanakaraju et al., 2018). For example, Drewes et al. (2008) reported poor 
removal for SMX (25-50%) during UV disinfection step. The poor removal was attributed to 
the characteristics of the water matrix containing dissolved organic carbon that competed 
for the low UV radiation during the treatment. To overcome this issue, the combination of 
UV with H2O2 (UV/H2O2) usually leads to better removals for pharmaceuticals with poor UV 
AOPs
Photocemical processes
UV oxidation (UV and 
UV/H2O2), photo-Fenton, 
photocatalysis
Non-photochemical 
processes
Fenton, ozonation, sonolysis, 
electrochemical
Hybrid processes
Sono-photolysis, 
photocatalytic ozonation, 
photoelectrocatalysis
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absorption. Enhancement of AMX degradation was reported when UV/H2O2 (10 mM H2O2) 
was applied in comparison to only UV treatment (Jung et al., 2012). Vogna et al. (2004) 
found that UV/H2O2 irradiation allowed complete transformation of CBZ after 4 min 
treatment although low removal (35%) of total organic carbon (TOC) was observed. Borikar 
et al. (2015) performed pilot-scale experiments in a water treatment plant and compared 
the efficiency of ozone/H2O2 and UV/H2O2 processes for the degradation pharmaceuticals 
obtaining high removal yields for both technologies (92-97%). Among the tested compounds, 
CBZ, fluoxetine, naproxen and gemfibrozil showed the highest removal with almost 
complete degradation. 
Regarding to Fenton and photo-Fenton oxidation, both processes have been found to 
be effective for the degradation of pharmaceuticals (Ahmed and Chiron, 2014; Arslan-Alaton 
and Dogruel, 2004; Ay and Kargi, 2010). Oxidation of AMX by photo-Fenton process was not 
influenced by the source of irradiation as demonstrated by Trovó et al. (2008) achieving 85 
and 89% removal respectively, under black and solar irradiation. Another investigation used 
doses higher that 5 mg L-1 of ferrate (Fe(VI)) for the partial elimination of SMX and CIP (85%) 
(Lee et al., 2009). Complete removal of CBZ (50 µM) in WWTP effluent was reported when 
solar photo-Fenton was applied during 30 min (Ahmed and Chiron, 2014). Although high 
removal yields that can be obtained by the application of Fenton processes, formation of 
toxic by-products can result from the treatment which could represent a serious drawback 
for the use of this technology at full scale (Wang and Wang, 2016). 
Among the less known AOPs, sonolysis treatment was applied for CIP degradation 
that was better removed when low frequency was applied (544 kHz) (De Bel et al., 2011). 
Electrochemical oxidation using TiO2 anode reported 80% oxidation of pharmaceutical 
micropollutants including SMX and CBZ. Nonetheless, when ozonation or UV/H2O2 systems 
were applied to these pharmaceuticals, complete removal was observed in shorter contact 
times in comparison to TiO2 treatment (Andreozzi et al., 2004). 
 
2.2.3 Biological treatment processes 
2.2.3.1 Conventional activated sludge 
Conventional activated sludge (CAS) is probably the most common biological 
treatment used in urban WWTPs. It is intended for the removal of organic matter based on 
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biological processes (i.e. aerobic, anaerobic systems) (Tran et al., 2018). CAS uses dissolved 
oxygen to promote the growth of microorganisms that can degrade pollutants at specific 
operational conditions (Ahmed et al., 2017; Michael et al., 2013). However, this treatment is 
usually not efficient enough for the removal of persistent micropollutants due to their 
recalcitrant nature and low quantity.  
Elimination and transformation of ECs during CAS is the result of two major 
processes: sorption and biodegradation (Grandclément et al., 2017). Metabolism and co-
metabolism are the mechanisms through which biodegradation can take place, co-
metabolism being the most likely to occur since many ECs are toxic or resistant to microbial 
activity (Tran et al., 2018). Moreover, micropollutants are present in wastewater at too low 
concentrations to be used as direct growth substrate. Thus, biodegradation of 
pharmaceuticals in CAS depends on the composition of the microbial community, in this case 
microorganisms involved in co-metabolic degradation, as well as on the presence of primary 
growth substrates (organic carbon, ammonium, etc.) (Tran et al., 2013). For example, 
ammonia-oxidizing bacteria involved in nitrification process could enhance the removal of 
pharmaceuticals and pesticide micropollutants by means of co-metabolic process as 
demonstrated by Margot et al. (2015b). 
As mentioned before, sorption onto activated sludge can be a significant removal 
pathway for some compounds. The tendency of micropollutants to accumulate in sludge is 
related to their physicochemical properties and can be evaluated using either sludge 
sorption constant (Kd) or the octanol-water partition coefficient (Kow). In general, the higher 
Kd (>3.2) or Kow values (>4.0) the higher sorption of the compounds to sludge (Joss et al., 
2006; Rogers, 1996). However, this prediction may not be accurate for polar or charged 
compounds such as fluoroquinolone antibiotics for which electrostatic interactions with 
sludge could result as the main reason for their removal during CAS (Golet et al., 2003).  
The combined effect of biodegradation and adsorption CAS systems can result in a 
wide range of removal efficiencies for ECs as shown in Fig. 2.3. Pharmaceuticals including 
antibiotics (AMX, CIP, SMX), anti-inflammatory drugs (ibuprofen, naproxen, salicylic acid), 
hormones (estrone, estriol) showed high removal (>80%) during biological treatment. In 
contrast, compounds like CBZ seemed to be resistant to biological treatment with average 
removal below 40%. It is worth noting that negative removals for some micropollutants after 
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CAS have been observed as result of different processes occurring during treatment. The 
enzymatic cleavage of metabolites and conjugates which transforms them back into the 
parent compounds and/or the release of compounds initially trapped in faecal particles 
during the decomposition of the latter lead to an increase in the concentration in effluents 
after treatment (Göbel et al., 2007; Grandclément et al., 2017; Verlicchi et al., 2012). 
Moreover, operational parameters such as sludge retention time (SRT), hydraulic retention 
time (HRT) and reactor design affect the performance of CAS leading to important variations 
in removal yields between WWTPs (Grandclément et al., 2017). For example, short SRT and 
low biomass concentration could lead to partial degradation of micropollutants (Tiwari et al., 
2017). Nonetheless, these problems can be overcome by the use of other biological 
treatment technologies such as membrane bioreactors. 
 
 
Fig. 2.3. Box–and-whisker plots showing variation in removal efficiencies of various pharmaceuticals 
in biological wastewater treatment processes. (Tran et al., 2018; with permission). 
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2.2.3.2 Membrane bioreactor 
Membrane bioreactor (MBR) technologies couple activated sludge treatment with a 
membrane separation process in order to retain the sludge in the system, thus promoting 
the microbial degradation of organic matter and, in some cases, micropollutants 
(pharmaceuticals). Typically, in a MBR the membrane module (hollow fibers or flat 
membranes) is submerged inside the reactor tank conforming a single unit (de Cazes et al., 
2014). MBRs are seen as more efficient systems for the removal of micropollutants as they 
present some advantages in comparison to CAS such as low space requirements, increased 
SRT in smaller reaction volumes and the almost inexistent presence of suspended solids in 
the permeate. Nonetheless, in order to achieve such a good performance continuous 
aeration in the lower part of the membrane is generally necessary in order to ensure oxygen 
saturation as well as to create turbulence to reduce as possible the membrane clogging and 
fouling which are the biggest disadvantages of this technology (de Cazes et al., 2014). In 
addition, MBR operation can be also affected by the sludge age and concentration, 
composition of wastewater, conductivity, operating temperature and pH (Ahmed et al., 
2017). 
Regarding to the effectiveness of MBRs for the removal of pharmaceutical 
micropollutants mixed performance was observed, varying from almost complete removal 
for some pharmaceuticals to almost negligible degradation for other compounds. Snyder et 
al. (2007) used a MBR for the treatment of primary effluent of a WWTP finding it effective 
for the removal of several pharmaceutical micropollutants including caffeine, 
acetaminophen and SMX. Similarly, Clara et al. (2005) tested a MBR at pilot scale for the 
removal of pharmaceuticals, musk fragrances and endocrine disrupting chemicals (EDCs) at 
different SRT and compared the result to the performance of CAS. Compounds like CBZ were 
not removed by CAS or MBR treatments, while ibuprofen or benzafibrate were highly 
eliminated (90%). Interestingly, Clara found no difference in treatment efficiencies between 
MBR and CAS. In the same line, a lab scale MBR was applied for the removal of polar 
pollutants from a municipal wastewater facility. MBR was found to enhance by 20-50% the 
degradation of pharmaceuticals showing medium removal (15-80%) in CAS treatment. 
Nonetheless, in the case of well degradable or recalcitrant pollutants removals were not 
improved by the MBR process (Weiss and Reemtsma, 2008). Actually, this observation was 
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reported in different studies where recalcitrant compounds such as CBZ were not eliminated 
at all after MBR treatment (Bernhard et al., 2006; Radjenović et al., 2009). Table 2.7 present 
a comparison between the removal efficiency and removal mechanism of target 
pharmaceuticals in MBR and CAS processes. 
 
Table 2.7. Comparison of removal efficiency of target pharmaceuticals in CAS and MBR processes. 
(Adapted from Tiwari et al., 2017; with permission). 
Pharmaceutical 
Removal MBR 
(%)a,c 
Removal CAS 
(%)a,b 
Biodegradation 
(%)c 
Sorption 
(%)b,c 
AMX >75 >75 >80 - 
SMX 66 51.9 50-90 1 
CIP 89 - 0 98 
CBZ 28 <25 <40 <5 
a: (Le et al., 2018); b: (Behera et al., 2011); c: (Kim et al., 2014) 
 
 
2.2.3.3 Enzymatic treatment 
Enzymes are versatile bio-catalysts that in recent years have attracted attention as an 
interesting option for the degradation of persistent pollutants. Generally, enzymatic 
processes are easy to control and can be operated over a broad range of conditions with low 
energy consumption (Torres et al., 2003). Enzymes catalyse specific reactions and mostly act 
under mild conditions (pH, temperature, solvents and ionic strength) which results in low 
environmental impact (Demarche et al., 2012). Moreover, the high selectivity and specificity 
of enzymes prevent undesired side reactions, thus making the treatment more cost effective 
(Demarche et al., 2012). Enzymatic treatment involves chemical processes based on the 
action of biological catalysis which render several advantages in comparison to conventional 
physico-chemical and biological processes. These biocatalysts can effectively treat 
environmental pollutants over a wide range of concentrations at a rapid rate with a lower 
risk of being inhibited by the effect of these compounds, although such inhibition is more 
likely to occur at high pollutant concentrations (Karam and Nicell, 1997). Thus, enzymes 
represent a promising tool for the selective removal of pharmaceutical pollutants from 
waste streams. 
Various enzymes have been described to potentially remove hazardous compounds 
from the environment. According to Demarche et al. (2012), enzymes like hydrolases (EC3: 
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lipases, esterases, cellulases), oxidoreductases (EC1: peroxidases, phenoloxidases) and lyases 
(EC4: decarboxylases, dehydratases) could be used for the biotransformation of pollutants. 
For example, hydrolases can be used as a pre-treatment for the degradation of biopolymers, 
whilst oxidoreductases could be applied to attack specific pollutants of different nature 
(Demarche et al., 2012; Nyanhongo et al., 2007). Oxidoreductases are extracellular enzymes 
that are generally produced by the white-rot fungi (WRF) for the degradation of lignin, the 
structural polymer found in wood. This consortium of oxidoreductase enzymes, also known 
as lignin modifying enzymes (LME), includes lignin peroxidase (LiP), manganese peroxidase 
(MnP), versatile peroxidase (VP) and laccase (Mester and Tien, 2000; Naghdi et al., 2018b). 
These enzymes act by generating highly reactive and non-specific radicals that randomly 
attack lignin molecules. In this way, LME can be used for the treatment not only of single 
molecules but also of mixtures, which perhaps is their greatest advantage (Mester and Tien, 
2000). Therefore, different studies have reported the use of LME for the biotransformation 
of various ECs including pharmaceutical compounds such as carbamazepine, diclofenac, 
naproxen, sulfamethoxazole and tetracyclines (Auriol et al., 2008; Eibes et al., 2011; Melo 
and Dezotti, 2013; Torres et al., 2003; Wen et al., 2009; Zhang and Geißen, 2010). Further 
discussion on the properties of oxidative enzymes, with special focus on the application of 
laccases, is presented in the next section. 
 
 
2.3 Oxidative enzymes 
The oxidative enzymes secreted by WRF can be classified into two main groups: 
peroxidases and phenol oxidases.  
 
2.3.1. Peroxidases 
Peroxidases are heme-containing enzymes which require the presence of peroxides 
such as hydrogen peroxide (H2O2) to catalyse a variety of reactions (Conesa et al., 2002). The 
catalytic cycle of peroxidases is a three-step reaction (Fig. 2.4). The native enzyme (Fe3+) is 
oxidized by hydrogen peroxide. This produces water and the oxidized form of peroxidase, 
called Compound I (Fe4+ -R+•). Then, Compound I oxidizes one molecule of substrate, 
resulting in a substrate radical and Compound II (Fe4+). Compound II oxidizes a second 
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substrate molecule, leading to a second substrate radical and the native peroxidase (reduced 
state Fe3+) (Conesa et al., 2002; Nakayama and Amachi, 1999; Torres et al., 2003). 
Peroxidases are differentiated according to their substrate specificity. Manganese 
peroxidase (MnP) uses Mn(II) as reducing substrate, whereas lignin peroxidase (LiP) oxidizes 
non-phenolic and phenolic compounds. Anyhow, the broad substrate observed for these 
enzymes is the result of their structural properties and high redox potential (1 V) (Demarche 
et al., 2012; Mester and Tien, 2000).  
 
Fig. 2.4. Catalytic cycle of peroxidases (Adapted from Torres et al., 2003; with permission). 
 
 
2.3.1.1 Lignin peroxidase (LiP; EC 1.11.1.14) 
Lignin peroxidase was the first LME discovered in the fungus Phanerochaete 
chrysosporium (Glenn et al., 1983). LiP is a monomeric glycol protein with molecular mass 
around 40 kDa with a heme group in its active site (Hammel and Cullen, 2008). Thus, this 
enzyme follows the classical catalytic mechanism of peroxidases which requires peroxide as 
electron acceptor for the oxidation of phenolic and aromatic non-phenolic compounds with 
similar structure to lignin. Enzymatic reactions catalysed by LiP include benzylic alcohol 
oxidations, side-chain cleavages, ring-opening reactions, demethoxylations and oxidative 
dechlorinations. In this way LiP is able to oxidize substrates with high redox potential such as 
polycyclic aromatic compounds, polychlorinated byphenyls and dyes (Wesenberg et al., 
2003). 
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2.3.1.2 Manganese peroxidase (MnP; EC 1.11.1.13) 
Manganese peroxidase enzyme is also a heme glycoprotein that can catalyse the 
oxidation and depolymerisation of natural substrates like lignin as well as recalcitrant 
xenobiotics in the presence of peroxide (Wong, 2009). However, MnP is unique among 
peroxidases because it prefers Mn2+ as its reducing substrate. Following the classical 
peroxidase catalytic mechanism (Fig. 2.5), Mn2+ is oxidized by both MnP I and MnP II 
compounds, resulting in the formation of Mn3+. Then, Mn3+ which is subsequently stabilized 
by chelation with organic acids (i.e. oxalate) produced by the fungi itself diffuses from the 
enzyme to oxidize substrates (Conesa et al., 2002). Although compound MnP I is also able to 
oxidize phenolic compounds (e.g. guaiacol) its efficiency is lower in comparison to MnP II 
compound (Mester and Tien, 2000). 
 
MnP+H2O2→MnP I+ H2O 
MnP I+Mn2+→MnP II+ Mn3+ 
MnP II+Mn2+→MnP+ Mn3++H2O 
Mn3++RH→Mn2++R + H+ 
Fig. 2.5. Catalytic cycle of manganese peroxidase 
 
 
2.3.1.3 Versatile peroxidase (VP; EC 1.11.1.16) 
Versatile peroxidase has been considered as a hybrid between MnP and LiP since it 
combines the substrate specificity of both peroxidases (Wesenberg et al., 2003). VP is able 
not only to oxidize Mn2+ but also phenolic and non-phenolic aromatic compounds that are 
typical substrates for LiP in the absence of manganese (Wong, 2009). 
 
2.3.2 Phenol oxidases 
Phenol oxidases are another group of oxidative enzymes that catalyse the oxidation 
of phenolic compounds by only using molecular oxygen. They are subdivided into two 
subgroups: tyrosinases and laccases. 
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2.3.2.1 Tyrosinase (Tyr; EC 1.10.3.1) 
Tyrosinase is a copper-containing protein known as monophenol oxidase or 
catecholase. Although it shares most of the substrates with laccases, the ability to oxidize 
tyrosine is exclusive to this enzyme (Demarche et al., 2012). Typically, tyrosinases catalyse 
two consecutive reactions: (i) the hydroxylation of monophenols with molecular oxygen to 
form o-diphenols; and (ii) the dehydrogenation of o-diphenols with oxygen to form o-
quinones. Quinones are mostly unstable and undergo non-enzymatic polymerization to yield 
water insoluble substances that can be easily removed by simple filtration (Karam and Nicell, 
1997).  
 
2.3.2.2 Laccase (EC 1.10.3.2) 
Laccases represent the largest subgroup of blue multicopper oxidases (Giardina et al., 
2010) firstly detected in the Japanese tree Rhus vernicifera (Kim et al., 2010). Since then, 
they have been found widely distributed in higher plants, bacteria, insects and fungi 
(Brijwani et al., 2010; Giardina et al., 2010). 
Laccases are characterized for being dimeric or tetrameric glycoproteins that usually 
contain four copper atoms organized into the active site (Durán et al., 2002; Riva, 2006). 
Using these redox active copper atoms laccases catalyse the oxidation of a wide variety of 
substrates, such as phenols, polyphenols, anilines, aryl diamines, methoxy-substituted 
phenols, aromatic diamines, hydroxyindiols, benzenethiols, inorganic/organic metal 
compounds and many others, by only using molecular oxygen that is reduced to water 
(Gasser et al., 2014; Giardina et al., 2010; Kunamneni et al., 2007). Structurally talking, the 
active center of laccases contains four atoms of copper which are classified into three groups 
according to their different spectroscopy characteristics (Fig. 2.6): Type 1 (T1) site copper 
atom absorbs intensely at 600 nm and is responsible for the blue colour, Type 2 (T2) normal 
copper invisible in the UV-Vis absorption spectrum and the Type 3 (T3) coupled binuclear 
copper center which absorbs markedly at 330 nm (Claus, 2004; Santhanam et al., 2011). The 
T1 copper center acts as the primary electron acceptor site where the enzyme catalyses the 
oxidation of substrates. The T2 and T3 copper centers form a trinuclear copper cluster site 
where molecular oxygen is reduced to water by accepting the electrons transferred from the 
T1 site (Polak and Jarosz-Wilkolazka, 2012; Torres et al., 2003). 
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Fig. 2.6. Schematic representation of the copper center in laccase (Adapted from Barrios-Estrada et 
al., 2018; with permission). 
 
 
The mechanism of catalysis followed by laccase involves mainly three steps: (i) 
reduction of the T1 copper site by the substrate, (ii) electron transfer from the T1 site to the 
T2/T3 copper cluster, and (iii) the reduction of molecular oxygen by the T2/T3 copper sites. 
This mechanism involves a four-electron reduction of O2 to water as shown in Fig. 2.7. In the 
resting state the enzyme is completely oxidized; then, a total reduction of the copper 
centers (Cu2+ to Cu+) by the substrate occurs in T1 site. Electrons are extracted individually 
from the reducing substrate and transferred to the T2/T3 cluster site resulting in the 
conversion of the resting form of the enzyme to a fully reduced state. Then, reduction of 
dioxygen takes place at the T2/T3 cluster site in two steps via the formation of peroxide 
intermediates and their subsequent reduction to water. In the last step, all four copper 
centers are oxidized, and O2- is released as a second water molecule. (Wong, 2009). The net 
result is the oxidation of four molecules of substrate to produce four radicals while reducing 
one molecule of oxygen to two molecules of water. The radicals formed can then undergo 
non-enzymatic reactions including hydration, hydrogen abstraction or polymerization for 
synthesizing new molecules with valuable functions (Claus, 2004; Kudanga et al., 2011; 
Wesenberg et al., 2003). Laccase attack can also result in the decarboxylation of phenol and 
methoxyphenolic acids or the demethylation of methoxyl groups. Dehalogenation of 
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substituents located in the ortho or phara position may also take place in the case of 
substituted compounds (Majeau et al., 2010). 
 
Fig. 2.7. Catalytic cycle of laccase (Adapted from Wong, 2009; with permission). 
 
 
The effectiveness of laccase for the oxidation of substrates depends on the difference 
of redox potentials between the T1 copper and the substrate. The pH of the medium also 
plays a significant role in the enzymatic catalysis reaction because it does not only affects the 
laccase activity but also the redox potential of the substrate (Polak and Jarosz-Wilkolazka, 
2012). Thus, laccases are unable to directly oxidize substrates presenting significantly higher 
redox potentials (>1.3 V). Additionally, steric hindrance issues could also impede catalytic 
oxidation of certain substrates (Kudanga et al., 2011). However, oxidation of recalcitrant 
substrates by laccase can be made possible by the addition of mediators: a group of low-
molecular weight organic compounds that after oxidation by laccase, form highly active 
radicals capable of oxidizing substrates that laccase alone cannot oxidize (Brijwani et al., 
2010; Kunamneni et al., 2007; Majeau et al., 2010). The factors affecting laccase oxidation of 
substrates will be further discussed in the next section. 
Overall, the wide substrate range observed in laccases as well as their simple 
requirements for catalysis make these enzymes suitable and attractive for bioremediation 
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applications. Therefore, in this investigation laccases were selected to carry out the 
biotransformation of pharmaceutical micropollutants in synthetic water. 
 
2.4 Application of laccase for pharmaceuticals removal 
In this section, the use of laccases for pharmaceutical micropollutants removal is 
presented. The bibliographic review will focus on the application of laccases for the 
biotransformation of pharmaceutical compounds from two perspectives: (i) using free 
laccase in form of crude culture extract or pure enzyme, and (ii) using immobilized laccase. 
 
2.4.1 Removal by free laccase 
2.4.1.1 Crude enzyme 
The term crude enzyme refers to the direct use of enzymes harvested from microbial 
cultures. The use of extracellular extracts for the degradation of pharmaceutical compounds 
instead of living cells may be advantageous in terms of a more controllable and targeted 
treatment, reaching high reaction kinetics and avoid the addition of nutrients or waiting for 
the growth of cells (Naghdi et al., 2018b; Stadlmair et al., 2018). Therefore, several research 
groups have devoted efforts to assess the role of extracellular enzymes in the 
biotransformation of pharmaceutical compounds. Table 2.8 shows some examples of recent 
studies reporting the degradation of pharmaceuticals by crude laccase. Guo et al. (2014) 
used crude enzyme of Phanerochaete chrysosporium at different concentrations for the 
degradation of SMX. Degradation yields up to 50% were obtained when laccase was added 
at a concentration of 6076 U L-1; however, it was observed that SMX degradation was not 
directly dependent on laccase activity and similar removal could be achieved at lower 
laccase concentration. Similarly, the potential of laccase from a Pycnoporus sanguineus 
culture extract was evaluated for the degradation of the antibiotics SMX, CIP, and 
norfloxacin (NOR) in single and mixture solutions. In vitro assays showed CIP and NOR were 
resistant to laccase degradation, whereas SMX concentration decreased by 29% after 72 h of 
treatment both in single and mixture reactions (Gao et al., 2018). Low removal of antibiotics 
was also reported by Suda et al. (2012) who tested a cell free extract from Trametes 
versicolor for the oxidation of four tetracyclines (tetracycline, chlortetracycline, doxycycline 
and oxytetracycline) obtaining removals in the range from 14-48% within 4 h. 
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Tran et al. (2010) used a crude enzyme solution with an initial laccase activity of 1500 
U L-1 for the degradation of ten pharmaceutical compounds at environmentally relevant 
concentrations (10 µg L-1). Complete removal of diclofenac, naproxen and indomethacin was 
observed within 12 h of incubation, while partial degradation of the rest of the compounds 
was observed. In a study carried out by Cabana et al. (2009) the degradation of triclosan 
(TCS) and other two endocrine disrupting chemicals by and enzymatic preparation from 
Coriolopsis polyzona was assessed. Authors observed the degradation efficiency of the 
micropollutants significantly varied depending on the compound. Moreover, reaction 
conditions (pH and temperature) had an important influence in the removal process so that 
65% of TCS (5 mg L-1) disappeared after 4 h treatment when the reaction was carried out at 
pH 5 and 50°C. In the same line, operational conditions were optimized in the attempt to 
maximize the oxidation of the anti-epileptic CBZ by Trametes versicolor crude laccase. The 
effect of temperature, pH and enzyme concentration were studied by a response surface 
methodology finding that performing the biotransformation at 35°C and pH 6 with 60 U L-1 
of enzyme led to 30% removal of the recalcitrant compound (Naghdi et al., 2018a).  
These results suggest that the performance of laccase to catalyse the degradation of 
pharmaceuticals depend on different factors such as substrate type, reaction conditions and 
enzymes properties. As observed in Table 2.8, the treatment of the same compound by 
enzymes from different sources can lead to different removal efficiencies. For example, 
complete degradation of diclofenac was observed with laccase from Trametes versicolor, 
whilst only 50% was attained when Pycnoporus sanguineus laccase was employed. However, 
it is important to consider that in order to properly compare the performance of different 
enzymes for the degradation of pharmaceutical(s) the operational conditions must be also 
comparable which is not often reported in literature. Anyhow, using crude enzyme solution 
brings some advantages. The utilization of crude enzyme without further enzyme 
purification could reduce the cost of the treatment process. Moreover, the possible 
presence of natural compounds in the crude solution produced during fungi growth may act 
as mediators favouring the degradation of some pharmaceuticals (Tran et al., 2010). 
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Table 2.8. Biotransformation of pharmaceutical micropollutants by crude laccase. 
Pharmaceutical Laccase source Concentration 
(mg L-1) 
Reaction conditions Efficiency 
(%) 
Reference 
Carbamazepine Trametes 
versicolor 
1 60 U mL-1 of laccase, 10 mL reaction, 
pH 6, 150 rpm, 24 h 
30 (Naghdi et al., 2018a) 
Chlortetracycline Trametes 
versicolor 
5 10 nkat mL-1, 0.5 mL reaction, pH 4.5, 
30°C, 150 rpm, 4 h 
48 (Suda et al., 2012) 
Chloramphenicol Trametes hirsuta 0.5 100 U of laccase, pH 5, 7 days 100 (Navada and Kulal, 2019) 
Diclofenac Trametes 
versicolor 
0.5 500 U L-1 of laccase, 100 mL reaction, 
pH 4.5, 50°C, 150 rpm, 5h 
99 (Lonappan et al., 2017) 
 Pycnoporus 
sanguineus 
10 100 U L-1 of laccase, pH 5, 25°C, 8 h 50 (Rodríguez-Delgado et al., 2016) 
 Trametes 
versicolor 
0.01 1500 U L-1 of laccase, 10 mL reaction, 
pH 4.5, 30°C, 125 rpm, 12 h  
100 (Tran et al., 2010) 
Ibuprofen Trametes 
versicolor 
0.01 1500 U L-1 of laccase, 10 mL reaction, 
pH 4.5, 30°C, 125 rpm, 12 h  
15 (Tran et al., 2010) 
Naproxen Trametes 
versicolor 
0.01 1500 U L-1 of laccase, 10 mL reaction, 
pH 4.5, 30°C, 125 rpm, 12 h  
100 (Tran et al., 2010) 
Sulfamethoxazole Pycnoporus 
sanguineus 
10 170 U L-1 of laccase, 25 mL reaction, 72 
h 
29 (Gao et al., 2018) 
Sulfamethoxazole Phanerochaete 
chrysosporium 
10 96-6076 U L-1 of laccase, 5 mL reaction, 
pH 4.5, 30°C, 48 h 
≤ 50 (Guo et al., 2014) 
Tetracycline Trametes 
versicolor 
5 10 nkat mL-1 of laccase, 0.5 mL 
reaction, pH 4.5, 30°C, 150 rpm, 4h 
16 (Suda et al., 2012) 
Triclosan Coriolopsis 
polyzona 
5 100 U L-1 of laccase, pH 5, 50°C, 8h 65 (Cabana et al., 2007) 
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2.4.1.2 Purified enzyme 
Purified laccases obtained from different strains of WRF have been used for the 
removal of pharmaceutical from water as shown in Table 2.9. Tran et al. (2010) used a 
commercial purified laccase from Trametes versicolor for the degradation of ten 
pharmaceutical micropollutants in spiked buffered water at pH 4.5. Similarly, to the results 
obtained with crude enzyme, purified laccase allowed fast and complete transformation of 
diclofenac, naproxen and indomethacin. High removal (>90%) of acetaminophen, 
imipramine, ketoconazole and TCS was achieved when purified laccase from Pleurotus 
ostreatus, Paraconiothyrium variable, Trametes versicolor and Pycnoporus sanguines were 
used (Ramírez-Cavazos et al., 2014; Stadlmair et al., 2017; Tahmasbi et al., 2016; Yousefi-
Ahmadipour et al., 2016). In contrast, Murugesan et al. (2010) reported that only 57% of TCS 
was transformed by laccase from Ganoderma lucidum. A commercial laccase purified from 
Myceliophthora thermophila has been reported to remove 65% and 40% of diclofenac (5 mg 
L-1) at pH 4 and 5, respectively, but no significant removal of naproxen was observed (Lloret 
et al., 2010). 
The effect of treatment conditions on the oxidation of diclofenac, mefenamic acid 
and TCS by commercial Trametes versicolor laccase was investigated by Margot et al. (2013). 
Experiments were carried out in spiked solutions at different pH values, enzyme 
concentrations, reaction times and temperatures. Results showed that the optimal 
conditions depended on the compound and that even if all the parameters considered were 
significant, pH had the greatest influence on the process performance. Thus, pH values 
between 4.5 to 6.5; temperatures above 25°C and 730 U L-1 of laccase led to removal yields 
higher than 90%. Interestingly, authors observed that the presence of other pharmaceuticals 
in the reaction mixture influenced the degradation. For example, the removal of diclofenac 
increased from 25 to 95% when mefenamic acid was also in the reaction medium. Low 
removal of different antibiotics was observed with the use of purified laccase. De Cazes et al. 
(2014) reported about 30% elimination of tetracycline treated with commercial Trametes 
versicolor laccase after 24 h reaction. In another work by Prieto et al. (2011), the same 
commercial purified laccase hardly reached 16% degradation of CIP (5 mg L-1). Table 2.9 
shows that not only antibiotics showed recalcitrance to laccase degradation since CBZ was 
also poorly degraded (<38%) irrespective to the type of laccase used (Nguyen et al., 2014b; 
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Tran et al., 2010). The inability of laccase to degrade compounds like CBZ has been related to 
the presence of functional groups (amide) in its structure that impede laccase attack (Yang 
et al., 2013). 
Overall, the results from the available studies demonstrate that laccases, either in 
crude or purified forms, can degrade a wide variety of pharmaceutical compounds at a broad 
range of operational conditions. However, most of the investigations cited here were 
performed a laboratory scale, in synthetic water and low reactional volumes which makes 
difficult to transpose these results to real wastewater applications. Moreover, some other 
considerations need to be taken into account for the potential application of these 
biocatalyst at higher scale such as the non-reusable nature of the enzyme, the possible 
inactivation due to environmental conditions or their reduced capacity to degrade 
compounds with considerable higher redox potential (Barrios-Estrada et al., 2018; Gasser et 
al., 2014). To overcome these limitations new treatment systems including the addition of 
redox mediators and the immobilization of the enzyme have been developed. In the next 
sections these options will be explored in more detail. 
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Table 2.9. Biotransformation of pharmaceutical micropollutants by purified laccase. 
Pharmaceutical Laccase source Concentration 
(mg L-1) 
Reaction conditions Efficiency  
(%) 
Reference 
Acetaminophen Pleurotus ostreatus 0.001 1.5 µM of laccase, 1.5 mL reaction, pH 
7.4, 25°C, 20 min 
100 (Stadlmair et al., 2017) 
Carbamazepine Asperguillus oryzae 5 90 U of laccase, 200 mL reaction 10 (Nguyen et al., 2014b) 
 Trametes 
versicolor 
0.01 6000 U L-1 of laccase, 10 mL reaction, 
pH 4.5, 30°C, 125 rpm, 3 h 
38 (Tran et al., 2010) 
Ciprofloxacin Trametes 
versicolor 
10 16.7 nKat mL-1 of laccase, 30°C, 150 
rpm, 20 h 
16 (Prieto et al., 2011) 
Diclofenac Asperguillus oryzae 5 90 µM min-1 of laccase, 200 mL 
reaction 
21 (Nguyen et al., 2014b) 
 Myceliophthora 
thermophila 
5 2000 U L-1 of laccase, 20 mL reaction, 
pH 4, 25°C, stirring, 8h 
65 (Lloret et al., 2010) 
 Pleurotus ostreatus 0001 1.5 µM of laccase, 1.5 mL reaction, pH 
7.4, 25°C, 20 min 
40 (Stadlmair et al., 2017) 
 Trametes 
versicolor 
0.01 6000 U L-1 of laccase, 10 mL reaction, 
pH 4.5, 30°C, 125 rpm, 3 h 
100 (Tran et al., 2010) 
Ibuprofen Trametes 
versicolor 
0.01 6000 U L-1 of laccase, 10 mL reaction, 
pH 4.5, 30°C, 125 rpm, 3 h 
38 (Tran et al., 2010) 
Imipramine Paraconiothyrium 
variable 
0.12 1.63 U of laccase, 5 mL reaction, pH 
4.9, 37°C, stirring, 5.7 h 
99 (Tahmasbi et al., 2016) 
Ketoconazole T versicolor 300 1 U mL-1 of laccase, pH 4.5, 45°C, 6h 98 (Yousefi-Ahmadipour et al., 2016) 
Sulfamethoxazole Asperguillus oryzae 5 90 µM min-1 of laccase, 200 mL 
reaction 
9 (Nguyen et al., 2014b) 
Tetracycline Trametes 
versicolor 
20 0,01 g L-1 of laccase, 100 mL reaction, 
pH6, 25°C, 24 h 
30 (De Cazes et al., 2014) 
Triclosan G lucidum 0.05 5 U of laccase, 1 mL reaction, pH 4, 
30°C, 24 h 
57 (Murugesan et al., 2010) 
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2.4.1.3 Laccase mediator system 
The effectiveness of laccase to catalyse the oxidation of pharmaceutical compounds is 
highly dependent on the redox potential of the enzyme. Moreover, the functional groups 
within the micropollutant structure also have an effect on the extent of their degradation by 
laccase. The presence of electron-donating groups (EDG) (e.g. amine (-NH2), hydroxyl (-OH), 
alkoxyl (-RO), alkyl (-R), acyl (-COR)) or electron withdrawing groups (EWG) (e.g. amide (-
CONR2), carboxylic (-COOH), halogen (-X) and nitro (-NO2)) could facilitate or oppose 
resistance to laccase attack (Yang et al., 2013). Thus, poor degradation of non-phenolic 
pharmaceutical micropollutants has been generally attributed to the presence of EWG in the 
molecular structure and to higher redox potential compared to laccase. 
Degradation efficiency of pharmaceutical micropollutants can be enhanced by using 
redox mediators, in the so-called laccase-mediator system, that act as electron shuttles 
between the target compounds and the enzyme. In a laccase mediator system, the 
enzymatic reaction becomes a two-step process (Fig. 2.8). First, the redox mediator reacts 
with the enzyme and generates strong oxidizing intermediates that then diffuses away from 
the enzymatic pocket and, by means of non-enzymatic mechanisms, enable the oxidation of 
compounds that in principle are not laccase substrates (Cañas and Camarero, 2010). 
Many different low molecular weight molecules have been used as mediators. The 
artificial mediators include compounds such as 2,2’-azino-bis-(3-ethylbenzothiazoline-6-
sulphonic acid) (ABTS), 1-hydroxybenzotriazole (HBT), violuric acid (VA), N-
hydroxyphtalamide (HPI), 2,2’,6,6’-Tetramethylpiperidine-N-oxyl (TEMPO) (Kunamneni et al., 
2008). Moreover in recent years, the use of natural compounds generated during the 
degradation of lignin by WRF have been also investigated for their potential application in 
bioremediation processes (Camarero and Ibarra, 2005; Cañas and Camarero, 2010). 
 
 
Fig. 2.8. Schematic diagram of laccase mediator system. 
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Mediators can be classified according to the oxidation mechanism they follow to 
promote the oxidation of substrates: hydrogen atom transfer, electron transfer and ionic 
oxidation. Mediators following the hydrogen atom transfer (HAT) mechanism include 
compounds that have N-hydroxyl functional groups in their chemical structure (e.g. 1-
hydroxylbenzotriazole, violuric acid). For HAT mechanism, the mediator undergoes the 
abstraction of a hydrogen atom to form nitroxyl radicals (N-O•) that will then react with 
target substrates (Kurniawati and Nicell, 2007). These types of mediators may be suitable for 
mediating the transformation of compounds with weak C-H bonds (Cantarella et al. 2003). 
The electron transfer (ET) route is followed by laccase-ABTS system. ABTS is an azino 
mediator that is oxidized by laccase to produce ABTS cation radicals (ABTS•+ or ABTS2+) that 
will then serve as a shuttle for electron transfer between the target substrate and the 
enzyme (Kunamneni et al., 2007). ABTS has been proposed as mediator for the 
transformation of compounds with relatively low oxidation potential (Catarella et al., 2003). 
Finally, TEMPO follows ionic mechanism to favour the oxidation of primary and secondary 
alcohols (Fabrini et al., 2002). It is oxidized by laccase forming an oxoammonium ion (N=O•) 
which subsequently oxidizes the substrate and is reduced to N-hydroxy-TEMPO. This species 
may undergo acid-induced disproportionation or be re-oxidized by laccase, resulting in the 
regeneration of the oxoammonium ion (Kurniawati and Nicell, 2007). Table 2.10 summarizes 
the characteristics of the most studied mediators. 
Several studies have demonstrated improvement in the removal of pharmaceutical 
micropollutants by the addition of mediators. Prieto et al. (2011) reported that the addition 
of ABTS increased the oxidation yields of CIP from 16 to 98% and of NOR from zero to 34% 
after 30 h treatment. Lloret et al. (2010) compared the removal of naproxen and diclofenac 
by Myceliophthora thermophila laccase and laccase-HBT system at pH 4 and 5. The authors 
showed that laccase-HBT was able to enhance the removal of diclofenac by 30% and 25% at 
pH 4 and 5, respectively; whereas naproxen removal was 60% and 40% respectively. In 
another study Hata et al. (2010) observed that the aminoxyl radicals generated in the 
laccase-HBT system could reduce the concentration of CBZ by 60% when a repeated dose of 
the mediator was added to the reaction medium. 
Laccase-mediator systems performance has been found to be dependent on the 
mediator concentration. The removal of CBZ was enhanced (from 47% to 95%) when the 
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concentration of ABTS increased from 6 to 14 µM in combination with Trametes versicolor 
laccase (Naghdi et al., 2018a). Blanquez et al. (2016) studied the removal of CIP and NOR by 
testing different natural mediators including SYR, acetosyringone and methyl syringate (500 
µM) at alkaline conditions. Results showed that acetosyringone was the best mediator 
achieving almost complete removal (>90%) for the two antibiotics in 24 h. However, when 
these authors increased by five-fold the concentration of mediators higher removal of the 
antibiotics was observed, leading to six and four-fold increased degradation of CIP and NOR 
respectively for acetosyringone and 17 and 20-fold enhanced removal in the case of methyl 
syringate (Blanquez et al., 2016). In another study, Murugesan et al. (2010) reported that 
using a mediator to pollutant ratio of 5:1, at a mediator concentration of 1mM, led to 
considerably better removal of TCS (up to 85%) using SYR or HBT compared to using laccase 
treatment alone. Margot et al., (2015a) investigated the removal of SMX with Trametes 
versicolor laccase mediated by ABTS, SYR and acetosyringone finding that mediators were 
consumed at a mediator-pollutant molar ratio of 1.1-16. However, increasing the mediator 
concentration beyond a limit may not affect the removal of the micropollutants as suggested 
by Ashe et al. (2016) who reported that naproxen was efficiently eliminated by Pleurotus 
ostreatus laccase in the presence of VA or HBT, but increasing concentration of VA from 0.5 
to 1 mM caused no improvement in the removal of the drug. 
The capacity of mediators to improve the degradation of pharmaceuticals is 
compound specific. For example, Ding et al. (2016) compared the performance of SYR and 
HBT (0.5 mM) for the removal of mixtures of sulfonamide, tetracycline and quinolone 
antibiotics. SYR showed better removal than HBT for sulfonamides and tetracyclines. Weng 
et al. (2012) investigated the effect of six mediators on degradation of sulfadimethoxine and 
sulfamanomethoxine by laccase. These authors reported that ABTS and VA provided the 
fastest transformation, while relatively slower transformation was observed with SYR and 4-
hydroxybenzyl alcohol and at last no significant impact of 4-hydroxyacetophenone and 4-
cyanopheno was evidenced (Weng et al., 2012). A screening of seven mediators for the 
degradation of trace organic pollutants showed that ABTS and VA were better at the 
transformation of phenolic compounds such as oxybenzone and pentachlorophenol, whilst 
non-phenolic compounds like naproxen were better removed by VAN and HBT (Ashe et al., 
2016). 
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An issue regarding the use of mediators is the possibility that radicals generated from 
the reaction could inactivate the laccase. The activity of laccase was reduced by 90% after 8 
h of contact with HBT mediator (Hata et al., 2010). Similarly, Ashe et al. (2016) reported a 
loss of activity of laccase after the addition of mediators. For example, when TEMPO, HPI, SA 
or VAN were added the loss of laccase activity was negligible (<10%) but also low pollutant 
removal was observed. In contrast, a significant loss in laccase activity was observed after 
the addition of VA, HBT or ABTS but the highest removals were obtained with these 
mediators (Ashe et al., 2016). Moreover, the extent of inactivation of the enzyme depends 
on the concentration of the mediator. Nguyen et al. (2014a) observed that laccase lost 14-
39% of its activity when HBT dose was in the range from 0.1-1 mM. 
The use of laccase-mediator systems for the treatment of pharmaceutical 
micropollutants shows promising results. However, the application of laccase-mediator 
systems in continuous operation is limited due to the necessity of constant addition of 
mediator which at the end increases the cost of the treatment and makes the process more 
difficult to operate (Nguyen et al., 2014b). Moreover, in some cases the use of mediator may 
increase the toxicity of the treated effluent as shown for ABTS and SYR (Kim and Nicell, 2006; 
Nguyen et al., 2014b). Thereby, the laccase-mediator treatment results ineffective or even 
adverse by creating another environmental problem. In order to develop an effective 
removal process based on the use of laccase and redox mediator, aspects such as the 
selection of the appropriate mediator and its optimal concentration and the monitoring of 
toxicity after treatment are critical and need to be investigated in detail. 
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Table 2.10. Characteristics of redox mediators used in laccase-mediator systems for the degradation of pharmaceutical micropollutants. 
Compound Type of mediator Free radicals generated Oxidation 
mechanism 
Chemical structure Substrates References 
ABTSA Synthetic ABTS+• 
ABTS2+ 
ET 
 
AMXI, CBZJ, CIPK, 
NORL, SPDM, STZN 
Naghdi et al. (2018a); 
Parra Guardado et al. 
(2019); Prieto et al. 
(2011); Rodríguez-
Rodríguez et al. (2012) 
HBTB Synthetic Aminoxyl HAT 
 
CBZ, NPXO, TCSP, 
DCFQ 
Ashe et al. (2016); Hata 
et al. (2010); Lloret et al. 
(2010); Murugesan et al. 
(2010) 
TEMPOC Synthetic Oxoammonium (N=O•) Ionic 
 
NPX 
Ashe et al.(2016) 
VAD Synthetic Aminoxyl HAT 
 
SPD, STZ, NPX Ashe et al. (2016); 
Rodríguez-Rodríguez et 
al. (2012) 
HPIE Synthetic Aminoxyl HAT 
 
NPX 
Ashe et al. (2016) 
SYRF Natural Phenoxyl HAT 
 
SMXR, TCS, CIP, DCF Lloret et al. (2010; 
Murugesan et al. (2010); 
Parra Guardado et al. 
(2019) 
VANG Natural Phenoxyl HAT 
 
NPX 
Ashe et al. (2016) 
PCAH Natural Phenoxyl HAT 
 
AMX, SMX, CIP 
Parra Guardado et al. 
(2019) 
A: 2,2-azino-nis (3-ethylbenzothiazoline-6-sulfnoic acid); B: 1-hydroxibenzotriazole; C: 2,2,6,6-tetramethylpiperidinyloxyl; D: Violuric acid; E: N-hydroxyphthalimide; F: Syringaldehyde; G: 
Vanillin; H: p-coumaric acid; I: Amoxicillin; J: Carbamazepine; K: Ciprofloxacin; L: Norfloxacin; M: Sulfapyridine; N: Sulfathiazole; O: Naproxen; P: Triclosan; Q: Diclofenac; R: Sulfamethoxazole. 
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2.4.2 Removal by immobilized laccase 
Although batch experiment setups are convenient for assessing the feasibility of using 
laccases for the removal of micropollutants, larger scale applications such as in a WWTP 
need to be operated in continuous mode. This necessitates that enzymes are retained in the 
reactor since continuous addition of enzymes, as mentioned above, would lead to increased 
treatment costs (Gasser et al., 2014). Moreover, large scale applications of enzymes often 
get hampered by their lack of long-term operational stability, susceptibility to inactivation 
and their difficult recovery or reusability. Enzyme immobilization is a potential solution for 
these problems since it allows continuous operation and reuse of the biocatalyst.  
Enzyme immobilization is a process in which an enzyme is located or confined into a 
matrix or support, resulting in insoluble forms that retain catalytic activity (Datta et al., 
2013). There are several reasons for using enzymes in immobilized form; immobilization 
enhances enzyme stability, protects enzyme from denaturation and facilitates handling and 
recovery as well as their reuse over several reaction cycles maintaining good catalytic 
efficiency (Cabana et al., 2009; Ji et al., 2017; Patel et al., 2014; Sheldon, 2007; Zheng et al., 
2016). According to several published reviews, methods for immobilization can be classified 
in different ways (An et al., 2015; Fernández-Fernández et al., 2013; Mohamad et al., 2015; 
Sheldon and van Pelt, 2013). However, there are typically three different types of 
immobilization approaches: (i) binding to a carrier, (ii) cross-linking, and (iii) 
entrapment/encapsulation (Fig. 2.9).  
 
 
Figure 2.9. Immobilization of enzymes. 
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The immobilization of enzymes to supports can be by adsorption (hydrophobic or Van 
der Waals interactions), ionic forces or covalent bonds, and can be performed on different 
types of material carriers. These materials are generally divided into organic (e.g. chitosan, 
alginate, polyamide), inorganic (silica, alumina, clay, active carbon) and hybrid/composite 
materials (silica-magnetite, chitosan-silica) (Cantone et al., 2013; Datta et al., 2013; Zdarta et 
al., 2018a). 
The immobilization via adsorption involves the enzyme being physically adsorbed or 
attached onto the support material. Adsorption is based on the creation of non-specific 
interactions mainly via hydrogen bonds, ionic or hydrophobic interactions. Thus, 
conformational changes in the enzyme structure are limited which results in the retention of 
high catalytic activity (Hernandez and Fernandez-Lafuente, 2011). Immobilization by 
covalent binding is based on the reaction of functional groups of the support material with 
functional groups of the enzyme (mainly –NH2, -SH, and –OH) resulting in the formation of 
strong chemical bonds which significantly increases laccase stability and reduces its leakage 
(Datta et al., 2013). Encapsulation refers to the confinement of the enzyme within 
semipermeable spheres made of polymers (Rochefort et al., 2008); whilst, entrapment is 
based on the retention of the enzyme within a polymeric grid or fibers which assures the 
integrity of the enzyme structure (Mohamad et al., 2015). The cross-linking involves the 
generation of intramolecular links between the molecules of the enzyme by means of 
bifunctional compounds such as GLU or carbodiimides. In this way, enzymes in the form of 
cross linking enzyme crystals (CLECs) or cross linking enzyme aggregates (CLEAs) form stable 
structures without the use of a solid supports (Cao et al., 2003; Sheldon and van Pelt, 2013). 
Table 2.11 presents the main advantages and disadvantages of the different 
immobilization techniques. Overall, immobilization methods involving the formation of 
chemical bonds provide stable attachment and reduce enzyme inactivation rates; however, 
the activity of the biocatalyst could be reduced due to the modification of the native enzyme 
structure induced by the covalent bonds (Sheldon, 2007). In contrast, adsorption and 
entrapment methods typically have fewer effects on the structure of the enzyme but 
provide less stability during the reaction (Durán et al., 2002). It is clear the immobilization 
process significantly influences the properties of the immobilized enzyme as the 
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immobilization method determines the process specification of an enzyme such as cost, 
catalytic activity, effectiveness and deactivation kinetics (Naghdi et al., 2018b). 
 
Table 2.11. Advantages and drawbacks of immobilization techniques. 
Immobilization 
technique 
Strength of 
interactions 
Advantages Drawbacks 
Adsorption Weak No enzyme modification 
Simple and inexpensive 
Reusability of support 
Lower efficacy level 
Desorption of enzymes 
Covalent bond Strong Strong and stable interactions 
Multipoint attachment 
Relatively simple method 
Variety of supports available 
Competitive inhibition issues 
Enzyme chemical modification 
Loss of functional 
conformation of enzyme 
Encapsulation Weak No enzyme modification 
Protection of enzyme 
Cost effective method 
Less concentration of 
enzymes 
Generation of unwanted 
products 
Entrapment Weak/strong No enzyme modification 
Fast method 
Low cost 
Enzyme leaking 
Pore diffusion limitations 
Low level of industrial 
application 
Cross-linking Strong No support needed 
High strength of interactions 
Polyfunctional reagents are 
required 
Denaturation or structural 
modification by cross-linker 
 
 
The selection of the immobilization method should be done not only taking into 
account the characteristics of each technique but also the type of biocatalyst to immobilize 
and the bio-catalytic process in which immobilized enzyme will be applied. In this sense, 
covalent binding seems to be the most suitable option for laccase immobilization for water 
and wastewater treatment applications since this approach typically yields more stable 
biocatalyst compared to other immobilization methods. Stability is a key factor if the 
immobilized enzymes will be used in tertiary wastewater treatment processes in which the 
enzymes are exposed to harsh environmental conditions (i.e. high pH, turbulent flows, 
denaturing agents) (Gasser et al., 2014). In comparison to the other immobilization 
techniques (adsorption, encapsulation) where the binding forces are too weak to prevent 
enzyme leakage, covalent immobilization results in a more stable attachment of the laccase 
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on the support (Sheldon, 2007). Thus, covalent binding of laccases on solid materials for 
pollutants removal has been intensively investigated (Cabana et al., 2009; Jahangiri et al., 
2014; Liu et al., 2012; Lloret et al., 2012; Mohammadi et al., 2018; Pezzella et al., 2014; Xu et 
al., 2013). 
According to Zdarta et al. (2018) the immobilization methodology has a strong 
influence in the selection of the carrier. However, the selected support not only serves as a 
surface where the enzyme can be attached, but its physical and chemical properties also 
have an influence in the properties of the immobilized enzyme (Cao et al., 2003). Materials 
with numerous functional groups facilitate covalent immobilization and multipoint 
attachment of the laccase molecules. In this way the stability of the biocatalyst is improved, 
however it might also lead to diffusional limitations in transport of substrates (Zdarta et al., 
2018a). Inorganic materials such as mesoporous silica and hollow carbon spheres (Fortes et 
al., 2017; Shao et al., 2019), organic carriers of natural origin like chitosan or coconut fibers 
(Cristóvão et al., 2012; Zheng et al., 2016) and even hybrid materials such as magnetic 
chitosan/clay beads (Aydemir and Güler, 2015) can be used for covalent immobilization. 
Organic and inorganic supports are an interesting option from the point of view of economy 
and stability, whilst hybrid and composites materials are attractive because they can be 
specially design for specific applications resulting in an improvement of the whole process. 
Inorganic materials are especially suitable for covalent immobilization of laccases for 
water treatment applications due to all the properties they display. These materials show 
exceptional mechanical and chemical stability properties which ensure the integrity of the 
biocatalyst during the process (Zucca and Sanjust, 2014). Inorganic carriers also have many 
different functional groups (i.e hydroxyl, carboxyl, carbonyl) that facilitates enzyme 
attachment and support functionalization with modifying agents like GLU or 3-
aminpropyltriethoxyxilane (APTES) which is convenient for covalent immobilization (Zucca 
and Sanjust, 2014). Another advantage is the large specific surface area (up to 1500 m2 g-1) 
inorganic carriers offer allowing high retention of enzyme (Magner, 2013; Thielemann et al., 
2011). Moreover, these materials are relatively easy and cheap to obtain due to their 
abundant presence in nature and their simple synthesis procedure. Thus, inorganic supports 
can be obtained in different shapes and sizes and even form part of hybrid or composite 
materials. The versatility showed by inorganic materials is important since activity of the 
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covalent bonded laccase usually depends on the size, specific area and shape of carrier 
material (dos Santos et al., 2015; Mohamad et al., 2015). 
In this sense, the use of inorganic (nano)particles are growing interest since they 
provide a large surface area for enzyme binding leading to higher laccase loading at the 
same time that minimizes diffusional limitations (Ansari and Husain, 2012; Zdarta et al., 
2018b). For instance, Trametes versicolor laccase was covalently immobilized onto TiO2 
nanoparticles and the resulting biocatalyst was used for the removal of the recalcitrant CBZ 
(Ji et al., 2016b). In comparison to free laccase the active TiO2 nanoparticles showed 
improved stability allowing degrading 60% of the pharmaceutical in combination with PCA as 
redox mediator. These authors observed a minimal loss of enzymatic activity at the end of 96 
h of reaction which was attributed to the improved conformational strength of the laccase 
on the support and the decrease of mass transfer resistance. In another study by Ji et al. 
(2016), the potentiality of cross-linked carbon nanotubes-based bio-catalytic membranes 
was investigated for the degradation of a mixture of five micropollutants including CBZ, 
diclofenac and ibuprofen in an enzymatic membrane reactor (EMR). The covalently 
immobilized membrane with laccase from Trametes versicolor yielded to high laccase 
loading and specific activity values (140 µg cm-2 and 0.40 U cm-2), and showed enhanced 
stability for long term storage and under hydraulic shear stress. The bio-catalytic membrane 
was able to degrade micropollutants at a high extent (46-90%) while keeping 84% of its 
original activity after 48 h of reaction which indicates the good stability of the immobilized 
enzyme.  
As shown in Table 2.12 broad range of support materials and immobilization 
techniques have been used for the preparation of biocatalyst for the degradation of 
pharmaceutical compounds in both synthetic and real wastewaters. For example, Kumar and 
Cabana (2016) reported the immobilization of laccase as CLEAS on magnetic nanoparticles 
(MAC-CLEAs) for the simultaneous treatment of 13 pharmaceuticals. The MAC-CLEAs 
showed enhanced storage stability over more than one year at 4˚C and the capacity to be 
reused even after 150 batch cycles with ABTS as substrate. Moreover, the biocatalyst was 
extremely efficient for the degradation of the mixture of pharmaceuticals achieving high 
removal yields (40-99%) for 10 of the 13 compounds including almost complete degradation 
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of mefenamic acid, acetaminophen, diclofenac atenolol and epoxy-CBZ within 12 h of 
reaction. 
Immobilization of laccases onto different supports not only improves enzyme stability 
for the degradation of the pharmaceuticals but also, in some cases, the carrier plays a 
complementary role in the removal process as demonstrated in several studies (Cabana et 
al., 2009; Dai et al., 2016; Naghdi et al., 2017; Nguyen et al., 2016; Shao et al., 2019). Shao et 
al. (2019) immobilized laccase onto hollow carbon nanospheres by both physical adsorption 
and covalent binding. The adsorbed biocatalyst showed the best results in terms of high 
enzyme loading (835 mg g-1) and excellent thermal, pH and long storage stability and 
reusability. The biocatalysts were then used for the removal of tetracycline and CIP 
hydrochloride obtaining high removal yields (up to 99%) for the two compounds which was 
attributed to the synergistic action of adsorption on the support and enzymatic degradation 
since the biocatalyst support showed high sorption capacity towards the antibiotics (55% for 
tetracycline and 77% for CIP).  
Similarly, Nguyen et al. (2016) observed that removal of bisphenol A, diclofenac, CBZ 
and SMX by laccase adsorbed on granular activated carbon in a packed-bed column was via 
the simultaneous adsorption and degradation processes, especially for the removal of the 
recalcitrant CBZ and diclofenac compounds. Authors suggested that the co-adsorption of 
laccase and micropollutants onto the carrier facilitated enzymatic degradation due to the 
enhancement of electro transfer between the laccase and substrate molecules after 
adsorption on the support surface. In this context, results interesting to explore the 
possibility of using support materials offering properties for combining enzyme 
immobilization and adsorption of both pollutants and reaction by-products. Such systems 
could lead to efficient processes were the enhanced bioconversion of pollutants due to the 
immobilization of enzyme would be reinforced by adsorption in order to obtain cleaner 
effluents in one step treatment. Therefore, future research should focus on the 
development of new support/sorbent materials as well as innovative immobilization 
techniques leading to multifunctional biocatalyst showing high catalytic properties for the 
removal of toxic environmental pollutants. 
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Table 2.12. Removal of pharmaceutical compounds by immobilized laccase. 
Pharmaceutical Enzyme source Immobilization 
technique 
Support material Reaction conditions Removal 
(%) 
Reference 
Acetaminophen Trametes 
versicolor 
Cross-linking Magnetic CLEAs 50 µg L-1 pollutant, 1000 U L-1 of 
laccase, 10 mL reaction, pH 7, 30°C, 6 
h in batch reactions with wastewater 
27 (Arca-Ramos et al., 2016) 
Trametes 
versicolor 
Cross-linking MAC-CLEAs 100 µg L-1 pollutant, 1000 U L-1 of 
laccase, 10 mL reaction, pH 7, 20˚C, 
12 h in batch reactions 
97 (Kumar and Cabana, 
2016) 
Amoxicillin Trametes 
versicolor 
Covalent 
immobilization 
TiO2 multichannel 
membrane 
10 µg L-1 pollutant, 1mM SYR, 5 L 
reaction, pH 6, 25°C, 24 h in EMR 
95 (Becker et al., 2016) 
Carbamazepine Trametes 
versicolor 
Covalent 
immobilization 
TiO2 nanoparticles 20 µM pollutant, 1mM PCA, 0,5 U ml-
1 of laccase, pH 7 in reactor 
60 (Ji et al., 2016b)016 
Trametes 
versicolor 
Adsorption Cross-linked carbon 
nanotube membranes 
20 µM pollutant, 0.45 U cm-2 of 
laccase, pH 5.5, 48 h in membrane 
cell  
48 (Ji et al., 2016a) 
Trametes 
versicolor 
Adsorption Biochar 20 ng L-1 pollutant, 20 mL reaction, 
25°C, 24 h in batch reaction with 
wastewater 
66 (Naghdi et al., 2017) 
Clofibric acid Trametes 
versicolor 
Adsorption Cross-linked carbon 
nanotube membranes 
20 µM pollutant, 0.45 U cm-2 of 
laccase, pH 5.5, 48 h in membrane 
cell  
45 (Ji et al., 2016a) 
Ciprofloxacin Trametes 
versicolor 
Covalent 
immobilization 
TiO2 multichannel 
membrane 
11 µg L-1 pollutant, 1mM SYR, 5 L 
reaction, pH 6, 25°C, 24 h in EMR 
93 (Becker et al., 2016) 
Diclofenac Asperguillus 
oryzae 
Adsorption Activated carbon 2.5 mg L-1 pollutant, 100 mL reaction, 
25°C, 2 h in batch reactions 
90 (Nguyen et al., 2016) 
Pleurotus 
florida 
Covalent 
immobilization 
Poly(lactic-co-glycolic 
acid) nanofiber 
50 mg L-1 pollutant, 4 U of laccase, 
25 mM SYR, 1 mL volume, pH 4, 
30°C, 5h 
100 (Sathishkumar et al., 
2012) 
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Table 2.12. Removal of pharmaceutical compounds by immobilized laccase (continuation). 
Pharmaceutical Enzyme source 
Immobilization 
technique 
Support material Reaction conditions 
Removal 
(%) 
Reference 
Diclofenac Trametes 
versicolor 
Cross-linking MAC-CLEAs 100 µg L-1 pollutant, 1000 U L-1 of 
laccase, 10 mL reaction, pH 7, 20˚C, 
12 h in batch reactions 
95 (Kumar and Cabana, 
2016) 
Ibuprofen Trametes 
versicolor 
Adsorption Cross-linked carbon 
nanotube membranes 
20 µM pollutant, 0.45 U cm-2 laccase, 
pH 5.5, 48 h in membrane cell 
60 (Ji et al., 2016a) 
Mefenamic acid Trametes 
versicolor 
Cross-linking MAC-CLEAs 100 µg L-1 pollutant, 1000 U L-1 of 
laccase, 10 mL reaction, pH 7, 20˚C, 
12 h in batch reactions 
99 (Kumar and Cabana, 
2016) 
Sulfamethoxazole Asperguillus 
oryzae 
Adsorption Carbon activated 2.5 mg L-1 pollutant, 100 mL volume, 
25°C, 2 h in batch reactions 
92 (Nguyen et al., 
2016) 
Trametes 
versicolor 
Covalent 
immobilization 
CPC silica beads 50 mg L-1 pollutant, 1 U mL-1 of 
laccase, 1mM HBT, 5 mL reaction, pH 
5, 40°C, 1 h in batch reactions 
76 (Rahmani et al., 
2015) 
Cerrena 
unicolor 
Cross-linking Magnetic CLEAs 100 mg L-1 pollutant, 20 U ml-1 of 
laccase, 5 µM ABTS, pH 7, 25°C, 48 h 
in batch reactions 
29 (J. Yang et al., 2017) 
Sulfathiazole Trametes 
versicolor 
Covalent 
immobilization 
CPC silica beads 50 mg L -1pollutant, 1 U ml-1 of 
laccase, 1mM HBT, 5 mL reaction, pH 
5, 40°C, 1 h in batch reactions 
85 (Rahmani et al., 
2015) 
Tetracycline Trametes 
versicolor 
Covalent 
immobilization 
Mono-channel ceramic 
membrane 
20 mg L-1 pollutant, 0,01 g L-1 of 
laccase, pH6, 25°C, 24 h in batch 
reactions 
56 (De Cazes et al., 
2014) 
Tetracycline Cerrena 
unicolor 
Cross-linking Magnetic CLEAs 100 mg L-1 pollutant, 20 U mL-1 of 
laccase, pH 7, 25°C, 48 h in batch 
reactions 
65 (J. Yang et al., 2017) 
Triclosan Trametes 
versicolor 
Encapsulation Carbon nanotube 
modified electrospun 
fibrous membranes 
10 mg L-1 pollutant, 2 mg of laccase, 
30 mL reaction, pH 7, 25°C, 5 h in 
batch reactions 
100 (Dai et al., 2016) 
Chapter 2 
 
71 
 
References 
Ahmed, M.B., Zhou, J.L., Ngo, H.H., Guo, W., Thomaidis, N.S., Xu, J., 2017. Progress in the biological 
and chemical treatment technologies for emerging contaminant removal from wastewater: A 
critical review. J. Hazard. Mater. 323, 274–298. https://doi.org/10.1016/j.jhazmat.2016.04.045 
Ahmed, M.M., Chiron, S., 2014. Solar photo-Fenton like using persulphate for carbamazepine 
removal from domestic wastewater. Water Res. 48, 229–236. 
https://doi.org/10.1016/J.WATRES.2013.09.033 
Akmehmet Balcıoğlu, I., Ötker, M., 2003. Treatment of pharmaceutical wastewater containing 
antibiotics by O3 and O3/H2O2 processes. Chemosphere 50, 85–95. 
https://doi.org/10.1016/S0045-6535(02)00534-9 
Alexander, J.T., Hai, F.I., Al-aboud, T.M., 2012. Chemical coagulation-based processes for trace 
organic contaminant removal: Current state and future potential. J. Environ. Manage. 111, 195–
207. https://doi.org/10.1016/j.jenvman.2012.07.023 
Alharbi, S.K., Price, W.E., Kang, J., Fujioka, T., Nghiem, L.D., 2016. Ozonation of carbamazepine, 
diclofenac, sulfamethoxazole and trimethoprim and formation of major oxidation products. 
Desalin. Water Treat. 57, 29340–29351. https://doi.org/10.1080/19443994.2016.1172986 
Almomani, F.A., Shawaqfah, M., Bhosale, R.R., Kumar, A., 2013. Removal of Emerging 
Pharmaceuticals from Wastewater by Ozone-Based Advanced Oxidation Processes. Environ. 
Prog. Sustain. Energy 35, 982–995. 
Altmann, J., Ruhl, A.S., Zietzschmann, F., Jekel, M., 2014. Direct comparison of ozonation and 
adsorption onto powdered activated carbon for micropollutant removal in advanced 
wastewater treatment. Water Res. 55, 185–193. 
https://doi.org/10.1016/J.WATRES.2014.02.025 
An, N., Zhou, C.H., Zhuang, X.Y., Tong, D.S., Yu, W.H., 2015. Immobilization of enzymes on clay 
minerals for biocatalysts and biosensors. Appl. Clay Sci. 114, 283–296. 
https://doi.org/10.1016/j.clay.2015.05.029 
Andreozzi, R., Campanella, L., Fraysse, B., Garric, J., Gonnella, A., Lo Giudice, R., Marotta, R., Pinto, G., 
Pollio, A., 2004. Effects of advanced oxidation processes (AOPs) on the toxicity of a mixture of 
pharmaceuticals. Water Sci. Technol. 50, 23–28. https://doi.org/10.2166/wst.2004.0304 
Andreozzi, R., Canterino, M., Marotta, R., Paxeus, N., 2005. Antibiotic removal from wastewaters: 
The ozonation of amoxicillin. J. Hazard. Mater. 122, 243–250. 
https://doi.org/10.1016/J.JHAZMAT.2005.03.004 
Ansari, S.A., Husain, Q., 2012. Potential applications of enzymes immobilized on/in nano materials: A 
review. Biotechnol. Adv. 30, 512–523. https://doi.org/10.1016/J.BIOTECHADV.2011.09.005 
Arca-Ramos, A., Kumar, V. V, Eibes, G., Moreira, M.T., Cabana, H., 2016. Recyclable cross-linked 
laccase aggregates coupled to magnetic silica microbeads for elimination of pharmaceuticals 
from municipal wastewater. Environ. Sci. Pollut. Res. 23, 8929–8939. 
https://doi.org/10.1007/s11356-016-6139-x 
Archer, E., Petrie, B., Kasprzyk-hordern, B., Wolfaardt, G.M., 2017. The fate of pharmaceuticals and 
personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and 
illicit drugs in a WWTW and environmental waters. Chemosphere 174, 437–446. 
https://doi.org/10.1016/j.chemosphere.2017.01.101 
 
Chapter 2 
 
72 
 
Arslan-Alaton, I., Dogruel, S., 2004. Pre-treatment of penicillin formulation effluent by advanced 
oxidation processes. J. Hazard. Mater. 112, 105–113. 
https://doi.org/10.1016/J.JHAZMAT.2004.04.009 
Ashe, B., Nguyen, L.N., Hai, F.I., Lee, D.J., van de Merwe, J.P., Leusch, F.D.L., Price, W.E., Nghiem, L.D., 
2016. Impacts of redox-mediator type on trace organic contaminants degradation by laccase: 
Degradation efficiency, laccase stability and effluent toxicity. Int. Biodeterior. Biodegrad. 113, 
169–176. https://doi.org/10.1016/j.ibiod.2016.04.027 
Auriol, M., Filali-Meknassi, Y., Adams, C.D., Tyagi, R.D., Noguerol, T.-N., Piña, B., 2008. Removal of 
estrogenic activity of natural and synthetic hormones from a municipal wastewater: Efficiency 
of horseradish peroxidase and laccase from Trametes versicolor. Chemosphere 70, 445–452. 
https://doi.org/10.1016/J.CHEMOSPHERE.2007.06.064 
Avisar, D., Lester, Y., Ronen, D., 2009. Sulfamethoxazole contamination of a deep phreatic aquifer. 
Sci. Total Environ. 407, 4278–4282. https://doi.org/10.1016/j.scitotenv.2009.03.032 
Ay, F., Kargi, F., 2010. Advanced oxidation of amoxicillin by Fenton’s reagent treatment. J. Hazard. 
Mater. 179, 622–627. https://doi.org/10.1016/J.JHAZMAT.2010.03.048 
Aydemir, T., Güler, S., 2015. Characterization and immobilization of Trametes versicolor laccase on 
magnetic chitosan-clay composite beads for phenol removal. Artif. Cells, Nanomedicine 
Biotechnol. 43, 425–432. https://doi.org/10.3109/21691401.2015.1058809 
Barbosa, M.O., Moreira, N.F.F., Ribeiro, A.R., Pereira, M.F.R., 2016. Occurrence and removal of 
organic micropollutants: An overview of the watch list of EU Decision 2015/495. Water Res. 94, 
257–279. https://doi.org/10.1016/j.watres.2016.02.047 
Barra Caracciolo, A., Topp, E., Grenni, P., 2015. Pharmaceuticals in the environment: Biodegradation 
and effects on natural microbial communities. A review. J. Pharm. Biomed. Anal. 106, 25–36. 
Barrios-Estrada, C., de Jesús Rostro-Alanis, M., Muñoz-Gutiérrez, B.D., Iqbal, H.M.N., Kannan, S., 
Parra-Saldívar, R., 2018. Emergent contaminants: Endocrine disruptors and their laccase-
assisted degradation – A review. Sci. Total Environ. 612, 1516–1531. 
https://doi.org/10.1016/J.SCITOTENV.2017.09.013 
Becker, D., Varela Della Giustina, S., Rodriguez-Mozaz, S., Schoevaart, R., Barceló, D., de Cazes, M., 
Belleville, M.P., Sanchez-Marcano, J., de Gunzburg, J., Couillerot, O., Völker, J., Oehlmann, J., 
Wagner, M., 2016. Removal of antibiotics in wastewater by enzymatic treatment with fungal 
laccase – Degradation of compounds does not always eliminate toxicity. Bioresour. Technol. 
219, 500–509. https://doi.org/10.1016/j.biortech.2016.08.004 
Behera, S.K., Kim, H.W., Oh, J.E., Park, H.S., 2011. Occurrence and removal of antibiotics, hormones 
and several other pharmaceuticals in wastewater treatment plants of the largest industrial city 
of Korea. Sci. Total Environ. 409, 4351–4360. https://doi.org/10.1016/j.scitotenv.2011.07.015 
Bernhard, M., Müller, J., Knepper, T.P., 2006. Biodegradation of persistent polar pollutants in 
wastewater: Comparison of an optimised lab-scale membrane bioreactor and activated sludge 
treatment. Water Res. 40, 3419–3428. https://doi.org/10.1016/j.watres.2006.07.011 
Blanquez, A., Guillen, F., Rodriguez, J., Arias, M.E., Hernandez, M., 2016. The degradation of two 
fluoroquinolone based antimicrobials by SilA, an alkaline laccase from Streptomyces ipomoeae. 
World J. Microbiol. Biotechnol. 32, 1–8. https://doi.org/10.1007/s11274-016-2032-5 
Borikar, D., Mohseni, M., Jasim, S., 2015. Evaluations of conventional, ozone and UV/H2O2 for 
removal of emerging contaminants and THM-FPS. Water Qual. Res. J. Canada 50, 140–151. 
https://doi.org/10.2166/wqrjc.2014.018 
Chapter 2 
 
73 
 
Brijwani, K., Rigdon, A., Vadlani, P. V., 2010. Fungal Laccases: Production, Function, and Applications 
in Food Processing. Enzyme Res. 2010, 1–10. https://doi.org/10.4061/2010/149748 
Bu, Q., Wang, B., Huang, J., Deng, S., Yu, G., 2013. Pharmaceuticals and personal care products in the 
aquatic environment in China: A review. J. Hazard. Mater. 262, 189–211. 
https://doi.org/10.1016/j.jhazmat.2013.08.040 
Cabana, H., Alexandre, C., Agathos, S.N., Jones, J.P., 2009. Immobilization of laccase from the white 
rot fungus Coriolopsis polyzona and use of the immobilized biocatalyst for the continuous 
elimination of endocrine disrupting chemicals. Bioresour. Technol. 100, 3447–3458. 
https://doi.org/10.1007/s10103-009-0744-6 
Cabana, H., Jiwan, J.L.H., Rozenberg, R., Elisashvili, V., Penninckx, M., Agathos, S.N., Jones, J.P., 2007. 
Elimination of endocrine disrupting chemicals nonylphenol and bisphenol A and personal care 
product ingredient triclosan using enzyme preparation from the white rot fungus Coriolopsis 
polyzona. Chemosphere 67, 770–778. https://doi.org/10.1016/j.chemosphere.2006.10.037 
Camarero, S., Ibarra, D., 2005. Lignin-Derived Compounds as Efficient Laccase Mediators for 
Decolorization of Different Types of Recalcitrant Dyes. Appl. Environ. Microbiol. 71, 1775–1784. 
https://doi.org/10.1128/AEM.71.4.1775 
Cañas, A.I., Camarero, S., 2010. Laccases and their natural mediators: Biotechnological tools for 
sustainable eco-friendly processes. Biotechnol. Adv. 28, 694–705. 
https://doi.org/10.1016/j.biotechadv.2010.05.002 
Cantone, S., Ferrario, V., Corici, L., Ebert, C., Fattor, D., Spizzo, P., Gardossi, L., 2013. Efficient 
immobilization of industrial biocatalysts: criteria and constrains for the selection of organic 
polymeric carriers and immobilization methods. Chem. Soc. Rev. 42, 6262–6276. 
https://doi.org/10.1039/c3cs35464d 
Cao, L., Langen, L. van, Sheldon, R.A., 2003. Immobilised enzymes: carrier-bound or carrier-free? 
Curr. Opin. Biotechnol. 14, 387–394. https://doi.org/10.1016/S0958-1669(03)00096-X 
Cars, O., Mölstad, S., Melander, A., 2001. Variation in antibiotic use in the European Union. Lancet 
357, 1851–1853. https://doi.org/10.1016/S0140-6736(00)04972-2 
Carvalho, I.T., Santos, L., 2016. Antibiotics in the aquatic environments : A review of the European 
scenario. Environ. Int. 94, 736–757. https://doi.org/10.1016/j.envint.2016.06.025 
Castiglioni, S., Fanelli, R., Calamari, D., Bagnati, R., Zuccato, E., 2004. Methodological approaches for 
studying pharmaceuticals in the environment by comparing predicted and measured 
concentrations in River Po, Italy. Regul. Toxicol. Pharmacol. 39, 25–32. 
https://doi.org/10.1016/j.yrtph.2003.10.002 
Celiz, M.D., Pérez, S., Barceló, D., Aga, D.S., 2009. Trace analysis of polar pharmaceuticals in 
wastewater by LC-MS-MS: Comparison of membrane bioreactor and activated sludge systems. 
J. Chromatogr. Sci. 47, 19–25. https://doi.org/10.1093/chromsci/47.1.19 
Choi, K.J., Kim, S.G., Kim, S.H., 2008. Removal of antibiotics by coagulation and granular activated 
carbon filtration. J. Hazard. Mater. 151, 38–43. https://doi.org/10.1016/j.jhazmat.2007.05.059 
Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., Kroiss, H., 2005. Removal of selected 
pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor 
and conventional wastewater treatment plants. Water Res. 39, 4797–4807. 
https://doi.org/10.1016/j.watres.2005.09.015 
 
Chapter 2 
 
74 
 
Clara, M., Strenn, B., Kreuzinger, N., 2004. Carbamazepine as a possible anthropogenic marker in the 
aquatic environment: investigations on the behaviour of Carbamazepine in wastewater 
treatment and during groundwater infiltration. Water Res. 38, 947–954. 
https://doi.org/10.1016/j.watres.2003.10.058 
Claus, H., 2004. Laccases: Structure, reactions, distribution. Micron 35, 93–96. 
https://doi.org/10.1016/j.micron.2003.10.029 
Conesa, A., Punt, P.J., van den Hondel, C.A.M.J.J., 2002. Fungal peroxidases: molecular aspects and 
applications. J. Biotechnol. 93, 143–158. https://doi.org/10.1016/S0168-1656(01)00394-7 
Cristóvão, R.O., Silvério, S.C., Tavares, A.P.M., Brígida, A.I.S., Loureiro, J.M., Boaventura, R.A.R., 
Macedo, E.A., Coelho, M.A.Z., 2012. Green coconut fiber: a novel carrier for the immobilization 
of commercial laccase by covalent attachment for textile dyes decolourization. World J. 
Microbiol. Biotechnol. 28, 2827–2838. https://doi.org/10.1007/s11274-012-1092-4 
Dai, Y., Yao, J., Song, Y., Wang, S., Yuan, Y., 2016. Enhanced adsorption and degradation of phenolic 
pollutants in water by carbon nanotube modified laccase-carrying electrospun fibrous 
membranes. Environ. Sci. Nano 3, 857–868. https://doi.org/10.1039/C6EN00148C 
Datta, S., Christena, L.R., Rajaram, Y.R.S., 2013. Enzyme immobilization: an overview on techniques 
and support materials. 3 Biotech 3, 1–9. https://doi.org/10.1007/s13205-012-0071-7 
De Bel, E., Janssen, C., De Smet, S., Van Langenhove, H., Dewulf, J., 2011. Sonolysis of ciprofloxacin in 
aqueous solution: Influence of operational parameters. Ultrason. Sonochem. 18, 184–189. 
https://doi.org/10.1016/J.ULTSONCH.2010.05.003 
de Cazes, M., Abejón, R., Belleville, M.P., Sanchez-Marcano, J., 2014. Membrane bioprocesses for 
pharmaceutical micropollutant removal from waters. Membranes (Basel). 4, 692–729. 
https://doi.org/10.3390/membranes4040692 
De Cazes, M., Belleville, M.P., Petit, E., Llorca, M., Rodríguez-Mozaz, S., De Gunzburg, J., Barceló, D., 
Sanchez-Marcano, J., 2014. Design and optimization of an enzymatic membrane reactor for 
tetracycline degradation. Catal. Today 236, 146–152. 
https://doi.org/10.1016/j.cattod.2014.02.051 
Demarche, P., Junghanns, C., Nair, R.R., Agathos, S.N., 2012. Harnessing the power of enzymes for 
environmental stewardship. Biotechnol. Adv. 30, 933–953. 
https://doi.org/10.1016/j.biotechadv.2011.05.013 
Ding, H., Wu, Y., Zou, B., Lou, Q., Zhang, W., Zhong, J., Lu, L., Dai, G., 2016. Simultaneous removal and 
degradation characteristics of sulfonamide, tetracycline, and quinolone antibiotics by laccase-
mediated oxidation coupled with soil adsorption. J. Hazard. Mater. 307, 350–358. 
https://doi.org/10.1016/j.jhazmat.2015.12.062 
dos Santos, J.C.S., Barbosa, O., Ortiz, C., Berenguer-Murcia, A., Rodriguez, R.C., Fernandez-Lafuente, 
R., 2015. Importance of the Support Properties for Immobilization or Purification of Enzymes. 
ChemCatChem 7, 2413–2432. https://doi.org/10.1002/cctc.201500310 
Drewes, J.E., Sedlak, D.., Snyder, S., Dickenson, E., 2008. Development of Indicators and Surrogates 
for Chemical Contaminant Removal during Wastewater Treatment and Reclamation-Final 
Report, WateReuse Foundation. 
Durán, N., Rosa, M.A., D’Annibale, A., Gianfreda, L., 2002. Applications of laccases and tyrosinases 
(phenoloxidases) immobilized on different supports: a review. Enzyme Microb. Technol. 31, 
907–931. https://doi.org/10.1016/S0141-0229(02)00214-4 
Chapter 2 
 
75 
 
Ebele, A.J., Abdallah, M.A., Harrad, S., 2017. Pharmaceuticals and personal care products (PPCPs) in 
the freshwater aquatic environment. Emerg. Contam. 3, 1–16. 
https://doi.org/10.1016/j.emcon.2016.12.004 
Ebert, I., Bachmann, J., Kuhnen, U., Kuster, A., Kussatz, C., Maletzki, D., Schluter, C., 2011. TOXICITY 
OF THE FLUOROQUINOLONE ANTIBIOTICS ENROFLOXACIN AND CIPROFLOXACIN TO 
PHOTOAUTOTROPHIC AQUATIC ORGANISMS. Environ. Toxicol. Chem. 30, 2786–2792. 
https://doi.org/10.1002/etc.678 
Eibes, G., Debernardi, G., Feijoo, G., Moreira, M.T., Lema, J.M., 2011. Oxidation of pharmaceutically 
active compounds by a ligninolytic fungal peroxidase. Biodegradation 22, 539–550. 
https://doi.org/10.1007/s10532-010-9426-0 
Fernández-Fernández, M., Sanromán, M.Á., Moldes, D., 2013. Recent developments and applications 
of immobilized laccase. Biotechnol. Adv. 31, 1808–1825. 
https://doi.org/10.1016/j.biotechadv.2012.02.013 
Fortes, C.C.S., Daniel-da-Silva, A.L., Xavier, A.M.R.B., Tavares, A.P.M., 2017. Optimization of enzyme 
immobilization on functionalized magnetic nanoparticles for laccase biocatalytic reactions. 
Chem. Eng. Process. Process Intensif. 117, 1–8. https://doi.org/10.1016/j.cep.2017.03.009 
Ganiyu, S.O., van Hullebusch, E.D., Cretin, M., Esposito, G., Oturan, M.A., 2015. Coupling of 
membrane filtration and advanced oxidation processes for removal of pharmaceutical residues: 
A critical review. Sep. Purif. Technol. 156, 891–914. 
https://doi.org/10.1016/J.SEPPUR.2015.09.059 
Gao, N., Liu, C.X., Xu, Q.M., Cheng, J.S., Yuan, Y.J., 2018. Simultaneous removal of ciprofloxacin, 
norfloxacin, sulfamethoxazole by co-producing oxidative enzymes system of Phanerochaete 
chrysosporium and Pycnoporus sanguineus. Chemosphere 195, 146–155. 
https://doi.org/10.1016/j.chemosphere.2017.12.062 
Gasser, C.A., Ammann, E.M., Shahgaldian, P., Corvini, P.F.X., 2014. Laccases to take on the challenge 
of emerging organic contaminants in wastewater. Appl. Microbiol. Biotechnol. 98, 9931–9952. 
https://doi.org/10.1007/s00253-014-6177-6 
Gavrilescu, M., Demnerova, K., Aamand, J., Agathos, S., Fava, F., 2015. Emerging pollutants in the 
environment : present and future challenges in biomonitoring , ecological risks and 
bioremediation. New Biotchnology 32, 147–156. 
Giardina, P., Faraco, V., Pezzella, C., Piscitelli, A., Vanhulle, S., Sannia, G., 2010. Laccases: a never-
ending story. Cell. Mol. life Sci. C. 67, 369–385. 
Gibs, J., Heckathorn, H.A., Meyer, M.T., Klapinski, F.R., Alebus, M., Lippincott, R.L., 2013. Occurrence 
and partitioning of antibiotic compounds found in the water column and bottom sediments 
from a stream receiving two wastewater treatment plant effluents in Northern New Jersey, 
2008. Sci. Total Environ. 458–460, 107–116. https://doi.org/10.1016/j.scitotenv.2013.03.076 
Glenn, J.K., Morgan, M.A., Mayfield, M.B., Kuwahara, M., Gold, M.H., 1983. An extracellular H2O2-
requiring enzyme preparation involved in lignin biodegradation by the white rot basidiomycete 
Phanerochaete chrysosporium. Biochem. Biophys. Res. Commun. 114, 1077–1083. 
https://doi.org/10.1016/0006-291X(83)90672-1 
Göbel, A., McArdell, C.S., Joss, A., Siegrist, H., Giger, W., 2007. Fate of sulfonamides, macrolides, and 
trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 372, 361–371. 
https://doi.org/10.1016/J.SCITOTENV.2006.07.039 
 
Chapter 2 
 
76 
 
Gogoi, A., Mazumder, P., Kumar, V., Chaminda, G.G.T., Kyoungjin, A., Kumar, M., 2018. Occurrence 
and fate of emerging contaminants in water environment : A review. Groundw. Sustain. Dev. 6, 
169–180. https://doi.org/10.1016/j.gsd.2017.12.009 
Golet, E.M., Xifra, I., Siegrist, H., Alder, A.C., Giger, W., 2003. Environmental exposure assessment of 
fluoroquinolone antibacterial agents from sewage to soil. Environ. Sci. Technol. 37, 3243–3249. 
https://doi.org/10.1021/es0264448 
Gonzalez-Martinez, A., Rodriguez-Sanchez, A., Martinez-Toledo, M. V, Garcia-Ruiz, M.-J., Hontoria, E., 
Osorio-Robles, F., Gonzalez-Lopez, J., 2014. Effect of ciprofloxacin antibiotic on the partial-
nitritation process and bacterial community structure of a submerged bio filter. Sci. Total 
Environ. 476–477, 276–287. https://doi.org/10.1016/j.scitotenv.2014.01.012 
Gonzalez-Pleiter, M., Gonzalo, S., Rodea-Palomares, I., Leganes, F., Rosal, R., Boltes, K., Marco, E., 
Fernandez-Pinas, F., 2013. Toxicity of five antibiotics and their mixtures towards photosynthetic 
aquatic organisms: Implications for environmental risk assessment. Water Res. 47, 2050–2064. 
https://doi.org/10.1016/j.watres.2013.01.020 
Gozlan, I., Rotstein, A., Avisar, D., 2013. Amoxicillin-degradation products formed under controlled 
environmental conditions: Identification and determination in the aquatic environment. 
Chemosphere 91, 985–992. https://doi.org/10.1016/j.chemosphere.2013.01.095 
Grandclément, C., Seyssiecq, I., Piram, A., Wong-Wah-Chung, P., Vanot, G., Tiliacos, N., Roche, N., 
Doumenq, P., 2017. From the conventional biological wastewater treatment to hybrid 
processes, the evaluation of organic micropollutant removal: A review. Water Res. 111, 297–
317. https://doi.org/10.1016/j.watres.2017.01.005 
Grenni, P., Ancona, V., Barra Caracciolo, A., 2018. Ecological effects of antibiotics on natural 
ecosystems : A review. Microchem. J. 136, 25–39. https://doi.org/10.1016/j.microc.2017.02.006 
Guerra, P., Kim, M., Shah, A., Alaee, M., Smyth, S.A., 2014. Occurrence and fate of antibiotic, 
analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment 
processes. Sci. Total Environ. 473–474, 235–243. 
https://doi.org/10.1016/j.scitotenv.2013.12.008 
Guo, X.L., Zhu, Z.W., Li, H.L., 2014. Biodegradation of sulfamethoxazole by Phanerochaete 
chrysosporium. J. Mol. Liq. 198, 169–172. https://doi.org/10.1016/j.molliq.2014.06.017 
Halling-Sorensen, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, F., Holten Lutzhoft, H.C., Jorgensen, S.E., 
1998. Occurrence, Fate and Effects of Pharmaceutical Substances in the Environment - A 
review. Chemosphere 36, 357–393. 
Hammel, K.E., Cullen, D., 2008. Role of fungal peroxidases in biological ligninolysis. Curr. Opin. Plant 
Biol. 11, 349–355. https://doi.org/10.1016/J.PBI.2008.02.003 
Hata, T., Shintate, H., Kawai, S., Okamura, H., Nishida, T., 2010. Elimination of carbamazepine by 
repeated treatment with laccase in the presence of 1-hydroxybenzotriazole. J. Hazard. Mater. 
181, 1175–1178. https://doi.org/10.1016/j.jhazmat.2010.05.103 
Heberer, T., 2002. Occurrence , fate , and removal of pharmaceutical residues in the aquatic 
environment : a review of recent research data. Toxicol. Lett. 131, 5–17. 
https://doi.org/10.1016/S0378-4274(02)00041-3 
Heberer, T., Reddersen, K., Mechlinski, A., 2002. From municipal sewage to drinking water: fate and 
removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci. 
Technol. 46, 81–88. 
Chapter 2 
 
77 
 
Hernandez, K., Fernandez-Lafuente, R., 2011. Control of protein immobilization: Coupling 
immobilization and site-directed mutagenesis to improve biocatalyst or biosensor performance. 
Enzyme Microb. Technol. 48, 107–122. https://doi.org/10.1016/J.ENZMICTEC.2010.10.003 
Homem, V., Santos, L., 2011. Degradation and removal methods of antibiotics from aqueous matrices 
- A review. J. Environ. Manage. 92, 2304–2347. https://doi.org/10.1016/j.jenvman.2011.05.023 
Jahangiri, E., Reichelt, S., Thomas, I., Hausmann, K., Schlosser, D., Schulze, A., 2014. Electron Beam-
Induced Immobilization of Laccase on Porous Supports for Waste Water Treatment 
Applications. Mol. . https://doi.org/10.3390/molecules190811860 
Ji, C., Hou, J., Chen, V., 2016a. Cross-linked carbon nanotubes-based biocatalytic membranes for 
micro-pollutants degradation: Performance, stability, and regeneration. J. Memb. Sci. 520, 869–
880. https://doi.org/10.1016/j.memsci.2016.08.056 
Ji, C., Hou, J., Wang, K., Zhang, Y., Chen, V., 2016b. Biocatalytic degradation of carbamazepine with 
immobilized laccase-mediator membrane hybrid reactor. J. Memb. Sci. 502, 11–20. 
https://doi.org/10.1016/j.memsci.2015.12.043 
Ji, C., Nguyen, L.N., Hou, J., Hai, F.I., Chen, V., 2017. Direct immobilization of laccase on titania 
nanoparticles from crude enzyme extracts of P. ostreatus culture for micro-pollutant 
degradation. Sep. Purif. Technol. 178, 215–223. https://doi.org/10.1016/j.seppur.2017.01.043 
Jos, A., Repetto, G., Rios, J.C., Hazen, M.J., Molero, M.L., del Peso, A., Salguero, M., Fernandez-Freire, 
P., Perez-Martin, J.M., Camean, A., 2003. Ecotoxicological evaluation of carbamazepine using six 
different model systems with eighteen endpoints. Toxicol. Vitr. 17, 525–532. 
https://doi.org/10.1016/S0887-2333(03)00119-X 
Joss, A., Zabczynski, S., Göbel, A., Hoffmann, B., Löffler, D., McArdell, C.S., Ternes, T.A., Thomsen, A., 
Siegrist, H., 2006. Biological degradation of pharmaceuticals in municipal wastewater 
treatment: Proposing a classification scheme. Water Res. 40, 1686–1696. 
https://doi.org/10.1016/J.WATRES.2006.02.014 
Jung, Y.J., Kim, W.G., Yoon, Y., Kang, J.-W., Hong, Y.M., Kim, H.W., 2012. Removal of amoxicillin by UV 
and UV/H2O2 processes. Sci. Total Environ. 420, 160–167. 
https://doi.org/10.1016/J.SCITOTENV.2011.12.011 
Kanakaraju, D., Glass, B.D., Oelgemoller, M., 2018. Advanced oxidation process-mediated removal of 
pharmaceuticals from water : A review. J. Environ. Manage. 219, 189–207. 
https://doi.org/10.1016/j.jenvman.2018.04.103 
Karam, J., Nicell, J.A., 1997. Potential Applications of Enzymes in Waste Treatment. Chem. Tech. 
Biotechnol 69, 141–153. https://doi.org/10.1002/(SICI)1097-4660(199706)69 
Kasprzyk-Hordern, B., Dinsdale, R.M., Guwy, A.J., 2008. The occurrence of pharmaceuticals, personal 
care products, endocrine disruptors and illicit drugs in surface water in South Walles, UK. Water 
Res. 42, 3498–3518. https://doi.org/10.1016/j.watres.2008.04.026 
Kim, J.-M., Park, S.-M., Kim, D.-H., 2010. Heterologous expression of a tannic acid-inducible laccase3 
of Cryphonectria parasitica in Saccharomyces cerevisiae. BMC Biotechnol. 10, 18. 
https://doi.org/10.1186/1472-6750-10-18 
Kim, M., Guerra, P., Shah, A., Parsa, M., Alaee, M., Smyth, S.A., 2014. Removal of pharmaceuticals 
and personal care products in a membrane bioreactor wastewater treatment plant. Water Sci. 
Technol. 69, 2221–2229. https://doi.org/10.2166/wst.2014.145 
 
Chapter 2 
 
78 
 
Kim, Y.-J., Nicell, J.A., 2006. Laccase-catalysed oxidation of aqueous triclosan. J. Chem. Technol. 
Biotechnol. 81, 1344–1352. https://doi.org/10.1002/jctb.1507 
Kim, Y., Choi, K., Jung, J., Park, S., Kim, P.-G., Park, J., 2007. Aquatic toxicity of acetaminophen, 
carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological 
risks in Korea. Environ. Int. 33, 370–375. https://doi.org/10.1016/j.envint.2006.11.017 
Kimura, K., Toshima, S., Amy, G., Watanabe, Y., 2004. Rejection of neutral endocrine disrupting 
compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Memb. 
Sci. 245, 71–78. https://doi.org/10.1016/J.MEMSCI.2004.07.018 
Klatte, S., Schaefer, H., Hempel, M., 2017. Pharmaceuticals in the environment – A short review on 
options to minimize the exposure of humans, animals and ecosystems. Sustain. Chem. Pharm. 
5, 61–66. https://doi.org/10.1016/j.scp.2016.07.001 
Kosma, C.I., Lambropoulou, D.A., Albanis, T.A., 2014. Investigation of PPCPs in wastewater treatment 
plants in Greece: Occurrence, removal and environmental risk assessment. Sci. Total Environ. 
466–467, 421–438. https://doi.org/10.1016/j.scitotenv.2013.07.044 
Košutić, K., Dolar, D., Ašperger, D., Kunst, B., 2007. Removal of antibiotics from a model wastewater 
by RO/NF membranes. Sep. Purif. Technol. 53, 244–249. 
https://doi.org/10.1016/J.SEPPUR.2006.07.015 
Kudanga, T., Nyanhongo, G.S., Guebitz, G.M., Burton, S., 2011. Potential applications of laccase-
mediated coupling and grafting reactions: A review. Enzyme Microb. Technol. 48, 195–208. 
https://doi.org/10.1016/j.enzmictec.2010.11.007 
Kumar, V.V., Cabana, H., 2016. Towards high potential magnetic biocatalysts for on-demand 
elimination of pharmaceuticals. Bioresour. Technol. 200, 81–89. 
https://doi.org/10.1016/J.BIORTECH.2015.09.100 
Kümmerer, K., 2009. Antibiotics in the aquatic environment – A review – Part I. Chemosphere 75, 
417–434. https://doi.org/10.1016/j.chemosphere.2008.11.086 
Kunamneni, A., Ballesteros, A., Plou, F., Alcalde, M., 2007. Fungal laccase - a versatile enzyme for 
biotechnological applications, Communicating Current Research and Educational Topics and 
Trends in Applied Microbiology. 
Kunamneni, A., Camarero, S., García-Burgos, C., Plou, F.J., Ballesteros, A., Alcalde, M., 2008. 
Engineering and Applications of fungal laccases for organic synthesis. Microb. Cell Fact. 7, 1–17. 
https://doi.org/10.1186/1475-2859-7-32 
Kurniawati, S., Nicell, J.A., 2007. Efficacy of mediators for enhancing the laccase-catalyzed oxidation 
of aqueous phenol. Enzyme Microb. Technol. 41, 353–361. 
https://doi.org/10.1016/j.enzmictec.2007.03.003 
Lawrence, J.R., Swerhone, G.D.W., Wassenaar, L.I., Neu, T.R., 2005. Effects of selected 
pharmaceuticals on riverine biofilm communities. Can. J. Microbiol. 51, 655–669. 
https://doi.org/10.1139/W05-047 
Le-Minh, N., Khan, S.J., Drewes, J.E., Stuetz, R.M., 2010. Fate of antibiotics during municipal water 
recycling treatment processes. Water Res. 44, 4295–4323. 
https://doi.org/10.1016/j.watres.2010.06.020 
Le, T.-H., Ng, C., Tran, N.H., Chen, H., Gin, K.Y.-H., 2018. Removal of antibiotic residues, antibiotic 
resistant bacteria and antibiotic resistance genes in municipal wastewater by membrane 
bioreactor systems. Water Res. 145, 498–508. https://doi.org/10.1016/J.WATRES.2018.08.060 
Chapter 2 
 
79 
 
Lee, Y., Zimmermann, S.G., Kieu, A.T., Von Gunten, U., 2009. Ferrate (Fe(VI)) application for municipal 
wastewater treatment: A novel process for simultaneous micropollutant oxidation and 
phosphate removal. Environ. Sci. Technol. 43, 3831–3838. https://doi.org/10.1021/es803588k 
Li, W.C., 2014. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil. 
Environ. Pollut. 187, 193–201. https://doi.org/10.1016/j.envpol.2014.01.015 
Lindberg, R.H., Ostman, M., Olofsson, U., Grabic, R., Fick, J., 2014. Occurrence and behaviour of 105 
active pharmaceutical ingredients in sewage waters of a municipal sewer collection system. 
Water 58, 221–229. https://doi.org/10.1016/j.watres.2014.03.076 
Liu, Y., Zeng, Z., Zeng, G., Tang, L., Pang, Y., Li, Z., Liu, C., Lei, X., Wu, M., Ren, P., Liu, Z., Chen, M., Xie, 
G., 2012. Immobilization of laccase on magnetic bimodal mesoporous carbon and the 
application in the removal of phenolic compounds. Bioresour. Technol. 115, 21–26. 
https://doi.org/10.1016/j.biortech.2011.11.015 
Lloret, L., Eibes, G., Feijoo, G., Moreira, M.T., Lema, J.M., 2012. Continuous operation of a fluidized 
bed reactor for the removal of estrogens by immobilized laccase on Eupergit supports. J. 
Biotechnol. 162, 404–406. https://doi.org/10.1016/j.jbiotec.2012.04.007 
Lloret, L., Eibes, G., Lú-Chau, T.A., Moreira, M.T., Feijoo, G., Lema, J.M., 2010. Laccase-catalyzed 
degradation of anti-inflammatories and estrogens. Biochem. Eng. J. 51, 124–131. 
https://doi.org/10.1016/j.bej.2010.06.005 
Lonappan, L., Rouissi, T., Laadila, M.A., Brar, S.K., Hernandez Galan, L., Verma, M., Surampalli, R.Y., 
2017. Agro-industrial-Produced Laccase for Degradation of Diclofenac and Identification of 
Transformation Products. ACS Sustain. Chem. Eng. 5, 5772–5781. 
https://doi.org/10.1021/acssuschemeng.7b00390 
Loos, R., Locoro, G., Comero, S., Contini, S., Schwesig, D., Werres, F., Balsaa, P., Gans, O., Weiss, S., 
Blaha, L., Bolchi, M., Manfred Gawlik, B., 2010. Pan-European survey on the occurrence of 
selected polar organic persistent pollutants in ground water. Water Res. 44, 4115–4126. 
https://doi.org/10.1016/j.watres.2010.05.032 
López-Serna, R., Jurado, A., Vázquez-Suñé, E., Carrera, J., Petrovic, M., Barcelo, D., 2013. Occurrence 
of 95 pharmaceuticals and transformation products in urban groundwaters underlying the 
metropolis of Barcelona, Spain. Environ. Pollut. 174, 305–315. 
https://doi.org/10.1016/j.envpol.2012.11.022 
Magner, E., 2013. Immobilisation of enzymes on mesoporous silicate materials. Chem. Soc. Rev. 42, 
6213–6222. https://doi.org/10.1039/C2CS35450K 
Mailler, R., Gasperi, J., Coquet, Y., Deshayes, S., Zedek, S., Cren-Olivé, C., Cartiser, N., Eudes, V., 
Bressy, A., Caupos, E., Moilleron, R., Chebbo, G., Rocher, V., 2015. Study of a large scale 
powdered activated carbon pilot: Removals of a wide range of emerging and priority 
micropollutants from wastewater treatment plant effluents. Water Res. 72, 315–330. 
https://doi.org/10.1016/J.WATRES.2014.10.047 
Majeau, J.A., Brar, S.K., Tyagi, R.D., 2010. Laccases for removal of recalcitrant and emerging 
pollutants. Bioresour. Technol. 101, 2331–2350. https://doi.org/10.1016/j.biortech.2009.10.087 
Margot, J., Copin, P.J., von Gunten, U., Barry, D.A., Holliger, C., 2015a. Sulfamethoxazole and 
isoproturon degradation and detoxification by a laccase-mediator system: Influence of 
treatment conditions and mechanistic aspects. Biochem. Eng. J. 103, 47–59. 
https://doi.org/10.1016/j.bej.2015.06.008 
 
Chapter 2 
 
80 
 
Margot, J., Lochmatter, S., Barry, D.A., Holliger, C., 2015b. Role of ammonia-oxidizing bacteria in 
micropollutant removal from wastewater with aerobic granular sludge. Water Sci. Technol. 73, 
564–575. https://doi.org/10.2166/wst.2015.514 
Margot, J., Maillard, J., Rossi, L., Barry, D.A., Holliger, C., 2013. Influence of treatment conditions on 
the oxidation of micropollutants by Trametes versicolor laccase. N. Biotechnol. 30, 803–813. 
https://doi.org/10.1016/j.nbt.2013.06.004 
Martin-Diaz, L., Franzellitti, S., Buratti, S., Valbonesi, P., Capuzzo, A., Fabbri, E., 2009. Effects of 
environmental concentrations of the antiepilectic drug carbamazepine on biomarkers and 
cAMP-mediated cell signaling in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 94, 177–
185. https://doi.org/10.1016/j.aquatox.2009.06.015 
Matilainen, A., Vepsäläinen, M., Sillanpää, M., 2010. Natural organic matter removal by coagulation 
during drinking water treatment: A review. Adv. Colloid Interface Sci. 159, 189–197. 
https://doi.org/10.1016/j.cis.2010.06.007 
Melo, C.F., Dezotti, M., 2013. Evaluation of a horseradish peroxidase-catalyzed process for triclosan 
removal and antibacterial activity reduction. J. Chem. Technol. Biotechnol. 88, 930–936. 
https://doi.org/10.1002/jctb.3924 
Mester, T., Tien, M., 2000. Oxidation mechanism of ligninolytic enzymes involved in the degradation 
of environmental pollutants. Int. Biodeterior. Biodegrad. 46, 51–59. 
https://doi.org/10.1016/S0964-8305(00)00071-8 
Michael, I., Rizzo, L., Mcardell, C.S., Manaia, C.M., Merlin, C., Schwartz, T., Dagot, C., Fatta-Kassinos, 
D., 2013. Urban wastewater treatment plants as hotspots for the release of antibiotics in the 
environment: A review. Water Res. 7, 957–995. https://doi.org/10.1016/j.watres.2012.11.027 
Minh, T.B., Leung, H.W., Loi, I.H., Chan, W.H., So, M.K., Mao, J.Q., Choi, D., Lam, J.C.W., Zheng, G., 
Martin, M., Lee, J.H.W., Lam, P.K.S., Richardson, B.J., 2009. Antibiotics in the Hong Kong 
metropolitan area: Ubiquitous distribution and fate in Victoria Harbour. Mar. Pollut. Bull. 58, 
1052–1062. https://doi.org/10.1016/j.marpolbul.2009.02.004 
Mohamad, N.R., Marzuki, N.H.C., Buang, N.A., Huyop, F., Wahab, R.A., 2015. An overview of 
technologies for immobilization of enzymes and surface analysis techniques for immobilized 
enzymes. Biotechnol. Biotechnol. Equip. 29, 205–220. 
https://doi.org/10.1080/13102818.2015.1008192 
Mohammadi, M., As’habi, M.A., Salehi, P., Yousefi, M., Nazari, M., Brask, J., 2018. Immobilization of 
laccase on epoxy-functionalized silica and its application in biodegradation of phenolic 
compounds. Int. J. Biol. Macromol. 109, 443–447. 
https://doi.org/10.1016/j.ijbiomac.2017.12.102 
Morse, A., Jackson, A., 2004. Fate of amoxicillin in two water reclamation systems. Water. Air. Soil 
Pollut. 157, 117–132. https://doi.org/10.1023/B:WATE.0000038878.22776.5b 
Murugesan, K., Chang, Y.Y., Kim, Y.M., Jeon, J.R., Kim, E.J., Chang, Y.S., 2010. Enhanced 
transformation of triclosan by laccase in the presence of redox mediators. Water Res. 44, 298–
308. https://doi.org/10.1016/j.watres.2009.09.058 
Naghdi, M., Taheran, M., Brar, S.K., Kermanshahi-pour, A., Verma, M., Surampalli, R.Y., 2018a. 
Biotransformation of Carbamazepine by Laccase-Mediator System: Kinetics, by-products and 
toxicity assessment. Process Biochem. 67, 147–154. 
https://doi.org/10.1016/j.procbio.2018.02.009 
 
Chapter 2 
 
81 
 
Naghdi, M., Taheran, M., Brar, S.K., Kermanshahi-pour, A., Verma, M., Surampalli, R.Y., 2018b. 
Removal of pharmaceutical compounds in water and wastewater using fungal oxidoreductase 
enzymes. Environ. Pollut. 234, 190–213. https://doi.org/10.1016/j.envpol.2017.11.060 
Naghdi, M., Taheran, M., Brar, S.K., Kermanshahi-pour, A., Verma, M., Surampalli, R.Y., 2017. 
Immobilized laccase on oxygen functionalized nanobiochars through mineral acids treatment 
for removal of carbamazepine. Sci. Total Environ. 584–585, 393–401. 
https://doi.org/10.1016/J.SCITOTENV.2017.01.021 
Nakayama, T., Amachi, T., 1999. Fungal peroxidase: its structure, function, and application. J. Mol. 
Catal. B Enzym. 6, 185–198. https://doi.org/10.1016/S1381-1177(98)00119-2 
Navada, K.K., Kulal, A., 2019. Enzymatic degradation of chloramphenicol by laccase from Trametes 
hirsuta and comparison among mediators. Int. Biodeterior. Biodegrad. 138, 63–69. 
https://doi.org/10.1016/j.ibiod.2018.12.012 
Nguyen, L.N., Hai, F.I., Dosseto, A., Richardson, C., Price, W.E., Nghiem, L.D., 2016. Continuous 
adsorption and biotransformation of micropollutants by granular activated carbon-bound 
laccase in a packed-bed enzyme reactor. Bioresour. Technol. 210, 108–116. 
https://doi.org/10.1016/j.biortech.2016.01.014 
Nguyen, L.N., Hai, F.I., Kang, J., Leusch, F.D.L., Roddick, F., Magram, S.F., Price, W.E., Nghiem, L.D., 
2014a. Enhancement of trace organic contaminant degradation by crude enzyme extract from 
Trametes versicolor culture: Effect of mediator type and concentration. J. Taiwan Inst. Chem. 
Eng. 45, 1855–1862. https://doi.org/10.1016/J.JTICE.2014.03.021 
Nguyen, L.N., Hai, F.I., Price, W.E., Leusch, F.D.L., Roddick, F., Ngo, H.H., Guo, W., Magram, S.F., 
Nghiem, L.D., 2014b. The effects of mediator and granular activated carbon addition on 
degradation of trace organic contaminants by an enzymatic membrane reactor. Bioresour. 
Technol. 167, 169–177. https://doi.org/10.1016/j.biortech.2014.05.125 
Nyanhongo, G.S., Gübitz, G., Sukyai, P., Leitner, C., Haltrich, D., Ludwig, R., 2007. Oxidoreductases 
from Trametes spp. in biotechnology: A wealth of catalytic activity. Food Technol. Biotechnol. 
45, 250–268. 
Ortiz de Garcia, S., Pinto Pinto, G., García Encina, P., Irusta Mata, R., 2013. Consumption and 
occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. 
Sci. Total Environ. 444, 451–465. https://doi.org/10.1016/j.scitotenv.2012.11.057 
Parra Guardado, A.L., Belleville, M.-P., Rostro Alanis, M. de J., Parra Saldivar, R., Sanchez-Marcano, J., 
2019. Effect of redox mediators in pharmaceuticals degradation by laccase: A comparative 
study. Process Biochem. 78, 123–131. https://doi.org/10.1016/J.PROCBIO.2018.12.032 
Patel, S.K.S., Kalia, V.C., Choi, J.H., Haw, J.R., Kim, I.W., Lee, J.K., 2014. Immobilization of Laccase on 
SiO2 Nanocarriers Omproves Its Stability and Reusability. J. Microbiol. Biotechnol. 24, 639–647. 
https://doi.org/10.4014/jmb.1401.01025 
Pezzella, C., Russo, M.E., Marzocchella, A., Salatino, P., Sannia, G., 2014. Immobilization of a 
pleurotus ostreatus laccase mixture on perlite and its application to dye decolourisation. 
Biomed Res. Int. 2014, 1–11. https://doi.org/10.1155/2014/308613 
Phuong Hoa, P.T., Managaki, S., Nakada, N., Takada, H., Shimizu, A., Ahn, D.H., Viet, P.H., Suzuki, S., 
2011. Antibiotic contamination and occurrence of antibiotic-resistant bacteria in aquatic 
environments of northern Vietnam. Sci. Total Environ. 409, 2894–2901. 
https://doi.org/10.1016/j.scitotenv.2011.04.030 
 
Chapter 2 
 
82 
 
Polak, J., Jarosz-Wilkolazka, A., 2012. Fungal laccases as green catalysts for dye synthesis. Process 
Biochem. 47, 1295–1307. https://doi.org/10.1016/j.procbio.2012.05.006 
Prieto, A., Möder, M., Rodil, R., Adrian, L., Marco-Urrea, E., 2011. Degradation of the antibiotics 
norfloxacin and ciprofloxacin by a white-rot fungus and identification of degradation products. 
Bioresour. Technol. 102, 10987–10995. https://doi.org/10.1016/j.biortech.2011.08.055 
Putra, E.K., Pranowo, R., Sunarso, J., Indraswati, N., Ismadji, S., 2009. Performance of activated 
carbon and bentonite for adsorption of amoxicillin from wastewater: Mechanisms, isotherms 
and kinetics. Water Res. 43, 2419–2430. https://doi.org/10.1016/J.WATRES.2009.02.039 
Quinn, B., Gagné, F., Blaise, C., 2008. The effects of pharmaceuticals on the regeneration of the 
cnidarian, Hydra attenuata. Sci. Total Environ. 402, 62–69. 
https://doi.org/10.1016/j.scitotenv.2008.04.039 
Radjenović, J., Petrović, M., Barceló, D., 2009. Fate and distribution of pharmaceuticals in wastewater 
and sewage sludge of the conventional activated sludge (CAS) and advanced membrane 
bioreactor (MBR) treatment. Water Res. 43, 831–841. 
https://doi.org/10.1016/j.watres.2008.11.043 
Radjenović, J., Petrović, M., Ventura, F., Barceló, D., 2008. Rejection of pharmaceuticals in 
nanofiltration and reverse osmosis membrane drinking water treatment. Water Res. 42, 3601–
3610. https://doi.org/10.1016/J.WATRES.2008.05.020 
Rahmani, K., Faramarzi, M.A., Mahvi, A.H., Gholami, M., Esrafili, A., Forootanfar, H., Farzadkia, M., 
2015. Elimination and detoxification of sulfathiazole and sulfamethoxazole assisted by laccase 
immobilized on porous silica beads. Int. Biodeterior. Biodegrad. 97, 107–114. 
https://doi.org/10.1016/j.ibiod.2014.10.018 
Ramírez-Cavazos, L.I., Junghanns, C., Ornelas-Soto, N., Cárdenas-Chávez, D.L., Hernández-Luna, C., 
Demarche, P., Enaud, E., García-Morales, R., Agathos, S.N., Parra, R., 2014. Purification and 
characterization of two thermostable laccases from Pycnoporus sanguineus and potential role 
in degradation of endocrine disrupting chemicals. J. Mol. Catal. B Enzym. 108, 32–42. 
https://doi.org/10.1016/j.molcatb.2014.06.006 
Riva, S., 2006. Laccases: blue enzymes for green chemistry. Trends Biotechnol. 24, 219–226. 
https://doi.org/10.1016/j.tibtech.2006.03.006 
Rivera-Utrilla, J., Sánchez-Polo, M., Ferro-García, M.Á., Prados-Joya, G., Ocampo-Pérez, R., 2013. 
Pharmaceuticals as emerging contaminants and their removal from water. A review. 
Chemosphere 93, 1268–1287. https://doi.org/10.1016/j.chemosphere.2013.07.059 
Rizzo, L., Fiorentino, A., Grassi, M., Attanasio, D., Guida, M., 2015. Advanced treatment of urban 
wastewater by sand filtration and graphene adsorption for wastewater reuse: Effect on a 
mixture of pharmaceuticals and toxicity. J. Environ. Chem. Eng. 3, 122–128. 
https://doi.org/10.1016/J.JECE.2014.11.011 
Rochefort, D., Kouisni, L., Gendron, K., 2008. Physical immobilization of laccase on an electrode by 
means of poly(ethyleneimine) microcapsules. J. Electroanal. Chem. 617, 53–63. 
https://doi.org/10.1016/J.JELECHEM.2008.01.027 
Rodriguez-Delgado, M., Ornelas-Soto, N., 2017. Laccases: A Blue Enzyme for Greener Alternative 
Technologies in the Detection and Treatment of Emerging Pollutants, in: Green Technologies 
and Environmental Sustainability. pp. 45–65. 
 
Chapter 2 
 
83 
 
Rodríguez-Delgado, M., Orona-Navar, C., García-Morales, R., Hernandez-Luna, C., Parra, R., 
Mahlknecht, J., Ornelas-Soto, N., 2016. Biotransformation kinetics of pharmaceutical and 
industrial micropollutants in groundwaters by a laccase cocktail from Pycnoporus sanguineus 
CS43 fungi. Int. Biodeterior. Biodegrad. 108, 34–41. https://doi.org/10.1016/j.ibiod.2015.12.003 
Rodríguez-Rodríguez, C.E., Jesús García-Galán, M., Blánquez, P., Díaz-Cruz, M.S., Barceló, D., Caminal, 
G., Vicent, T., 2012. Continuous degradation of a mixture of sulfonamides by Trametes 
versicolor and identification of metabolites from sulfapyridine and sulfathiazole. J. Hazard. 
Mater. 213–214, 347–354. https://doi.org/10.1016/J.JHAZMAT.2012.02.008 
Rogers, H.R., 1996. Sources, behaviour and fate of organic contaminants during sewage treatment 
and in sewage sludges. Sci. Total Environ. 185, 3–26. https://doi.org/10.1016/0048-
9697(96)05039-5 
Rosal, R., Rodrıguez, A., Perdigon-Melon, J.A., Petre, A., Garcia-Calvo, E., Gomez, M.J., Aguera, A., 
Fernandez-Alba, A.R., 2010. Occurrence of emerging pollutants in urban wastewater and their 
removal through biological treatment followed by ozonation. Water Res. 44, 578–588. 
https://doi.org/10.1016/j.watres.2009.07.004 
Santhanam, N., Vivanco, J.M., Decker, S.R., Reardon, K.F., 2011. Expression of industrially relevant 
laccases: Prokaryotic style. Trends Biotechnol. 29, 480–489. 
https://doi.org/10.1016/j.tibtech.2011.04.005 
Sathishkumar, P., Chae, J.C., Unnithan, A.R., Palvannan, T., Kim, H.Y., Lee, K.J., Cho, M., Kamala-
Kannan, S., Oh, B.T., 2012. Laccase-poly(lactic-co-glycolic acid) (PLGA) nanofiber: Highly stable, 
reusable, and efficacious for the transformation of diclofenac. Enzyme Microb. Technol. 51, 
113–118. https://doi.org/10.1016/j.enzmictec.2012.05.001 
Shao, B., Liu, Z., Zeng, G., Liu, Y., Yang, X., Zhou, C., Chen, M., Liu, Y., Jiang, Y., Yan, M., 2019. 
Immobilization of laccase on hollow mesoporous carbon nanospheres: Noteworthy 
immobilization, excellent stability and efficacious for antibiotic contaminants removal. J. 
Hazard. Mater. 362, 318–326. https://doi.org/10.1016/j.jhazmat.2018.08.069 
Sheldon, R.A., 2007. Enzyme immobilization: The quest for optimum performance. Adv. Synth. Catal. 
349, 1289–1307. https://doi.org/10.1002/adsc.200700082 
Sheldon, R.A., van Pelt, S., 2013. Enzyme immobilisation in biocatalysis: Why, what and how. Chem. 
Soc. Rev. 42, 6223–6235. https://doi.org/10.1039/c3cs60075k 
Snyder, S.A., Adham, S., Redding, A.M., Cannon, F.S., DeCarolis, J., Oppenheimer, J., Wert, E.C., Yoon, 
Y., 2007. Role of membranes and activated carbon in the removal of endocrine disruptors and 
pharmaceuticals. Desalination 202, 156–181. https://doi.org/10.1016/J.DESAL.2005.12.052 
Stackelberg, P.E., Gibs, J., Furlong, E.T., Meyer, M.T., Zaugg, S.D., Lippincott, R.L., 2007. Efficiency of 
conventional drinking-water-treatment processes in removal of pharmaceuticals and other 
organic compounds. Sci. Total Environ. 377, 255–272. 
https://doi.org/10.1016/j.scitotenv.2007.01.095 
Stadlmair, L.F., Letzel, T., Drewes, J.E., Grassmann, J., 2018. Enzymes in removal of pharmaceuticals 
from wastewater: A critical review of challenges, applications and screening methods for their 
selection. Chemosphere 205, 649–661. https://doi.org/10.1016/j.chemosphere.2018.04.142 
Stadlmair, L.F., Letzel, T., Drewes, J.E., Graßmann, J., 2017. Mass spectrometry based in vitro assay 
investigations on the transformation of pharmaceutical compounds by oxidative enzymes. 
Chemosphere 174, 466–477. https://doi.org/10.1016/j.chemosphere.2017.01.140 
 
Chapter 2 
 
84 
 
Suárez, S., Carballa, M., Omil, F., Lema, J.M., 2008. How are pharmaceutical and personal care 
products (PPCPs) removed from urban wastewaters? Rev. Environ. Sci. Biotechnol. 7, 125–138. 
https://doi.org/10.1007/s11157-008-9130-2 
Suda, T., Hata, T., Kawai, S., Okamura, H., Nishida, T., 2012. Treatment of tetracycline antibiotics by 
laccase in the presence of 1-hydroxybenzotriazole. Bioresour. Technol. 103, 498–501. 
https://doi.org/10.1016/j.biortech.2011.10.041 
Sui, Q., Cao, X., Lu, S., Zhao, W., Qiu, Z., Yu, G., 2015. Occurrence, sources and fate of 
pharmaceuticals and personal care products in the groundwater: A review. Emerg. Contam. 1, 
14–24. https://doi.org/10.1016/j.emcon.2015.07.001 
Tahmasbi, H., Khoshayand, M.R., Bozorgi-Koushalshahi, M., Heidary, M., Ghazi-Khansari, M., 
Faramarzi, M.A., 2016. Biocatalytic conversion and detoxification of imipramine by the laccase-
mediated system. Int. Biodeterior. Biodegradation 108, 1–8. 
https://doi.org/10.1016/J.IBIOD.2015.11.029 
Ternes, A.T., Joss, A., 2006. Human pharmaceuticals, hormones and fragances. The challenge of 
micropollutants in urban water management. IWA Publishing. 
Ternes, T.A., 1998. Occurrence of drugs in Germany sewage treatment plants and rivers *. Water Res. 
32, 3245–3260. 
Ternes, T.A., Stumpf, M., Mueller, J., Haberer, K., Wilken, R., Servos, M., 1999. Behavior and 
occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, 
Canada and Brazil. Sci. Total Environ. 225, 81–90. 
Thielemann, J.P., Girgsdies, F., Schlögl, R., Hess, C., 2011. Pore structure and surface area of silica 
SBA-15: influence of washing and scale-up. Beilstein J. Nanotechnol. 2, 110–118. 
Tiwari, B., Sellamuthu, B., Ouarda, Y., Drogui, P., Tyagi, R.D., Buelna, G., 2017. Review on fate and 
mechanism of removal of pharmaceutical pollutants from wastewater using biological 
approach. Bioresour. Technol. 224, 1–12. https://doi.org/10.1016/j.biortech.2016.11.042 
Togola, A., Budzinski, H., 2008. Multi-residue analysis of pharmaceutical compounds in aqueous 
samples. J. Chromatogr. A 1177, 150–158. https://doi.org/10.1016/J.CHROMA.2007.10.105 
Torres, E., Bustos-Jaimes, I., Le Borgne, S., 2003. Potential use of oxidative enzymes for the 
detoxification of organic pollutants. Appl. Catal. B Environ. 46, 1–15. 
https://doi.org/10.1016/S0926-3373(03)00228-5 
Tran, N.H., Chen, H., Reinhard, M., Mao, F., Gin, K.Y., 2016. Occurrence and removal of multiple 
classes of antibiotics and antimicrobial agents in biological wastewater treatment processes. 
Water Res. 104, 461–472. https://doi.org/10.1016/j.watres.2016.08.040 
Tran, N.H., Reinhard, M., Gin, K.Y., 2018. Occurrence and fate of emerging contaminants in municipal 
wastewater treatment plants from different geographical regions-a review. Water Res. 133, 
182–207. https://doi.org/10.1016/j.watres.2017.12.029 
Tran, N.H., Urase, T., Kusakabe, O., 2010. Biodegradation Characteristics of Pharmaceutical 
Substances by Whole Fungal Culture Trametes versicolor and its Laccase. J. Water Environ. 
Technol. 8, 125–140. https://doi.org/10.2965/jwet.2010.125 
Tran, N.H., Urase, T., Ngo, H.H., Hu, J., Ong, S.L., 2013. Insight into metabolic and cometabolic 
activities of autotrophic and heterotrophic microorganisms in the biodegradation of emerging 
trace organic contaminants. Bioresour. Technol. 146, 721–731. 
https://doi.org/10.1016/J.BIORTECH.2013.07.083 
Chapter 2 
 
85 
 
Trovó, A.G., Melo, S.A.S., Nogueira, R.F.P., 2008. Photodegradation of the pharmaceuticals 
amoxicillin, bezafibrate and paracetamol by the photo-Fenton process—Application to sewage 
treatment plant effluent. J. Photochem. Photobiol. A Chem. 198, 215–220. 
https://doi.org/10.1016/J.JPHOTOCHEM.2008.03.011 
UNESCO, 2014. UNESCO Project. Emerging Pollutants in Wastewater Reuse in Developing Countries, 
International Initiative in Water Quality (IIWQ). 
van der Grinten, E., Pikkemaat, M.G., van den Brandhof, E., Stroomber, G.J., Kraak, M.H.S., 2010. 
Comparing the sensitivity of algal, cyanobacterial and bacterial bioassays to different groups of 
antibiotics. Chemosphere 80, 1–6. https://doi.org/10.1016/j.chemosphere.2010.04.011 
Van Stempvoort, D.R., Roy, J.W., Grabuski, J., Brown, S.J., Bickerton, G., Sverko, E., 2013. An artificial 
sweetener and pharmaceutical compounds as co-tracers of urban wastewater in groundwater. 
Sci. Total Environ. 461–462, 348–359. https://doi.org/10.1016/j.scitotenv.2013.05.001 
Verlicchi, P., Al Aukidy, M., Zambello, E., 2012. Occurrence of pharmaceutical compounds in urban 
wastewater: Removal, mass load and environmental risk after a secondary treatment—A 
review. Sci. Total Environ. 429, 123–155. https://doi.org/10.1016/J.SCITOTENV.2012.04.028 
Verma, A.K., Dash, R.R., Bhunia, P., 2012. A review on chemical coagulation/flocculation technologies 
for removal of colour from textile wastewaters. J. Environ. Manage. 93, 154–168. 
https://doi.org/10.1016/j.jenvman.2011.09.012 
Vogna, D., Marotta, R., Andreozzi, R., Napolitano, A., D’Ischia, M., 2004. Kinetic and chemical 
assessment of the UV/H2O2 treatment of antiepileptic drug carbamazepine. Chemosphere 54, 
497–505. https://doi.org/10.1016/S0045-6535(03)00757-4 
Wang, J., Wang, S., 2016. Removal of pharmaceuticals and personal care products (PPCPs) from 
wastewater : A review. J. Environ. Manage. 182, 620–640. 
https://doi.org/10.1016/j.jenvman.2016.07.049 
Watkinson, A.J., Murby, E.J., Costanzo, S.D., 2007. Removal of antibiotics in conventional and 
advanced wastewater treatment: Implications for environmental discharge and wastewater 
recycling. Water Res. 41, 4164–4176. https://doi.org/10.1016/J.WATRES.2007.04.005 
Weiss, S., Reemtsma, T., 2008. Membrane bioreactors for municipal wastewater treatment - A viable 
option to reduce the amount of polar pollutants discharged into surface waters? Water Res. 42, 
3837–3847. https://doi.org/10.1016/j.watres.2008.05.019 
Wen, X., Jia, Y., Li, J., 2009. Degradation of tetracycline and oxytetracycline by crude lignin peroxidase 
prepared from Phanerochaete chrysosporium – A white rot fungus. Chemosphere 75, 1003–
1007. https://doi.org/10.1016/J.CHEMOSPHERE.2009.01.052 
Weng, S.S., Ku, K.L., Lai, H.T., 2012. The implication of mediators for enhancement of laccase 
oxidation of sulfonamide antibiotics. Bioresour. Technol. 113, 259–264. 
https://doi.org/10.1016/j.biortech.2011.12.111 
Wesenberg, D., Kyriakides, I., Agathos, S.N., 2003. White-rot fungi and their enzymes for the 
treatment of industrial dye effluents. Biotechnol. Adv. 22, 161–187. 
https://doi.org/10.1016/J.BIOTECHADV.2003.08.011 
Westerhoff, P., Yoon, Y., Snyder, S., Wert, E., 2005. Fate of endocrine-disruptor, pharmaceutical, and 
personal care product chemicals during simulated drinking water treatment processes. Environ. 
Sci. Technol. 39, 6649–6663. https://doi.org/10.1021/es0484799 
 
Chapter 2 
 
86 
 
Wong, D.W.S., 2009. Structure and Action Mechanism of Ligninolytic Enzymes. Appl. Biochem. 
Biotechnol. 157, 174–209. https://doi.org/10.1007/s12010-008-8279-z 
Xu, R., Zhou, Q., Li, F., Zhang, B., 2013. Laccase immobilization on chitosan/poly(vinyl alcohol) 
composite nanofibrous membranes for 2,4-dichlorophenol removal. Chem. Eng. J. 222, 321–
329. https://doi.org/10.1016/j.cej.2013.02.074 
Yang, G.C.C., Tang, P.-L., 2016. Removal of phthalates and pharmaceuticals from municipal 
wastewater by graphene adsorption process. Water Sci. Technol. 73, 2268–2274. 
https://doi.org/10.2166/wst.2016.006 
Yang, J., Lin, Y., Yang, X., Ng, T.B., Ye, X., Lin, J., 2017. Degradation of tetracycline by immobilized 
laccase and the proposed transformation pathway. J. Hazard. Mater. 322, 525–531. 
https://doi.org/10.1016/j.jhazmat.2016.10.019 
Yang, S., Hai, F.I., Nghiem, L.D., Price, W.E., Roddick, F., Moreira, M.T., Magram, S.F., 2013. 
Understanding the factors controlling the removal of trace organic contaminants by white-rot 
fungi and their lignin modifying enzymes: A critical review. Bioresour. Technol. 141, 97–108. 
https://doi.org/10.1016/j.biortech.2013.01.173 
Yang, Y., Ok, Y.S., Kim, K.H., Kwon, E.E., Tsang, Y.F., 2017. Occurrences and removal of 
pharmaceuticals and personal care products (PPCPs) in drinking water and water/sewage 
treatment plants: A review. Sci. Total Environ. 596–597, 303–320. 
https://doi.org/10.1016/j.scitotenv.2017.04.102 
Yousefi-Ahmadipour, A., Bozorgi-Koshalshahi, M., Mogharabi, M., Amini, M., Ghazi-Khansari, M., 
Faramarzi, M.A., 2016. Laccase-catalyzed treatment of ketoconazole, identification of 
biotransformed metabolites, determination of kinetic parameters, and evaluation of micro-
toxicity. J. Mol. Catal. B Enzym. 133, 77–84. https://doi.org/10.1016/J.MOLCATB.2016.07.015 
Yu, Z., Peldszus, S., Huck, P.M., 2008. Adsorption characteristics of selected pharmaceuticals and an 
endocrine disrupting compound—Naproxen, carbamazepine and nonylphenol—on activated 
carbon. Water Res. 42, 2873–2882. https://doi.org/10.1016/J.WATRES.2008.02.020 
Zdarta, J., Meyer, A.S., Jesionowski, T., Pinelo, M., 2018a. A General Overview of Support Materials 
for Enzyme Immobilization: Characteristics, Properties, Practical Utility. catalysts 8, 1–27. 
https://doi.org/10.3390/catal8020092 
Zdarta, J., Meyer, A.S., Jesionowski, T., Pinelo, M., 2018b. Developments in support materials for 
immobilization of oxidoreductases: A comprehensive review. Adv. Colloid Interface Sci. 258, 1–
20. https://doi.org/10.1016/j.cis.2018.07.004 
Zenker, A., Cicero, M.R., Prestinaci, F., Bottoni, P., Carere, M., 2014. Bioaccumulation and 
biomagnification potential of pharmaceuticals with a focus to the aquatic environment. J. 
Environ. Manage. 133, 378–387. https://doi.org/10.1016/j.jenvman.2013.12.017 
Zhang, G., Ji, S., Xi, B., 2006. Feasibility study of treatment of amoxillin wastewater with a 
combination of extraction, Fenton oxidation and reverse osmosis. Desalination 196, 32–42. 
https://doi.org/10.1016/J.DESAL.2005.11.018 
Zhang, Y., Geißen, S.-U., 2010. In vitro degradation of carbamazepine and diclofenac by crude lignin 
peroxidase. J. Hazard. Mater. 176, 1089–1092. https://doi.org/10.1016/J.JHAZMAT.2009.10.133 
Zhang, Y., Marrs, C.F., Simon, C., Xi, C., 2009. Wastewater treatment contributes to selective increase 
of antibiotic resistance among Acinetobacter spp. Sci. Total Environ. 407, 3702–3706. 
https://doi.org/10.1016/j.scitotenv.2009.02.013 
Chapter 2 
 
87 
 
Zheng, F., Cui, B.K., Wu, X.J., Meng, G., Liu, H.X., Si, J., 2016. Immobilization of laccase onto chitosan 
beads to enhance its capability to degrade synthetic dyes. Int. Biodeterior. Biodegrad. 110, 69–
78. https://doi.org/10.1016/j.ibiod.2016.03.004 
Zucca, P., Sanjust, E., 2014. Inorganic materials as supports for covalent enzyme immobilization: 
Methods and mechanisms. Molecules 19, 14139–14194. 
https://doi.org/10.3390/molecules190914139 
 
  
 88 
 
 89 
 
 
 
 
 
 
 
Chapter 3 
Effect of redox mediators in pharmaceuticals degradation by 
laccase: A comparative study 
 
 
 
 
 
 
 
The chapter has been published as: 
Ana Luisa Parra Guardado, Marie-Pierre Belleville, Magdalena de Jesús Rostro Alanís, 
Roberto Parra Saldívar, José Sánchez-Marcano (2019) Effect of redox mediators in 
pharmaceuticals degradation by laccase: a comparative study. Process Biochemistry, 78, 123-
131 
 90 
 
 
3. Effect of redox mediators in pharmaceuticals degradation by 
laccase: A comparative study 
 
 
Abstract 
Bio-catalytic processes have recently attracted attention as an interesting option for the 
degradation of persistent pollutants as they are capable to catalyse specific reactions at mild 
conditions and low environmental impact. In this work the potential to transform 
pharmaceutical micropollutants of a novel laccase from Pycnoporus sanguineus CS43 was 
compared to the commercial laccases Trametes versicolor and Myceliophtora thermophila. 
In the absence of redox mediators micropollutants were resistant to degradation, except for 
the antibiotic amoxicillin that was transformed by all laccases. The influence of natural and 
synthetic redox mediators (syringaldehyde, p-coumaric acid and ABTS) on the laccase 
oxidation system was investigated. Results showed the degradation of a complex mixture of 
pharmaceuticals is both compound and redox mediator dependent. Syringaldehyde resulted 
as the best redox mediator allowing the highest degradation yields of the antibiotics 
amoxicillin (80%), sulfamethoxazole (100%) and ciprofloxacin (40%) within 3 h treatment. 
Overall, commercial laccases showed better catalytic performance in comparison to P. 
sanguineus CS43 laccase especially in the presence of redox mediators. The successful 
transformation of pharmaceuticals by the combined action of different laccases and redox 
mediators demonstrate the potential of these systems for the removal of complex pollutant 
matrices. 
 
Keywords: Laccase, Pharmaceutical micropollutants, Redox mediators, Bio degradation 
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3.1. Introduction 
Pharmaceuticals are synthetic or natural chemicals found in prescription medicines, 
therapeutic and veterinary drugs with a worldwide annual consumption estimated to 100 
000 tons per year [1]. The broad use of pharmaceuticals leads to its continuous release into 
the environment as intact substances or metabolites that are ineffectively removed by 
conventional wastewater treatment plants [2,3]. Hence, pharmaceuticals are detected in 
water bodies at concentrations from µg L-1 to ng L-1 representing a threat to aquatic 
ecosystems and human health [4,5]. 
The degradation of pharmaceutical compounds implies an important challenge due to 
their low bioavailability and complex structure. To date, several processes for the removal of 
these pollutants have been studied, including conventional techniques (activated sludge, 
filtration, coagulation, flocculation, sedimentation) advanced oxidation processes 
(ozonation, UV irradiation, Fenton oxidation), adsorption and membrane processes [3,6]. 
Recently, the use of “hybrid processes”, which are a combination of two or more treatment 
processes, was reviewed since it seems to be an effective way to remove micropollutants 
[7]. Nonetheless, the high cost of operation, the inconstant efficiencies obtained and the 
possible formation of hazardous by-products are major drawbacks to their successful 
application of these technologies [3]. 
A promising alternative treatment is the use of ligninolytic enzymes obtained from 
white rot fungi cultures (laccases, peroxidases, manganese peroxidases) since they catalyse 
specific reactions under moderate operational conditions preventing undesired side-
reactions [8,9]. 
Particullarly, Laccases (1.10.3.2) are able to catalyse single electron oxidation of 
phenolic moieties via phenoxy radicals with the reduction of oxygen to water. Furthermore, 
laccases catalyze the oxidization of phenolic compounds, amines, methoxy-substituted 
phenols and some inorganic compounds [10]. Numerous studies have indicated that laccases 
present a great potential in the bioremediation of contaminated effluents with dyes [11], 
phenolic compounds [12], pesticides [13], pharmaceuticals and personal care products [14–
18]. The oxidation effectiveness of substrates by laccase depends on factors such as the 
difference of redox potential between laccase T1 copper and substrate, pH of the medium 
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and chemical structure of substrates [19]. However, non-phenolic compounds like 
pharmaceuticals are not always suitable for laccase oxidation since their redox potential is 
usually higher than the redox potential of most laccases produced by fungi [20]. Moreover, 
the presence of certain functional groups in the structure of the substrate can greatly 
influence its transformation. Functional groups like hydroxyl and amines, better known as 
electron donating groups (EDG) make substrates more susceptible to laccase attack. 
Whereas electron withdrawing functional groups including amides, nitro and carboxylic 
groups will prevent laccase oxidation resulting in a more difficult process [9]. 
Laccase catalysis can be extended by the inclusion of redox mediators that act as 
electron shuttle between the enzyme and substrate. This mechanism involves the oxidation 
of the mediator by laccase, which results in the production of highly reactive and stable 
radical species that diffuse away from enzyme’s active site to react with other substrates 
[21]. Thereby, it is possible to oxidize chemical compounds that in principle are not 
substrates of laccase. Mediators differ from each other in terms of optimal reaction 
conditions, substrate specificity and the mechanism followed to oxidize substrates (electron 
transfer, hydrogen atom transfer and ionic oxidation) [21,22]. Hence, understanding the role 
of mediators in laccase catalysed reactions is an important matter. Recently, the evaluation 
of critical aspects such as type and dose of mediator and their influence of laccase stability 
and effluent toxicity for the removal of trace organic compounds was reported [23]. 
However, this study is only focused on the performance comparison of a laccase with 
different mediator combinations, similarly to most of the previous investigations evaluating 
laccase-mediator systems for the removal of environmental pollutants [24,25]. Only few 
investigations have studied and compared the effect of different type of oxidative enzymes 
on the treatment of organic pollutants alone or in combination with several redox mediator 
compounds [26,27]. Therefore, research on the performance of different laccase-mediator 
combinations under identical operational conditions for the removal of pharmaceutical 
pollutants is still limited. A study with this focus would allow properly comparing and 
understanding the synergy between different laccase formulations and mediators and their 
effect in the oxidation of pharmaceutical compounds. 
In the present work the potential of three different laccases (Myceliophthora 
thermophila, Trametes versicolor and Pycnoporus sanguineus CS43) for the degradation of 
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three antibiotics (amoxicillin, ciprofloxacin and sulfamethoxazole) and one antiepileptic 
(carbamazepine) in free enzyme systems was evaluated. Firstly, specific aspects such as the 
effect of pH and temperature were assessed for the potential improvement of the 
treatment. Then, the performance of each laccase with selected natural (syringaldehyde and 
p-coumaric acid) and synthetic (ABTS) redox mediators was compared in terms of 
degradation efficiency. In this sense, a cyclic voltammetry study was carried out in order to 
understand the interactions between redox mediators and substrates and the mechanism 
involved for the oxidation of each compound. 
 
 
3.2. Materials and methods 
3.2.1. Chemicals and enzymes  
The pharmaceuticals (amoxicillin (AMX), ciprofloxacin (CIP), carbamazepine (CBZ) and 
sulfamethoxazole (SMX)), mediators (2,2’-azino-bis-(3-ethylbenzothiazoline-6-sulphonic 
acid)) (ABTS), p-coumaric acid (PCA), syringaldehyde (SYR)) and all other chemicals were 
purchased from Sigma-Aldrich. The structure of pharmaceuticals and redox mediators is 
shown in Table. 3.1. Stock solutions (100 mg L-1) of AMX, CIP and SMX were prepared in 
citrate-phosphate buffer 0.1 M, pH 7. Considering the lack of solubility in water of CBZ the 
stock solution of this compound was prepared in pure ethanol at a concentration of 15,625 
mg L-1. ABTS solution (5 mM) was prepared just before use in buffer citrate-phosphate pH 7. 
Stock solutions of SYR and PCA (114.9 mM) were prepared in pure ethanol. 
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Table 3.1. Chemical structure of pharmaceuticals and mediators used in this work. 
ANTIBIOTICS                                                                                                            ANTIEPILEPTIC 
Amoxicillin (AMX)      Ciprofloxacin (CIP)      Sulfamethoxazole (SMX)         Carbamazepine (CBZ) 
 
 
 
 
MEDIATORS 
p-coumaric acid (PCA)   Syringaldehyde (SYR)   2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid 
                                                                                                      (ABTS) 
 
 
 
 
 
 
 
Three different laccase preparations were tested. Laccases from Pycnoporus 
sanguineus CS43 (PSL) were obtained from a tomato medium according to Ramirez-Cavazos 
et al. [28] with some modifications. In short, mycelia were removed from the culture 
supernatant by filtration using two tangential flow filters in series, with respective pore sizes 
of 0.5 and 0.2 µm. The 0.2 µm filtrate (laccase cocktail) was then filtered on a 10 kDa 
ultrafiltration membrane. The resulting enzymatic preparation is a laccase cocktail 
containing at least two isoenzymes. A complete characterization of such laccase cocktail has 
been reported by Orlikowska et al. [29]. Laccase powder from Trametes versicolor (ref 
51639, activity ≥10 U mg-1) (TVL) was purchased from Sigma-Aldrich. Commercial laccase 
produced by submerged fermentation from Myceliophthora thermophila (59.5 g L-1 of pure 
laccase) (MTL) was provided by Novozymes (Denmark). 
 
3.2.2. Laccase activity assay 
The laccase activity was determined by measuring the oxidation of 0.5 mM ABTS 
solution prepared in citrate-phosphate buffer (0.1 M, pH 4). The reaction was monitored at 
420 nm (Ɛ420 = 36000 M-1 cm-1) with a spectrophotometer (Shimadzu UV-2401PC). One 
enzyme activity unit (U) was defined as the amount of enzymes that oxidized 1 μmol of ABTS 
per min. 
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3.2.3. Pharmaceuticals oxidation by laccases 
Degradation experiments were run in 100 or 250 ml Erlenmeyer flasks at 25°C under 
dark conditions to avoid light oxidation and continuous stirring to ensure O2 saturation of 
the reaction medium. Reaction mixtures (50 or 100 ml) contained one or a mixture of all 
pollutants in buffer citrate-phosphate (0.1 M) pH 7; each pollutant concentration was fixed 
at 20 mg L-1 (molar concentration: 55 µM AMX, 79 µM SMX and 60 µM CIP) except in the 
case of CBZ where it was 10 mg L-1 (molar concentration: 85µM). Some experiments were 
also carried out at different pH (citrate-phosphate buffer 0.1 M pH in the range of 3-7) and 
different temperatures (15 – 40 °C). 
To assess the effectiveness of redox-mediator for enhancing the bio-oxidation of 
micropollutants, experiments were carried out as described above after adding one of the 
following mediators (ABTS, PCA and SYR) at a concentration of 520 µM to the reaction 
medium. Mediator:substrate molar ratios up to 9:1 (depending on the pharmaceutical) were 
tested in order to ensure the effective removal of the micropollutants due to the mediator 
action. Reactions were initiated by adding one of the three enzyme preparations at the 
concentration of 1 200 U L-1. To monitor the degradation process, samples of 1 ml were 
withdrawn every 24 h when there was no redox-mediator in the reaction medium. When 
using mediators, samples were taken every 20 minutes during the first three hours and then 
every hour until 8 h. It is worth noting that the number of samples taken was limited in order 
to keep the variation of reaction volume below 15%. After sampling, aliquots were 
inactivated in a water bath at 100 °C for 5 minutes and filtered with CHROMAFIL Xtra H-
PTFE-20/30 filters to immediately be analysed by HPLC-MS. In order to verify the 
repeatability of the treatments all experiments were carried out several times and at least 
duplicated. The results reported in all figures correspond to the average of the experiments 
with their corresponding standard deviations that are given in figures or captions. Controls 
without enzyme neither mediator as well as controls with mediator but no enzyme were run 
in parallel to assess the role of enzymes on the removal of the pharmaceuticals. 
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3.2.4. HPLC-MS quantitative analysis 
Micropollutants concentration during enzymatic treatment was analysed using a 
HPLC Alliance – Waters e2695 separations module equipped with a C18 Raptor column (150 
x 2.1 mm, 5 µm) coupled to a MS Micromass Quatro micro API (tri-quadripole) detector. 5 µl 
of sample were injected and two eluents, namely eluent A (95% water – 5% methanol) and 
eluent B (100% methanol), were passed through the column at a flow rate of 0.25 ml min-1 in 
the following gradient program: 0-3 min, 100% (A), 3-8 min, 100% (B) and 8-15 min, 100% 
(A).  
 
3.2.5. Redox potential determinations 
Cyclic voltammetry experiments were carried out in sodium phosphate buffer 0.1 M, 
pH 7, using a VERSASTAT3 voltammetry analyser (Princeton Applied Research). A cell of 250 
ml was used in all voltammetry studies. The electrochemical cell consisted of an Ag/AgCl 
reference electrode, a platinum wire counter electrode and a graphite working electrode. 
Scan rates of 0.5 V s-1 were applied whereas the concentration of substrates and mediators 
were in the range of 0.2 – 3 mM according to molar concentrations used in degradation 
reactions.  
 
 
3.3. Results and discussion 
3.3.1. Oxidation of pharmaceuticals by laccases 
The potential of each one of three laccases to transform pharmaceutical active 
compounds was initially evaluated without mediators. Firstly, each pharmaceutical was 
treated individually with 60 U of each laccase. After 72 h of enzymatic oxidation no sign of 
laccase-catalysed degradation for SMX, CIP and CBZ was found by any of the enzymes tested 
(results not shown). In contrast the antibiotic AMX was effectively transformed (Fig. 3.1). 
From the enzymes tested, PSL showed the highest affinity for AMX reaching 72% removal. 
Commercial laccases TVL and MTL presented similar performance with 58% degradation at 
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the end of the reaction. In the case of PSL the first signs of oxidation were visible after 24 h 
of reaction. 
No conversion was detected in controls without enzyme, except for AMX where a 
decrease in concentration was observed. Belonging to the β-lactam penicillins, AMX is an 
antibiotic known to be unstable in aqueous solutions due to its fast hydrolysis and 
degradation to various sub-products [30]. Nonetheless, the self-degradation of AMX was 
much lower in comparison to reactions where enzymes were added, evidencing the effective 
catalytic action of laccases on the antibiotic removal (Fig. 3.1). 
 
 
Fig. 3.1. Oxidation of AMX in single substrate by laccases from M. thermophila ( ), P. 
sanguineus (   ) and T. versicolor (   ), control without enzyme () at 25 °C and pH 7.  
 
 
Affinity of laccase towards substrates is influenced mainly by the redox potential of 
the specific laccase and the presence of strong electron donating functional groups (EDG) or 
electron withdrawing functional groups (EWG) [23]. Functional EDG prone to be attacked by 
laccase include hydroxyl (-OH), amines (-NH2), alkoxy (-RO), alkyl (-R) and acyl (-COR). On the 
other hand, EWG such as carboxylic (-COOH), amide (-CONR2), halogen (-X) and nitro (-NO2) 
may prevent electron abstraction from occurring by forming a steric shield [9]. Hence, 
removal efficiencies obtained in this study can be attributed to the chemical structure of the 
pharmaceuticals. Effective oxidation of AMX can be explained by the presence of a group 
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hydroxyl attached to an aromatic ring that enables the catalytic action of laccases. The slight 
difference in removal efficiency among laccases may be due to the redox potential of the 
enzyme that varies depending on the fungal source. Indeed, the AMX degradation results 
discussed above are in good agreement with the removal of AMX by TVL was previously 
reported by Becker et al. [31] who observed that even if self-degradation of AMX in blanks 
runs was obvious, the observed complete oxidation of this antibiotic in an enzymatic 
membrane reactor after 24 h of treatment was the result of the enzymatic oxidation. 
The antibiotic SMX contains an amine (EDG) and a sulfonamide (EWG) group in its 
structure. The influence of both groups on the degradation has not been clearly established. 
In some studies effective removal of the pharmaceutical was reported [32], whereas in 
others the sulfone group has been related with its recalcitrance to degradation [33]. Guo et 
al. [32] reported that white-rot fungus P. chrysosporium could oxidize SMX. In contrast, 
Margot et al. [25] observed SMX was recalcitrant to purified TVL oxidation in absence of 
redox mediators. Interestingly, higher removal of the antibiotic was obtained by fungal 
cultures in comparison to purified laccase as demonstrated by Gao et al. [34] who observed 
high oxidation yields of SMX by using P. chrysosporium and P. sanguineus fungal cultures; 
but visible lower catalytic effects were obtained when the corresponding purified enzyme 
extracts were used. Possibly, the effect of other enzymes or compounds present in fungal 
cultures enhanced SMX removal. In addition, low oxidation of SMX would be also attributed 
to the redox potential of selected laccases. The redox potential of sulfonamides is estimated 
to be in the range of 0.858-1.158 V which is considerable high in comparison to redox 
potential of most laccases (0.5-0.8 V). Indeed, these compounds are recalcitrant to the 
oxidation by laccase [35]. In the case of CIP and CBZ both pharmaceuticals possess strong 
EWG. The amide group in CBZ and the presence of the carboxyl and halogen group in CIP 
make them highly resistant to laccase oxidation [33,36]. The lack of oxidation observed in 
this study agrees with literature. Ji et al. [37] who reported less than 5% removal of CBZ by 
free laccase treatment.  
Considering the limited oxidative performance of laccases towards pharmaceuticals in 
single substrate assays, simultaneous conversion of AMX, SMX, CIP and CBZ in mixtures, was 
carried out to study potential substrate mediation/competition effect in the reaction. 
Investigation on the effect of substrate mixtures on enzyme specificity is of high interest to 
Chapter 3 
 
99 
 
assess the applicability of enzymes as a treatment option since treated wastewaters 
generally contain a complex mixture of pollutants. In these experiments the concentration of 
SMX, CIP and CBZ remain unchanged in the reaction medium, confirming their recalcitrance 
to enzymatic oxidation (data not shown). Laccase affinity towards these substrates was not 
influenced by the presence of others micropollutants in the reaction. Nonetheless, their 
presence results also on a very slight decrease of the AMX concentration. However, this 
decrease is difficult to be considered as result of the enzymatic degradation because of the 
self-oxidation of this substrate is of the same order of magnitude. 
The simultaneous presence of micropollutants in a reaction media can affect the 
removal efficiency in the system. The results presented until now in literature are sometimes 
contradictory and depends on the mixture of pharmaceuticals studied. For example, Ji et al. 
[14] who studied the free enzymatic removal of five representative pharmaceuticals 
bisphenol-A (BPA), diclofenac (DCF), clofibric acid, ibuprofen (IBP) and CBZ) observed that 
degradation yield in mixtures of three molecules was doubled respect to samples with only 
one pharmaceutical. The increase in degradation was attributed to the presence of 
bisphenol-A, a phenolic compound and then after enzyme oxidation would form phenoxyl 
radicals that can act as redox mediator between laccase and other micropollutants more 
recalcitrant to enzymatic degradation. On the contrary, Margot et al. [38] observed that 
removal yield was four times lower in the presence of mefenamic acid and diclofenac 
compared to single compound solution. Authors suggest that a competitive effect between 
substrates takes place thus reducing removal yields. Nguyen et al. [33] studied the 
simultaneous removal of SMX, CBZ, DCF and BPA with a commercial laccase. No effect of the 
mixture of micropollutants on the removal was observed. These authors attributed the 
resistance (SMX and CBZ) or the vulnerability (DCF and BPA) to laccase oxidation to the 
chemical structure of each compound. Seems like the cocktail effect of micropollutants 
mixtures in laccase catalytic system depends on the presence of more reactive compounds 
that could promote the removal of recalcitrant ones [39]. Indeed, the presence of different 
compounds in the reaction media is strongly dependent on the mixture studied. In the 
present work the degradation of AMX observed could have an influence of the degradation 
of other micropollutants in the mixture. 
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Furthermore, effective removal of pharmaceutical mixtures directly depends on the 
type of enzyme and compound as demonstrated by Stadlmair et al. [27]. These authors 
tested different types of oxidative enzymes for the multiple conversions of acetaminophen, 
DCF and sotalol and they observed that inhibition or enhancement effect in case of 
horseradish peroxidase did not occur with laccase from Pleurotus ostreatus. The poor 
degradation performance obtained in this investigation could be also related to the 
operational conditions which were not optimized. Indeed, enzyme reactivity generally 
depends on conditions such as pH and temperature. The effect of these parameters was 
studied only for AMX since it was the most sensitive compound to enzymatic degradation. 
 
3.3.2. Effect of pH and temperature in the oxidation of AMX by laccases 
Removal of AMX by enzymatic treatment was investigated at different pH. Laccase 
produced by P. sanguineus, M. thermophila and T. versicolor were used for this purpose. In 
order to evaluate AMX self-degradation, similar experiments were carried out by replacing 
the enzymatic solution by the same amount of corresponding buffer. Results obtained are 
reported in Fig. 3.2a. 
As observed in the control reactions, AMX in aqueous solution was less stable at 
acidic conditions in comparison to neutral pH values. After 48 h at pH 3 around 80% of the 
compound was disappeared. At higher pH values, self-degradation decreased and stabilized 
at around 30% (pH 5-7). It is important to note that after enzyme addition, no AMX removal 
was observed at pH 3 by any of the laccases used. Moreover, AMX transformation yield 
significantly variated depending on the type of laccase considered. According to Fig. 3.2a the 
addition of MTL leads to a slight decrease of AMX concentration in comparison to the 
control as long as pH is less or equal to 5. However, at pH values higher than 5, no 
considerable transformation was observed regarding to the control curve.  
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Fig. 3.2. (a) Oxidation of AMX at different pH by laccases from M. thermophila (●), P. 
sanguineus () and T. versicolor (), control without enzyme (+) after 48 h at 25 °C. (b) Effect 
of temperature on the oxidation of AMX at pH 6 after 48 h by laccases from M. thermophila  
(  ), P. sanguineus (  ) and T. versicolor (  ), control without enzyme (). 
 
The TVL presented a completely different reactivity towards AMX in function of pH. 
No oxidation occurred when pH was in the range from 3 to 5. Nonetheless, when pH was 
higher than 5, AMX concentration significantly decreased in comparison to control reactions 
(residual concentrations at pH 6 was 52% versus 73% and 34% versus 69% at pH 7). The best 
performance of TVL was thus achieved between pH6 and 7. PSL was definitely the best 
enzyme for the AMX degradation. In comparison to controls this enzyme allowed to improve 
AMX degradation from pH 4 to 7. The best performance was observed between pH 5 and 6. 
In such conditions AMX was almost completely removed (residual concentration less than 
1% and 4% at pH 5 and 6 respectively). 
Optimal pH depends on the laccase properties as well as on the substrate properties, 
since pH can alter the charge of the compound and the configuration shape of the enzyme 
(a) 
  
 
 
 
 
 
 
 
 
 
 
 
((b) 
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which is fundamental for the access or the binding of substrates to the active site [38]. These 
results are in good agreement with the conversions reported by Lloret et al. [40] and Margot 
et al. [38], who reported an optimal pH around 5.5 for the degradation of several 
micropollutants. Even though in some cases oxidation can be observed at low pH values, 
acidic conditions may lead to complete enzyme deactivation. According to the results 
presented in this work pH 6 would represent the balance between laccase activity and 
stability to maximize AMX oxidation capacity; therefore, pH 6 was chosen to evaluate the 
influence of temperature in the catalytic system. 
The effect of temperature on the removal of AMX was evaluated at 15, 25 and 40°C. 
From Fig. 3.2b it can be noticed that the increase of reaction temperature leads to an 
increase of AMX self-degradation from 6% at 15 °C to nearly 40% at 40°C. This is not 
surprising, since most of chemical reactions are favoured by temperature. AMX contains an 
EDG prone to laccase catalytic activity; hence laccase properties will be determinant to find 
the best reactivity conditions. Regardless of the tested temperature, MTL did not improve 
considerably the removal of AMX. These results were expected since this enzyme presented 
little activity at pH 6. After the addition of TVL, residual content of AMX decreased as 
temperature increased. The highest AMX removal (around 50%) was obtained at 40°C. 
However, if self-degradation is taken into account, no significant bio-oxidation increase was 
observed when passing from 25°C to 40°C. The best oxidation performance was obtained 
with PSL reaching removal values up to 80% and 90% after only 24 h at 25 and 40°C 
respectively. Afterwards reaction slowed down –probably due to the decrease of substrate 
concentration- even so the final AMX concentrations were less than 4 and 3% respectively. It 
is also important to remark that PSL showed good oxidation performance even at 15 °C. 
After 24 h 65% of AMX was successfully transformed. 
Similar behaviour was also reported by Margot et al. [38] for the removal of DCF and 
mefenamic acid by T. versicolor laccase, removal increased from 10 to 25 °C but then no 
additional removal was observed at higher temperatures. Authors suggested that optimal 
temperature depends on the substrate properties since laccase denaturation is less likely to 
occur in the temperature range tested. The three laccases tested in this work are produced 
by different strains of white rot fungi; therefore, they are expected to display different 
catalytic properties. Moreover, commercial TVL and MTL are purified or partially purified 
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enzymes contrary to the laccase cocktail from PSL. The better performance of PSL could be 
attributed to the presence of at least two laccase isoforms in the culture supernatant as well 
as some impurities. All these components in PSL supernatant could have protected the 
active centre from pH and temperature variations making the laccase cocktail the same or 
more stable than the purified isoforms as suggested by Ramirez-Cavazos et al. [41]. 
 
3.3.3. Oxidation of pharmaceuticals by laccases in the presence of redox mediators 
In this section the mediated action of two natural mediators: p-coumaric acid and 
syringaldehyde was compared with the influence of the synthetic mediator ABTS for the 
oxidation of the pharmaceutical active compounds in mixtures. As mentioned in section 3.1, 
factors such as molecular structure of the micropollutant, redox potential of the enzyme, 
type and concentration of mediator can strongly influence the degradation process. In this 
sense we chose to work with mediator compounds that follow different oxidation 
mechanisms: hydrogen atom transfer (SYR and PCA) and electron transfer (ABTS). Mediator 
concentration was fixed at 520 µM to provide a high mediator:substrate molar ratio to allow 
the effective removal of the studied pharmaceuticals by laccase-mediator systems as 
demonstrated by Murugesan et al. [42]. Finally, all degradation reactions as well as control 
reactions were followed for at least 3 h.  
 
3.3.3.1. Effect of p-coumaric acid addition 
Degradation yields obtained after PCA addition variate in function of the substrate-
enzyme couple as shown in Fig. 3.3. It is important to note that no effect of PCA addition on 
the transformation of pharmaceuticals was observed in control reactions, suggesting that 
degradation was carried out effectively by the laccase-mediator system. The same 
observation can be done for all the couples enzyme-mediator studied. 
In the case of TVL, addition of PCA leads to a slow but continuous oxidation of SMX 
and CIP (Fig. 3.3a and 3.3c). Respectively 31% and 40% of these compounds were removed 
after 2 h of reaction; afterwards their concentrations remained nearly constant. However, 
TVL was still unable to oxidize AMX contrary to PSL which allowed removing 40% of AMX in 
less than 40 minutes of reaction. Again, the increase of reaction time did not lead to an 
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enhancement of AMX removal; the residual concentration after 2 h stayed constant at 60% 
of the initial concentration. Regarding to CBZ, no sign of degradation was observed after PCA 
addition. In fact, it was not transformed by any couple laccase-mediator studied confirming 
the recalcitrance of this antiepileptic to biodegradation (data not shown).  
 
 
Fig. 3.3 Residual concentration of (a) AMX, (b) SMX and (c) CIP in mixture after 170 minutes 
treatment with laccase-PCA mediator system: M. thermophila (●), P. sanguineus () and T. 
versicolor (). Control without enzyme (+) at 25 °C and pH 7. Standard deviation less than 
10% from duplicate experiments. 
 
(a) 
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The mechanism of reaction followed by PCA for substrate oxidation is based on 
hydrogen atom transfer (HAT) in which mediator remove a hydrogen atom to create 
phenoxyl radical. Nevertheless, the effectiveness of this oxidation process is also related to 
the redox potential of PCA which altogether with the affinity of the enzyme for the mediator 
and the reactivity/stability of radicals formed will control the yield of laccase-mediator 
reactions [40,43]. Following this mechanism PCA has been reported as an excellent laccase 
mediator, especially for the removal of recalcitrant pollutants such as polycyclic aromatic 
hydrocarbons (PAH) [43,44]. In this way, PCA was reported to enhance the removal of the 
recalcitrant CBZ in hybrid membrane reactors, both in single [37] and mixture micropollutant 
solutions [39]. The improved degradation of CBZ in the mentioned works could be attributed 
to the improved stability of immobilized enzyme used in the bioreactors compared with free 
laccase. Although in the present investigation PCA did not enhance CBZ oxidation, its effect 
in the removal of other persistent pollutants was validated. 
In this study from all the enzymes, TVL showed higher affinity to PCA since better 
degradation yields were observed specially towards recalcitrant pharmaceuticals such as CIP. 
Although redox potential of PCA was high enough to start oxidizing the pharmaceuticals, 
most likely phenoxyl radicals formed were not stable to continue with the process. For 
instance, visible effects were observed at the end of three hours with relatively low 
oxidation ratios (10-40%). 
 
3.3.3.2. Effect of ABTS addition 
The effects of ABTS addition on the transformation of pharmaceuticals are presented 
in Fig. 3.4. The presence of ABTS in the reaction medium allowed the oxidation of AMX and 
SMX by TVL and MTL. Degradation percentage observed for AMX by TVL was higher than the 
obtained with MTL; a complete removal of AMX was observed after 2 h of reaction with TVL 
whereas about 90% of removal was achieved after 3 h with MTL (Fig. 3.4a). Moreover, it is 
worth noting that during the first 90 minutes of reaction, ABTS did not favour the oxidation 
of SMX by any of both laccases. Visible effects were only observed after 2 h with removal 
efficiencies up to 30 and 50% by MTL and TVL respectively (Fig. 3.4b). 
 
Chapter 3 
 
106 
 
 
Fig. 3.4. Time course degradation of AMX (a), SMX (b) and CIP (c) by laccases in presence of 
ABTS as mediator at pH 7 and 25 °C. M. thermophila (●), P. sanguineus () and T. versicolor 
(). Control without enzyme (+). Standard deviation less than 10% from duplicate 
experiments. 
 
 
Few studies have reported the degradation of SMX by laccase-mediator systems 
[25,34,45]. Margot et al. [25] obtained similar removal yields to those obtained in this work 
(30%) with T. versicolor laccase in presence of ABTS in pure compound solutions but at 
longer reaction times (10 h). ABTS is an azino mediator that undergoes oxidation by means 
of electron transfer mechanism and has been proposed for the transformation of 
(a) 
 
 
 
 
 
 
 
 
 
 
 
(b) 
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compounds with relatively weak C-H bonds [46]. Nonetheless, in general, the reactivity of 
mediators towards substrates in laccase-mediator systems varies depending on the 
functional groups in the substrate [21]. SMX presents a phenylamine in its structure whereas 
AMX shows a phenol group. Since both groups are susceptible for laccase degradation, 
phenol may be an easier substrate to be transformed due to the presence of electron-
donating substituents at the benzene ring which decreases the electrochemical potential 
[47]. 
Last assumption was confirmed by means of the electrochemical analysis carried out 
with substrates and mediators. When AMX or SMX were added to a solution of ABTS an 
increase in the oxidation current for both cation (ABTS●+) and dication (ABTS●2+) forms was 
observed. ABTS dication current increased from 11.5 to 23 mA in presence of AMX and from 
11.5 to 13.5 mA for SMX. This phenomenon was previously reported by Bourbonnais et al. 
[48] for the oxidation of veratryl alcohol with ABTS. According to these authors, during cyclic 
voltammetry determinations the mediator is oxidized at the electrode and then radicals 
formed diffuse in the solution to oxidize the substrate. In the case of ABTS the reaction relies 
on the two electrons oxidation of substrate that regenerates the cation radical at the 
electrode, resulting in a current increase compared to the oxidation of ABTS alone. The fact 
that the increase of oxidation current for AMX is significantly higher than for SMX suggest 
that radicals formed during AMX oxidation are more stable and regenerates faster at the 
electrode making easier AMX transformation in comparison to SMX. 
Independently of the enzyme tested, the presence of ABTS did not allow CIP 
oxidation. These results contrast with those reported by Prieto et al. [49] where almost 
complete degradation of CIP (i.e. 97%) by T. versicolor-ABTS system was achieved but in 
their case the reaction was carried out for 30 h. In addition to the difference of reaction 
times, the absence of CIP biodegradation could be related to the difference of fungal species 
used to produce the laccases. It may also result from a competition with AMX and SMX 
oxidation. ABTS cation radicals reacted first with AMX and SMX during 3 h, by that time 
radicals may not be stable or available anymore to continue with the oxidation which would 
limit the reaction [24]. Further research would be necessary to determine the optimal 
reaction parameters as well as the factors limiting the reaction (i.e. availability of ABTS and 
laccase stability). 
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On the contrary to the results obtained for TVL and MTL, ABTS did not significantly 
react with PSL since lower degradation percentages were obtained with this couple. A 
different behaviour was reported by Gao et al. [34] who tested a laccase extract from P. 
sanguineus for the degradation of antibiotics, among them CIP and SMX, in single and 
mixture solution. They carried out reactions at 30 °C in the presence of ABTS (1 mM) 
obtaining high transformation yields (85-100%) but 72 h were necessary to achieve these 
removal yields. The high transformation yields obtained by Gao could be influenced by the 
operational conditions used in their experiments, higher temperatures and mediator 
concentration as well as longer reaction times may favour the transformation of 
pharmaceuticals. 
 
3.3.3.3. Effect of syringaldehyde addition 
The addition of SYR to the pharmaceuticals mixture resulted on a high enzymatic 
degradation (50-100%) (Fig. 3.5). Among all pharmaceuticals studied, SMX was removed 
with the highest efficiency by all laccases. MTL showed the best performance with almost 
100% degradation within the first 10 minutes of reaction (Fig. 3.5b). TVL and PSL also 
completely transformed SMX after 1.5 and 2.5 h. These results are better to those reported 
by Shi et al. [50] who observed almost a complete degradation of SMX after 30 min with a 
laccase from Echinodontium taxodii but in the presence of higher SYR concentration (1 mM). 
Similarly, AMX was well removed by the couple MTL-SYR attaining 80% removal 
within the first 30 minutes. After this time the reaction stabilized and no significant increase 
in degradation was observed before the end of the experiment. In the case of TVL and PSL 
moderate transformation yields of AMX were obtained; 50% of removal was achieved at the 
end of 3 h (Fig. 3.5a). Increasing the reaction time up to 8 h showed no significant 
enhancement in degradation; after 4h AMX removal leveled off around to 70%. Degradation 
of AMX in presence of different concentrations of SYR (0.1 and 1 mM) was described by 
Becker et al. [31]. These authors reported removal yields from 89 to 95% depending on the 
mediator concentration. Interestingly, authors observed that the use of SYR slightly reduced 
removal yield of AMX in comparison with the treatment with only laccase. Such negative 
effect was not observed in this study, on the contrary, enhanced oxidation of AMX was 
observed for all laccases tested. 
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Fig. 3.5. Oxidation of AMX (a), SMX (b) and CIP (c) by laccases in presence of SYR as mediator 
at pH 7 and 25 °C. M. thermophila (●), P. sanguineus () and T. versicolor (). Control 
without enzyme (+). Standard deviation less than 10% from duplicate experiments. 
 
 
SYR was able to oxidize CIP altogether with MTL and TVL attaining 40% removal after 
3h of reaction and up to 60% at the end of 8 h. To our knowledge, results obtained in this 
study represent the highest CIP degradation yield reported for a laccase catalysed oxidation 
by free enzymes using SYR as mediator. Laccase-SYR system was previously tested for the 
degradation of CIP with very low removal yields [36,51]. For example, Ding et al. [36] 
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observed negligible removal of CIP by free laccase. Moreover, the degradation was not 
improved by the presence of SYR even at concentrations as high as 2 mM.  
Mediator SYR belongs to the group of substituted phenols compounds that have been 
proved as suitable laccase mediators [26,52]. The mechanism of reaction followed by SYR for 
the oxidation of non-phenolic substrates is the generation of phenoxyl radicals by HAT [53]. 
Structurally, SYR presents a phenol group which is easily oxidized by laccase and two 
methoxy substituents in ortho position that increase the stability of phenoxyl radicals. 
Therefore, the efficiency of SYR as mediator in terms of speed and conversion yield is related 
to the high concentration and stability of the phenoxyl radicals formed during oxidation 
reactions [47]. This actually explains the high and fast conversion yields obtained in this 
study. 
Overall, from all mediators studied the best results were obtained with SYR. The 
presence of SYR accelerates degradation of the pharmaceuticals within the first 3 h of 
reaction, after this time no further transformation was observed. Various hypotheses could 
explain the threshold observed: loss of mediators and/or laccase activity, enhancement of 
the concentration of oxidation products, etc. all of these possibilities could have a negative 
influence on the degradation rate. For example, some authors have demonstrated that an 
excess of mediators, as is the case of this work, can result on the acceleration of the loss of 
laccase activity by the attack of the radicals formed during mediator oxidation to enzyme’s 
catalytic sites [24,37,54]. However, in this work samples taken from the supernatant still 
showed enzymatic activity for the three laccases after 7 h of reaction (results not presented). 
Indeed, it is also possible a competition for the oxidative process between the 
pharmaceuticals and oxidation products formed. De Cazes [16,55] has already noticed this 
effect for the degradation of tetracycline and erythromycin with immobilized enzymes. The 
authors observed a decrease of the degradation yield with time up to stabilization of 
antibiotics concentration after 24 h of reaction. Then, substrates solutions were replaced by 
fresh ones and the initial degradation activity was reached again. They were able to repeat 
the same cycles during more than 200 h. 
As mentioned at the beginning of this section, CBZ was not transformed by any 
laccase-mediator system assayed. Poor removal of CBZ was previously reported even in the 
presence of redox mediators like SYR or ABTS [37,54]. As previously discussed, the low 
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removal amounts can be attributed to the presence of strong EWG in its structure making 
the pharmaceutical not suitable for biodegradation. Moreover, recent evidence suggests 
that reaction conditions could play a determinant role in CBZ degradation. Naghdi et al. [56] 
observed that addition of ABTS increased degradation of CBZ from 30% to 82% in 24 h by a 
laccase extract from T. versicolor, but when reaction conditions were optimized to 35 °C, pH 
6, with 60 U L-1 of enzyme concentration and 18 μM of mediator up to 95% removal was 
obtained. Further investigation should be done in order to find the conditions allowing CBZ 
degradation in the matrix. 
Generally, the addition of redox mediators resulted in the increase of 
pharmaceuticals degradation. However, the degradation yield depends on the mediator type 
and laccase used. The best combination of mediator/laccase leading to the highest removal 
of AMX was TVL in combination with ABTS. In the case of SMX the antibiotic was better 
removed by MTL and SYR. Similarly, CIP highest removal was obtained by both MTL and TVL 
in presence of SYR.  
From the three redox mediators SYR showed as the most effective mediator allowing 
the degradation of AMX, SMX and CIP in short periods of time. The effectiveness of SYR to 
mediate the oxidation of pharmaceuticals was followed by ABTS and PCA which presented 
the slowest reaction yields. MTL and TVL were the most reactive enzymes showing high 
affinity to SYR (Table 3.2). 
 
 
Table 3.2. Reactivity of selected laccases towards mediators. 
Pharmaceutical 
Laccase 
M. thermophila T. versicolor P. sanguineus 
AMX SYR (++) ABTS (+++) SYR (+) 
SMX SYR (+++) SYR (++) SYR (+) 
CIP SYR (+++) SYR (+++) - 
CBZ - - - 
(+++) very reactive; (++) reactive; (+) less reactive. 
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3.4. Conclusions 
Results of this work show that without mediators, laccases only oxidized amoxicillin. 
Operational conditions had an important influence in the removal yield of the antibiotic that 
was favoured at acidic conditions (pH 5-6). 
In presence of redox mediators, pharmaceuticals degradation was both mediator and 
laccase dependent. Syringaldehyde and ABTS showed as the best redox mediators allowing 
the highest transformation yields (50-100%) in less than 3 h. However, there is not a broad 
spectrum mediator since carbamazepine was not transformed by any laccase-mediator 
system. From our knowledge this is the most detailed study presenting the enzymatic 
degradation of amoxicillin in laccase-mediator systems that was better degraded by laccase 
in presence of ABTS but closely followed by syringaldehyde. Results suggest that amoxicillin 
oxidation occurs by the ET mechanism of reaction but analysis of the reaction products will 
be needed to confirm this assumption. The best degradation yields of ciprofloxacin and 
sulfamethoxazole were reached by using a commercial laccase and syringaldehyde as 
mediator. These results show that pharmaceuticals containing phenolic groups are removed 
depending on the redox potential of the mediator and the stability of the radicals formed. 
Overall, commercial laccases presented better performance for the degradation of 
micropollutants in laccase-mediator systems. Nonetheless, the data obtained by the 
comparison of performance among the three different laccase formulations in the model 
study under the same controlled conditions offer valuable information of the potential use 
of this biocatalyst for the treatment of complex pollutant matrices where different oxidative 
characteristics are often needed. 
This study demonstrates the potential utility of laccase-mediator systems for 
treatment of complex micropollutant mixtures. Notwithstanding the progress realized, many 
drawbacks like stabilization or decay of the enzymatic activity are still present. Further 
studies to improve these enzymatic processes are being carried out, they include the study 
of their ecotoxicity. Moreover, the study of the immobilization of different laccase-mediator 
systems in order to reuse the enzymes is also under way.  
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4. Novel method for the covalent immobilization of laccases on silica gel 
and its application for the elimination of pharmaceutical micropollutants 
 
 
Abstract 
In the present work a novel methodology for the covalent immobilization of laccase onto 
silica gel carriers by using glutaraldehyde in vapour phase is proposed. The influence of 
different parameters on the immobilization conditions were evaluated by a 23 full factorial 
design. Through regression analysis the process was well fitted by a linear polynomial 
equation (R2=0.90899; Adj-R2=0.8559) under which laccase activity reached 14 ± 2 U g-1 of 
beads with a protein immobilization yield of 35%. The biocatalyst was characterized and 
then tested in the removal of pharmaceutical micropollutants in the presence of redox 
mediators. High removal yields (40-100%) were obtained within 3 h of treatment as the 
result of the synergistic effect of laccase-mediator biotransformation and adsorption on the 
support. Moreover, the reusability of the biocatalyst was proved during 7 degradation 
cycles. Although the addition of redox mediators allowed high removal yields, these 
compounds led to the increase in the acute toxicity of the effluent as suggested by the 
Microtox® assay, which variated on the type of mediator. Notwithstanding the toxicity issue, 
the biocatalyst proposed in this investigation could be a promising alternative for the 
application of enzymatic treatment in bioremediation applications.  
 
Keywords: Laccase, covalent immobilization, redox mediators, pharmaceutical 
micropollutants, Toxicity test 
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4.1. Introduction 
World wide access to pharmaceutical products (PPs) has improved living conditions in 
benefit of the society. Nonetheless, the broad use of pharmaceuticals also results in their 
continuous release into the environment as unchanged compounds or metabolites that are 
inefficiently removed by traditional wastewater treatment plants (WWTPs) (Grandclément 
et al., 2017). For instance, PPs have been detected in water sources and even in drinking 
water at concentrations as low as micrograms or nanograms per liter (Heberer, 2002). At 
these low concentrations pharmaceuticals have the potential to cause short and long term 
toxicity, endocrine disrupting effects in aquatic fauna and humans. Moreover, the presence 
of low quantity of antibiotics in treated wastewaters can also result on antibiotic-resistance 
in bacteria (Luo et al., 2014; Voulvoulis et al., 2015). 
To address this environmental issue advanced processes such as extraction, 
adsorption on activated carbon, ozonation, Fenton oxidation and electrochemical 
techniques have been introduced to WWTPs. In order to meet high quality of the treated 
water these tertiary treatments combined to conventional biological treatments allow the 
oxidation and/or the removal of PPs but limitations such as higher cost, formation of 
hazardous by-products and low efficiency have been reported (Luo et al., 2014).  
An alternative to chemical and/or physical methods for the removal of PPs in water is 
the use of enzyme catalysed processes. The bioremediation with biocatalyst such as 
laccases, lipases or tyrosinases can be considered as environmentally friendly processes 
because they consume less chemicals, water, energy and produce less waste in comparison 
to other chemical oxidative processes (Zdarta et al., 2018). In particular laccases receive 
special attention since they are able to catalyse the oxidation of phenolic and non-phenolic 
compounds by only using molecular oxygen that is reduced to water. Hence, since the past 
two decades several reports have confirmed the effectiveness of laccases for the removal of 
a broad range of pollutants including pharmaceuticals (Barrios-Estrada et al., 2018; De Cazes 
et al., 2014; Ding et al., 2016). 
Despite all advantages of enzymatic treatment of wastewaters, the use of laccases in 
environmental applications present some drawbacks related to their limited stability in 
solution, difficult recovery and reusability which results in high operational costs. However, 
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these disadvantages can be overcome by immobilization of enzymes on different supports 
such as silica, magnetic nanoparticles, chitosan microspheres or Amberlite beads (Fortes et 
al., 2017; Jiang et al., 2005; Patel et al., 2014; Spinelli et al., 2013). Among the different types 
of carriers, silica-based materials are highly suitable for enzyme immobilization due to their 
great biocompatibility. Moreover, the hydrophilicity of the surface of silica particles can be 
modulated in order to promote enzyme immobilization not only by adsorption but also via 
covalent bonds (Patel et al., 2014; Zdarta et al., 2018). Covalent immobilization is a rapid 
method based in the creation of strong covalent bonds between the enzyme and the 
activated groups on the surface of the support (Fernández-Fernández et al., 2013). The 
result is a multipoint attachment of the enzyme to the support that significantly enhances 
enzyme reusability and reduces enzyme leaching.  
However, in order to develop a successful immobilization method, the properties of 
the enzyme and the type of support have to be evaluated since parameters such as 
immobilization yield and efficiency are highly influenced by the carrier material (Sheldon and 
van Pelt, 2013). Moreover, immobilization conditions play an important role in the process 
for which optimization is indispensable. Thereby, a continuous searching of new materials 
and immobilization protocols is necessary in order to provide a wide spectrum of biocatalyst 
that can be effectively applied in industrial processes.  
In the present study, a novel method for the covalent immobilization of laccases and 
the potential application of the biocatalyst for the degradation of PPs in water is proposed. 
Laccase immobilization was carried out on commercial functionalized silica gel particles that 
were previously activated with glutaraldehyde in vapour phase. The effects of concentration 
and pH of the enzymatic solution and the contact time during the immobilization process 
were evaluated by a full factorial design. The biocatalyst obtained was then characterized in 
terms of activity, stability at different pH and temperature conditions and long-term storage 
and compared to the performance of free enzyme. Finally, immobilized laccase was tested 
for the degradation of PPs containing different antibiotics (amoxicillin, ciprofloxacin, 
sulfamethoxazole) and an anti-epileptic (carbamazepine) and the reusability of the 
biocatalyst was also evaluated during several degradation cycles. 
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4.2. Materials and methods 
4.2.1 Chemicals and enzymes 
The pharmaceuticals (amoxicillin (AMX), ciprofloxacin (CIP), carbamazepine (CBZ) and 
sulfamethoxazole (SMX)), the mediators (p-coumaric acid (PCA), syringaldehyde (SYR), 2,2’-
azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS)), the cross-linker agent 
glutaraldehyde (GLU) (25% aqueous solution) and all other chemicals were purchased from 
Sigma-Aldrich. Stock solutions (100 mg L-1) of AMX and SMX were prepared in citrate-
phosphate buffer 0.1 M, pH 7. Given the low water solubility of CIP, the antibiotic was pre-
dissolved in hydrochloric acid (0.1 N) and then in buffer citrate-phosphate pH 7. The 
compounds CBZ, SYR and PCA were prepared in pure ethanol at a concentration of 15625 
mgL-1 for the pharmaceutical and 114.9 mM for the mediators. Fresh ABTS solution (5 mM) 
was prepared just before use in buffer citrate-phosphate pH 7. 
3-Aminopropyl-functionalized silica gel (particle size 40 - 63 µm) from Sigma-Aldrich was 
used as support for laccase immobilization. Three different laccase preparations were 
tested. Laccase powder from Trametes versicolor (ref 38429, activity ≥0.5 U mg-1 and ref 
51639, activity ≥10 U mg-1) (TVL) was purchased from Sigma-Aldrich. TVL ref 51639 was used 
for the determination of immobilization conditions and oxidation reactions with mediators; 
the rest of the experiments where this enzyme was used were done with TVL ref 38429. 
Commercial laccase produced by submerged fermentation from Myceliophthora 
thermophila (59.5 g L-1 of pure laccase) (MTL) was provided by Novozymes (Denmark). 
Laccases from Pycnoporus sanguineus CS43 (PSL) were obtained from a tomato medium as 
described by Ramirez-Cavazos et al. with some modifications. In short, mycelia were 
removed from the culture supernatant by filtration using two tangential flow filters in series, 
with respective pore sizes of 0.5 and 0.2 µm. Afterwards, the 0.2 µm filtrate (laccase 
cocktail) was concentrated on a 10 kDa ultrafiltration membrane (Ramírez-Cavazos et al., 
2014). 
 
4.2.2 Laccase activity essay and protein estimation 
The laccase activity was determined by measuring the oxidation of 1 mM ABTS at 420 
nm (Ɛ420 = 36000 M-1 cm-1) in 0.1 M citrate-phosphate buffer (pH 4) at 25 °C. One enzyme 
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activity unit (U) was defined as the amount of enzyme that oxidized 1 μmol of ABTS per min. 
Immobilized laccase activity was assayed by incubating approximately 8 mg of biocatalyst 
(dry weight) in 50 ml solution of ABTS (1 mM) prepared in citrate-phosphate buffer (0.1 M, 
pH 4) at 25 °C with continuous stirring. The absorbance at 420 nm was monitored every 
minute during a period of 10 minutes. Immobilized laccase activity was expressed in U g-1 
solid. 
Protein concentrations were estimated by the method of Lowry using bovine serum 
albumin as a standard (Lowry et al., 1951). The quantity of protein immobilized on the 
support was calculated by the difference between the amount of protein initially added and 
the recovered in the supernatant and washing solutions. All spectrophotometric 
measurements were carried out on a Shimadzu UV-2401PC spectrophotometer. 
 
4.2.3 Laccase immobilization 
Laccases were covalently immobilized on the surface of silica gel particles. Firstly, the 
silica gel particles were activated with GLU in vapour phase. 100 mg of 3-Aminopropyl-
functionalized silica gel were uniformly dispersed on the bottom of an aluminium plate (35 
mL) and placed inside a glass vessel (100 mL) containing approximately 15 mL of 25% GLU 
solution into a closed vessel (5 L) which was kept at 30°C for different periods of time (18, 30 
and 42 h). Then, the GLU-activated powder was placed in 5 mL of enzymatic solution 
containing 107, 203 or 300 U of one of studied laccases (TVL, MTL and PSL) in 0.1 M buffer 
citrate-phosphate pH 4.3, 5.66 or 7. The solution was maintained for 1, 1.5 or 2 h at 25 °C 
under stirring so that the free GLU –CHO groups in the silica could react with amino groups 
of enzymes. Finally, the enzyme-activated solid was washed with buffer citrate-phosphate 
(0.1 M, pH 4) and stored at 4 °C. The supernatant from enzyme grafting process and the 
solutions produced from the four washing steps were stored for protein determination. 
Bound protein expressed as percentage was calculated as the ratio between the 
amount of protein immobilized and the protein content in the initial enzymatic solution. 
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4.2.4 Experimental design and statistical analysis 
In this study, 23 full-factorial experimental design was used to evaluate the influence 
of three parameters (concentration of enzyme solution (X1), immobilization time (X2) and pH 
of enzyme solution (X3)) in the activity of immobilized laccase. For each factor three levels 
were selected: low level (-1), high level (+1) and basic level (zero) (Table 4.1). A total of 10 
experimental runs, including two replicates at the central point were carried out in duplicate 
using MTL as a model enzyme. The obtained responses are shown in Table 4.2. From 
experimental data, analysis of variance (ANOVA) was done and regression coefficients were 
obtained using Statistica™ software. Curvature check for the response was assessed and if 
significant considered. Moreover, the proportion of variance explained by the model 
obtained was given by the multiple coefficient of determination R2.  
The regression equation based on the first-order model with three parameters (X1, X2 
and X3) and their interactions is presented as follows: 
 
Yi = b0 + b1X1 + b2X2+ b3X3 + b12X1X2 + b13X1X3 + b23X2X3 + b123X1X2X3 (1) 
 
Where Yi represents the predicted response (activity of immobilized laccase); X1, X2 and X3 
are the coded levels of the factors enzyme concentration, immobilization time and pH of 
immobilization. The regression coefficients are: b0 the constant regression coefficient; b1, b2, 
b3 and b12, b13, b23 and b123 the regression coefficients for the main and interaction effects 
respectively. 
 
Table 4.1. Factor levels used according to the 23 factorial design. 
Variable 
Level 
-1 0 1 
X1: Concentration of enzyme solution (U) 107 203 300 
X2: Immobilization time (h) 1 1.5 2 
X3: pH of enzyme solution 4.33 5.66 7 
 
 
 
 
Chapter 4 
 
126 
 
4.2.5 Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) 
The presence of functional groups on the enzyme and support before and after 
immobilization was evaluated by FTIR spectroscopy. Analysis was done using a Nicolet 
“Nexus” spectrometer (ThermoFisher) equipped with a diamond ATR “Golden Gate” plate. 
The scan range was 400-4000 cm-1 using 128 scans per spectrum with a resolution of 4 cm-1. 
 
4.2.6 Characterization of free and immobilized laccase 
Optimum pH and pH stability 
The pH of maximum laccase activity (free and immobilized) was investigated using 1 
mM ABTS in 0.1 M citrate-phosphate buffer (pH 3-7). The relative activity was calculated as 
the ratio between the activity at each pH and the maximum attained. 
The effect of pH on the enzyme stability was studied by incubating laccase in 0.1 M 
citrate-phosphate buffer (pH 4 and 7) at 25 °C during 24 h. Samples were taken and 
transferred to standard conditions for activity measurement. The residual activity was 
calculated in reference to the initial activity value obtained at each pH. 
 
Optimum temperature and thermostability 
The effect of temperature (15-65°C) on laccase activity was determined by measuring 
the activity at the corresponding temperature under the standard conditions described for 
both free and immobilized enzymes. The relative activity was calculated as the ratio 
between the activity at each temperature and the maximum attained.  
Studies of thermal stability of immobilized laccase were carried out by measuring the 
residual activity of the laccase exposed to different temperatures (25, 45 and 55°C) in 0.1 M 
citrate-phosphate buffer (pH 7) for different incubation periods and compared with the 
results obtained with free laccase. Samples were transferred to standard reaction conditions 
to determine the laccase activity with ABTS as previously described. 
 
Storage stability 
Storage stability of free and immobilized laccase was investigated at 4°C. For this, 
both laccase formulations were kept in plastic tubes containing buffer (0.1 M) citrate-
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phosphate pH 7. The residual activities were obtained after 1 and 2 months by measuring 
the remaining activity of each enzyme at standard conditions. 
 
4.2.7 Oxidation of pharmaceuticals by immobilized laccase 
Degradation experiments were run in 25 mL glass cells at 25°C under continuous 
stirring to ensure O2 saturation of the reaction medium and dark conditions to avoid light 
oxidation. Reaction media (5 mL) contained a mixture of all pollutants in buffer 0.1 M 
citrate-phosphate pH 7 and one redox mediator (ABTS, PCA and SYR) at a concentration of 
520 µM. Micropollutants concentration was fixed at 20 mg L-1 except for CBZ where it was 
only 10 mg L-1. Reactions started when 2.5 U (164 ± 18 mg) of immobilized TVL were added 
to the medium. The degradation process was monitored during 4 h by withdrawing samples 
at regular times. After sampling, aliquots were centrifuged at high speed for five minutes to 
separate the reaction medium from the biocatalyst; then, the medium was filtered with 
CHROMAFIL Xtra H-PTFE-20/30 filters to immediately be analysed by HPLC-MS. 
In order to evaluate the reusability of the biocatalyst, experiments were carried out 
as described above using SYR as redox mediator and 2.5 U of immobilized TVL. The reaction 
was followed for 2 h (one cycle). At the end of each cycle the reaction solution was 
separated from immobilized enzyme by centrifugation, filtered and immediately analysed by 
HPLC-MS. Then, immobilized enzyme was washed three times with buffer citrate-phosphate 
(0.1 M, pH 7) and afterwards used for a new cycle of degradation in the same conditions as 
described above. The biocatalyst was reused for a total of 9 cycles. Enzymatic degradation 
was calculated considering the initial and final concentration of micropollutants in the 
reaction solution for each cycle. 
All experiments were carried out by duplicate and control without immobilized 
enzyme neither mediator, control with only 3-Aminopropyl-functionalized silica particles and 
control with inactive immobilized enzyme and mediator were run in parallel to assess the 
role of immobilized enzyme on the removal of the pharmaceuticals except for biocatalyst 
reusability where only control with inactive immobilized enzyme and mediator was run. 
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4.2.8 Microtox test 
Acute toxicity of the mixture of PPs before and after enzymatic treatment was 
evaluated by the Microtox® bacteria toxicity test based on the general principles described 
by ISO (2007) (Karczmarczyk et al., 2014). The toxicity of samples was determined by 
measuring the effect on the luminescence of marine bacteria. Bacterial luminescence was 
measured using a Microtox® Model 500 Analyzer (Modern Water Inc.; United Kingdom). The 
bacteria used in this method was the strain Vibrio fischeri NRRL B-11177. This bacterium 
emited luminescence during growth relating to extracellular respiration which was linked 
itself to cell activity. As the activity of the cell could be reduced by the presence of toxic 
elements, bioluminescence is therefore a very good indicator of state of the bacterium and 
thus of the global toxicity of the sample. This device allowed for the acute toxicity test with 
the help of the software MicrotoxOmni®. 
The test performed in this investigation is called 81.9% basic test were a serie of 
dilutions starting from 81.9% of the initial sample concentration are carried out by adding 
22% NaCl solution to allow Vibrio fischeri normal activity and therefore luminescence 
emission. Before measuring the bacteria luminescence, pH of the samples were adjusted 
between 6.5 and 7.5 with sodium hydroxide or sulfuric acid, followed by a 0.2 µm-filtration 
with syringe filters in order to eliminate any precipitate or solid matter in the solution. The 
results were expressed as EC50,15 which corresponds to the concentration of sample (% v/v) 
that causes a 50% reduction in light emission of the luminescent bacteria after 15 min of 
contact. The EC50 values reported in this study are expressed as percentage (% v/v) of the 
initial sample and were estimated according to the Basic Test protocol of the software. 
 
4.2.9 HPLC-MS analysis 
Determination of pharmaceuticals concentration was carried out on a HPLC Alliance – 
Waters e2695 separations module coupled to a MS Micromass Quatro micro API (tri-
quadripole) detector and a Raptor-C18 column (150 x 2.1 mm) with particle size of 5 µm. The 
conditions for analysis were: 5 µL of sample injection volume, sample elution at 0.25 mL min-
1 with a gradient of (A) 95% water - 5% methanol and (B) 100% methanol. The gradient 
program was set as follows: 0-3 min, 100% (A); 3-8 min, 100% (B) and 8-15 min, 100% (A). 
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4.3. Results and discussion 
4.3.1 Immobilization of laccase on silica gel particles and determination of immobilization 
conditions 
Commercial amino-functionalized silica gel micro particles were used for the 
evaluation of covalent immobilization of laccase. This support was selected once the 
immobilization of enzyme on its surface is rapid and easy due to its porous structure (60 Å 
pore size), large specific surface area (550 m2 g-1) and content of amino groups (~1.05 mmol 
of NH2 g-1). 
For this type of immobilization, glutaraldehyde - a bifunctional agent - is added to 
form covalent bonds between primary amines on the enzyme and an amino functionalized 
support (Cantone et al., 2013). Generally, this step is carried out in liquid phase when the 
solid carrier is submerged in a liquid solution of GLU for a determined period of time. 
Nonetheless, while working with small size supports (micro to nanoparticles) a good 
dispersion in the GLU solution has to be guaranteed in order to avoid potential 
agglomeration of the particles and an uneven deposition of GLU on the support that could 
lead to low immobilization yields. In the present study a novel method for the covalent 
immobilization of laccases on commercial amino functionalized silica gel micro particles is 
proposed.  
The new immobilization protocol consists in crosslinking laccase on the support 
previously activated by using GLU in vapour phase (Fig. 4.1). The relatively high volatility of 
GLU at room temperature allows its evaporation, resulting in the deposition of the activating 
agent on the support in a dry environment. The GLU vapour phase activation step was 
performed by keeping in the same closed vessel silica particles and 25% GLU solution for 
different periods of time. Temperature was set at 30°C to ensure GLU evaporation. After the 
designated time, silica gel particles which were originally white became orange making 
evident the reaction of GLU on the solid (Fig. 4.2). The coloration on silica particles was 
uniform and no agglomeration was observed. 
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Fig. 4.1. Covalent immobilization of laccase con silica gel via activation with glutaraldehyde 
in vapour phase. 
 
 
Based on preliminary experiments, three different contact times (18, 30 and 42 h) 
were evaluated. Results showed that short activation periods (18 h) yielded to higher 
specific activity of immobilized enzyme (data not shown). Therefore, GLU activation during 
18 h was chosen to carry out all further experiments. GLU vapour cross-linking technique is 
often used for the fabrication of biosensors and for the modification of nanofibrous 
materials (i.e. water insolubility property) (Anh et al., 2002; Destaye et al., 2013). From our 
knowledge this is the first investigation where vapour phase deposition of GLU is used for 
the immobilization of enzymes onto silica gel particles for bioremediation purposes. 
 
 
Fig. 4.2. Silica gel microparticles (a) before and (b) after activation with GLU in vapour phase. 
 
 
In order to determine the immobilization conditions for the novel method, a design of 
experiments (DOE) approach was applied to evaluate the parameters influencing and 
improving laccase immobilization. A 23 full factorial design was performed where the range 
of variation of each level was chosen based on theoretical considerations as well as on 
preliminary experiments. The factors evaluated by the design were concentration of enzyme 
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solution, time of immobilization and pH of enzyme solution for which the activity expressed 
by immobilized laccase (U g-1 solid) was considered as the response variable. It is worth 
noting that GLU time of contact was not considered in the present design since its influence 
on the response was found to not be significant (data not shown). Thus, a total of 10 
experiments fully replicated were performed and experimental responses are presented in 
Table 4.2. 
 
Table 4.2. Values for the response (activity of biocatalyst) according to the 23 factorial design 
Assay 
Factors 
Activity of immobilized laccase 
(U g-1 solid) 
X1 X2 X3 Observed value Predicted value  
1 -1 -1 -1 2.77 2.52 
2 -1 -1  1 3.90 3.83 
3 -1  1 -1 2.92 2.77 
4 -1  1  1 7.26 6.64 
5  1 -1 -1 1.73 1.90 
6  1 -1  1 2.80 3.79 
7  1  1 -1 3.25 3.41 
8  1  1  1 2.83 2.73 
9  0  0  0 2.50 2.37 
10  0  0  0 2.23 2.37 
11 -1 -1 -1 2.22 2.52 
12 -1 -1  1 3.81 3.83 
13 -1  1 -1 2.66 2.77 
14 -1  1  1 5.97 6.64 
15  1 -1 -1 2.02 1.90 
16  1 -1  1 4.83 3.79 
17  1  1 -1 3.63 3.41 
18  1  1  1 2.57 2.73 
19  0  0  0 2.50 2.37 
20  0  0  0 2.23 2.37 
 
 
Using the experimental data and by applying multiple regression analysis a first order 
model predicting the response was obtained: 
 
Yi = 3.45 – 0.49X1 + 0.44X2 + 0.80X3 - 0.33X1X2 – 0.50X1X3 – 0.64X1X2X3 (2) 
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The statistical significance of the model was evaluated by the analysis of variance 
(ANOVA) as shown in Table 4.3.  
The model has a good fit as expressed by the correlation coefficient (R2= 0.908) 
meaning that the regression model explains 90% of the total variation of the response, 
whilst the other 10% is explained by the residues. The model presented significant curvature 
(p = 0.003) suggesting that the data would be better fitted by other type of design such as 
Response Surface Methodology (RSM). Nonetheless, the main objective of this work was to 
study the influence of the chosen parameters on the response and for this the first order 
model regression was enough, so the model was accepted. Moreover, the residuals plots 
and normal data distribution obtained from the raw residual analysis also validated the 
model. 
 
Table 4.3. Analysis of variance (ANOVA) for the first order model for activity of immobilized 
laccase. 
Factor SS df MS F p 
Curvature 3.76 1 3.76 13.59 0.0031 
X1 3.86 1 3.86 13.97 0.0028 
X2 3.08 1 3.08 11.12 0.0059 
X3 10.17 1 10.17 36.79 0.0001 
X1:X2 1.69 1 1.69 6.13 0.0292 
X1:X3 3.97 1 3.97 14.36 0.0026 
X1:X2:X3 6.61 1 6.61 23.89 0.0004 
Error  3.32 12 0.28   
Total SS 36.46 19    
SS=sum of squares; df=degrees of freedom; MS=mean square; F=F distribution value; X1=concentration enzyme 
solution; X2=immobilization time; X3=pH enzyme solution. 
R2=0.90899; Adj-R2=0.8559 
 
 
The significance of the factors was verified by p-value statistical parameter. Factors 
showing a p-value below 0.05, with a confidence level higher than 95% were considered as 
statistically significant for the immobilization process. In this sense, it is important to 
mention that the final model represented by Eq. 2 was run excluding insignificant effects 
(factors and interactions) as observed in Table 4.3. The influence of each factor and the way 
they affected the response is expressed in the model’s equation and is given by the 
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coefficient of each factor and interaction. Thus, from Eq. 2 the factors were ranked regarding 
to their significance: 
 
X3 (+) > X1X2X3 (-) > X1X3 (-) > X1 (-) >X2 (+) >X1X2 (-) 
 
where the sign in parentheses describes if the effect in the response is either positive or 
negative. 
The most significant factor affecting the response was pH of enzyme solution. The 
model shows that response was positively affected when pH passed from the low (pH 4.33) 
to the high level (pH 7). Given the low stability of GLU groups at acidic or alkaline pH values, 
immobilization using GLU activated supports is usually favoured at neutral conditions 
(Barbosa et al., 2013). At these pH values the most reactive amino group in the protein tends 
to be terminal amino group which are more likely to react with the polymer (cyclic 
hemiacetal oligomer) form of GLU to form stable structures (Barbosa et al., 2013; Spinelli et 
al., 2013). Moreover, GLU crosslinking kinetics at neutral or basic conditions are faster in 
comparison to acidic conditions resulting favourable for the formation of covalent bonds. 
(Spinelli et al., 2013). 
The pH of immobilization also affects laccase stability. It is known that MTL can retain 
100% of its initial activity at pH 7 and room temperature for at least 24 h (Lloret et al., 2010). 
It is possible that the high stability of laccase at these conditions (room temperature and 
neutral pH) favoured immobilization in comparison to pH 4. Jiang et al. (2005) also reported 
pH 7 as the optimal value for the immobilization of P. sanguineus laccase on magnetic 
chitosan microspheres. Authors suggested the low stability and denaturation of the enzyme 
as well as the degradation of the support as the cause for the low laccase activity and 
protein loading at more acidic conditions. 
The second and third more significant variables in the model were the interactions 
among the three studied factors and the interaction of laccase concentration and pH of 
immobilization, both interactions negatively affecting the response. For example, it was 
observed that when enzyme concentration and pH were in the low level (107 U and pH 4.33) 
the response decreased. Same would be expected if both parameters are present at their 
high level (Table 4.2). Such effect is probably caused by the high and positive coefficient 
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value for pH. Thus, in order to achieve a higher response, enzyme concentration should be at 
the -1 level (107 U) and pH at the +1 level (pH 7). 
The following parameter affecting the response was the concentration of enzymatic 
solution which influenced the response in a negative way. Low amounts of enzyme led to 
higher activity of the biocatalyst with values up to 5.9 and 7.2 U g-1. This behaviour was also 
observed by Fortes et al. (2017) for the immobilization of laccase on magnetic nanoparticles 
and it was attributed to the saturation of the support by the enzyme. An excess of enzyme 
on the support may lead to a lack of intermolecular space resulting in the occurrence of 
mass transfer limitations that affects the dispersion of substrate and products (Fortes et al., 
2017).  
On the other hand, the immobilization time had a positive influence on laccase 
immobilization; the active beads obtained after 2 hours of grafting showed almost twice as 
much activity (experiments 2 and 4). Immobilization time is also crucial variable for the 
whole process. Whereas too short contact time can result in a limited amount of laccase 
molecules reacting with the solid, too long immobilization periods lead to oversaturation of 
the support causing the mass transfer limitations before mentioned that reflects in lower 
activity (Zheng et al., 2016). In this work longer immobilization time allowed to most of the 
aldehyde groups to be blocked by amino-groups in laccase resulting in a biocatalyst with 
considerable higher activity. 
Finally, the last significant parameter was the interaction between laccase 
concentration and time of immobilization with a negative effect. According to the model, 
low activity would be expected when both time of immobilization and laccase concentration 
are either at their low or high levels. From the obtained model we can conclude that the 
best conditions to maximize the response are when laccase concentration is at the low level 
and when time and pH of immobilization are fixed at their highest level. Thereby, GLU 
activation time of 18 h, 107 U of enzyme, 2 h of grafting and pH 7 were selected as the 
immobilization parameters for all further experiments. 
The successful development of an immobilization method depends mainly on the 
type of support and enzyme chosen since they directly influence performance parameters 
such as immobilization yield. In this sense, TVL and PSL were tested with the aim of 
evaluating the performance of this novel immobilization method with different laccases. 
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Immobilization protocol was carried out according to the optimal conditions previously 
established. Nevertheless, immobilization trials were also carried out at pH 5 since this pH 
was previously reported as the optimum pH for the immobilization of TVL and PSL on 
ceramic membranes (Barrios-Estrada et al., 2018). 
The highest activity was observed when immobilization was carried out at pH 7 for 
both PSL and TVL (Table 4.4). Nonetheless it is worth noting that no significant difference in 
the measured activity was observed between pH 5 and 7. Among the three enzymes TVL 
yielded the highest specific activity with 13 and 13.6 U g-1 biocatalyst at pH 5 and pH 7 
respectively and retained the highest amount of protein (35%). Similar specific activity 
values were obtained for the covalent immobilization of C. unicolor C-139 on silica beds at 
pH 5 (Songulashvili et al., 2012) and M. thermophila on Eupergit C carrier at pH 7 (Lloret et 
al., 2012). 
 
Table 4.4. Immobilization yield and activity in the immobilization of laccases on 3-
Aminopropyl-functionalized silica micro particles at pH 7. 
Enzyme 
Activity  
(U g-1 biocatalyst) 
Immobilization capacity  
(mg g-1 biocatalyst) 
Bound protein  
(%) 
MTL 4.5 ± 2.1 37.9 ± 15.4 21.6 ± 10.3 
PSL 0.76 N.D N.D 
TVL 13.6 ± 2.3 13.5 ± 6.2 35.4 ± 4.7 
N.D: Not determined due to the low activity measured 
 
 
In the case of MTL, a large quantity of protein bounded to the support as suggested 
by the value of immobilization capacity (38 mg g-1) (Table 4.4), however, the resulting active 
beads showed a quite low activity. This is probably due to the age of the commercial 
preparation of MTL which was provided by Novozymes 5 years ago. Since the residual 
activity was less than 2/3 of the initial activity, a high volume of commercial preparation was 
required to prepare the enzyme solution. The resulting solution therefore contained large 
amounts of inactive proteins that competed with the active enzymes to bind to the carrier, 
leading to a biocatalyst with low activity. 
Among the different types of active solids, active beads prepared with PSL reported 
the lowest activity with only 0.41 U g-1 and 0.76 U g-1 at pH 5 and 7 respectively. These low 
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activities may be resulted from the presence of impurities in the enzymatic extract. Indeed, 
Ji et al. observed a poor performance when they immobilized a crude laccase extract from P. 
ostreatus on titania particles. These authors suggested that the functionalized carrier could 
have been buried by the non-enzyme components present in the extract. Thus, the surface 
area available on the support and the cross linking interaction between the enzyme and 
support were reduced which led to lower enzyme loading and activity (Ji et al., 2017). 
According to their investigation, dilution of the crude extract before immobilization 
significantly improved laccase loading and apparent activity of the biocatalyst by reducing 
the competitive effect between the enzyme and the other components to attach on the 
support. In this study, PSL and MTL extracts were diluted 2 and 9 times respectively prior to 
immobilization; it was probably not enough to make the surface of the solid more accessible 
to enzymes which is more evident in the case of PSL. 
Overall beads prepared with TVL showed the best results in terms of immobilization 
yield and activity. Therefore, TVL was chosen to carry out the next stages: characterization of 
immobilized enzyme and degradation of pharmaceutical micropollutants. 
 
4.3.2 Characterization of free and immobilized TVL 
Characterization of the resulting biocatalyst is important due to the shift in optimum 
operating conditions that can occur after laccase immobilization. This change is basically due 
to the interactions between the support and enzyme that usually change the conformation 
of laccase. Successful immobilization can lead to an enzyme showing increased stability 
towards harsh environmental conditions in comparison to the soluble form (Mohamad et al., 
2015; Rodrigues et al., 2013). In this section the activity and stability of free and immobilized 
laccase were compared at different values of pH, temperature and for long term storage. 
Moreover, Fourier Transform Infrared spectroscopy (ATR-FTIR) characterization was done in 
order to confirm the presence of laccase on the surface of the carrier due to the covalent 
binding. 
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Optimum pH and temperature 
Optimal pH of activity for free and immobilized TVL was investigated in the pH range 
from 3 to 7 in 0.1 M citrate-phosphate buffer at room temperature. From Fig. 4.3a can be 
observed that pH did not significantly influence the activity of immobilized enzyme in 
comparison to free enzyme. Actually both immobilized and free laccase showed a similar 
activity versus pH profile, except at pH 6 where relative activity of immobilized laccase was 
on average 15% lower than free enzyme. Moreover, both free and immobilized systems 
exhibited the maximum activity at pH 3. According to Jiang et al. (2005) immobilization can 
create a microenvironment surrounding the enzyme where an unequal partitioning of H+ 
and OH- concentrations caused by electrostatic interactions with the support can cause a 
change in optimal pH. The fact that a shift in optimal pH did not occur in this study suggests 
that electrostatic interactions were not involved during immobilization and the process was 
rather carried out through covalent interaction as observed in other investigations (Jiang et 
al., 2005; Misra et al., 2014). 
 
Fig. 4.3. Effect of (a) pH and (b) temperature on free and immobilized TVL. pH (3-7) and 
temperature (15-65°C) were tested with 1 mM ABTS in 0.1 M citrate-phosphate buffer. Free 
and immobilized enzymes are represented by open and closed symbols respectively. 
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The effect of temperature on TVL activity of free and immobilized enzyme was 
investigated in the range 15-65°C under standard conditions (0.1 M citrate-phosphate buffer 
pH 4). The optimum temperature for free and immobilized laccase was 55°C (Fig. 4.3b). 
Immobilized enzyme showed a broader profile displaying relative activities up to 16% higher 
in comparison to free enzyme for all temperatures tested and retained more than 80% of 
the activity in the range from 35 to 65°C; except at 15°C where free enzyme showed higher 
relative activity in comparison to the immobilized form (58 and 48% respectively). 
 
pH stability and thermostability 
Thermostability was evaluated when both free and immobilized laccases were 
incubated in buffer citrate-phosphate (pH 7) at selected temperatures in the range from 25 
to 55 °C. It was observed that the activity of immobilized laccase at 45°C and 55°C dropped 
more rapidly than that of free enzyme within the first 4 h (Fig. 4.4b). However, for longer 
incubation times at 55°C, the residual activity of immobilized enzymes remained constant 
(around 25%) while those of free enzymes continued decreasing to reach 6% after 24 hours 
of incubation. Incubation at 45°C led to similar activity loss for both free and immobilized 
laccases with residual activity values of 45% and 52% respectively at the end of 24 h. At 25°C 
low thermal inactivation was observed with less than 10% loss on activity for both free and 
immobilized laccases. 
Overall, immobilization increased TVL resistance to temperature especially in the case 
of long-term exposure. Similar observation was reported by Fortes et al. (2017) for the 
thermal stability of Asperguillus oryzae laccase immobilized on magnetic nanoparticles at 
60°C. These authors observed a higher kinetic constant of enzyme deactivation (k) for free 
enzyme than for immobilized form. Nonetheless, at the long term, immobilization enhanced 
laccase thermal stability allowing to keep the same residual activity for almost 5 h, whilst 
those of free enzyme continued decreasing with incubation time. Lettera et al. (2015) also 
observed increased stability when immobilized recombinant laccase POXA 1b from P. 
ostreatus on Epoxy activated poly(methacrylate) beads in the range from 25 to 65°C with a 
two-fold increase in enzyme half-life (t1/2) values. It seems clear that supports offer a 
stabilizing environment to enzyme making it more resistant to extreme conditions. 
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Fig. 4.4 pH (a) and thermal stability (b) of free and immobilized TVL on silica particles. pH 
values: 4 ( ) and 7 ( ). Temperature values: 25°C (×), 45°C ( ) and 55°C ( ). The open and 
closed symbols represent free enzyme and immobilized enzyme respectively. 
 
 
Storage stability 
In general, stability of enzymes in solution is affected during storage, resulting in a 
gradual reduction of their activity. To assess the storage stability of both free and 
immobilized enzymes, a solution of free enzymes (152 U mL-1) and active beads (100 mg mL-
1) were kept at 4°C in buffer citrate-phosphate (0.1 M, pH 7) and residual activity was 
measured after one and two months. Results showed that immobilized laccase retained 72% 
and 47% of its initial activity after one and two months of storage respectively. In contrast, 
residual activity of free laccase almost reached 44% at the end of the first month. After two 
months of storage, it was not possible to measure the residual activity as fungi flocs were 
observed in the media. The lost in activity observed in the immobilized enzyme could be 
attributed to the natural loss of laccase activity during time. Nonetheless, these results show 
that storage stability was improved by the immobilization process in comparison to free 
enzyme. It is well known that the multipoint fixation of enzyme to supports via covalent 
bond increases stability by reducing the occurrence of changes in the active conformation of 
the immobilized enzyme (Sari et al., 2006). 
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Fourier Transform Infrared spectroscopy (ATR-FTIR) characterization 
The immobilization of TVL on silica gel micro particles was assessed by ATR-FTIR. Fig. 
4.5 presents the FTIR spectra of free TVL, untreated 3-Aminopropyl-functionalized silica gel 
and the silica gel particles after laccase immobilization. Characteristic bands of free laccase 
were observed at 3300 cm-1 (OH and NH vibrations), 2900 cm-1 (CH stretch), 1630 cm-1 
(attributed to a secondary amide structure-CONH), 1350 cm-1 (CN stretching of amines) and 
1100 cm-1 (COC groups) in agreement with literature (Tavares et al., 2015). Pristine silica gel 
particles presented a strong band centered at 1050 cm-1 attributed to the vibration of Si-O-Si 
and two weak peaks at 1616 cm-1 and 1523 cm-1 corresponding to Si-OH and primary amine 
NH groups. After laccase immobilization, FTIR spectrum showed the characteristic bands of 
silica gel particles. Moreover, the presence of the specific signals from the enzyme at 1400 
cm-1 and 1600 cm-1 on the active silica spectrum confirms the immobilization of the enzyme 
on the support. Nonetheless, the decrease in vibration bands attributed to the enzyme 
suggests that laccase was immobilized in low quantity as confirmed by the immobilization 
capacity value (13.5 mg protein g-1 silica) calculated for TVL (Table 4.4). 
 
Fig. 4.5. FITR-ATR spectra of laccase (blue line), untreated 3-aminopropyl functionalized silica 
gel (red line) and TVL immobilized on silica gel particles (green line). 
 
4.3.3 Oxidation of pharmaceuticals by immobilized laccase 
The capacity of immobilized TVL for the oxidation of a mixture of four pharmaceutical 
micropollutants was evaluated in batch reactions. As a first attempt micropollutants were 
treated directly with the immobilized biocatalyst and the oxidation efficiency was assessed. 
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After 48 h no significant oxidation was observed for any pharmaceutical (data not shown). 
This observation confirmed the recalcitrance of these micropollutants to laccase degradation 
which was already reported by Parra Guardado et al. (2019). In this previous work, the 
potential of free laccases (MTL, PSL and TVL) for the biotransformation of the four 
pharmaceuticals into both single-component and mixture solutions was investigated; in all 
cases studied, bio-oxidation was negligible. These authors attributed the poor removal to 
the complex chemical structure of the compounds which make them not easy to be oxidized 
by laccase. 
Taking into account the inability of immobilized enzyme to transform the selected 
pharmaceuticals, redox mediators were added to the reaction and their role in the oxidation 
process was evaluated. Redox mediators are compounds that laccase can easily oxidize 
resulting in the production of radical species with higher oxidative capacity than the laccase 
itself. In this work the compounds SYR, PCA and ABTS were chosen since they have already 
demonstrated to enhance the oxidation of AMX, SMX and CIP in free enzyme systems (Parra 
Guardado et al., 2019). Mediator concentration was fixed at 520 µM and reactions were 
followed for 4 h. Time course degradation of AMX, CIP, SMX and CBZ by immobilized laccase-
mediator systems as well as the adsorption-based removal by the support is shown in Fig. 
4.6. 
Firstly, the adsorption capacity of the support was studied. Tests were carried out 
with both untreated particles and inactivated immobilized particles. No significant 
adsorption of the antibiotics by the pristine support was observed (less than 10%); only 18% 
of CBZ was adsorbed after 4 h (data not shown). On the other hand, tests with inactivated 
biocatalyst reported adsorptions that varied from 10% to 40% for AMX, 30% to 40% for SMX, 
13% to 40% for CIP and 40% to 52% for CBZ (Fig. 4.6). Higher adsorption observed with this 
control in comparison to untreated particles could be attributed to interaction between the 
denatured enzymes, which “coated” the silica carrier, and the micro pollutants; thus, 
increasing its sorption capacity.  
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Fig. 4.6. Residual concentration of (a) AMX, (b) SMX, (c) CIP and (d) CBZ in mixture after 4 h 
treatment with immobilized TVL on silica particles and different redox mediators: ABTS ( ), 
SYR ( ) and PCA ( ). The open symbols represent the removal by adsorption on the support 
with inactivated laccase. Measurements were carried out by duplicate, with standard 
deviations less than 15%. 
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Removal of organic pollutants via adsorption by the support has been extensively 
described. For example, Cabana et al. (2009) reported adsorption values from 40 to 60% for 
nonylphenol, bisphenol A and triclosan by inactivated laccase covalently immobilized on 
Celite R-633 supports. Ciprofloxacin hydrochloride adsorption reached 77% when 
mesoporous carbon nanospheres were used (Shao et al., 2019). Inactive immobilized 
Magnetic Cu2+ -chelated silica particles removed 38% of pentachlorophenol by adsorption 
(Wang et al., 2012).  
As observed in Fig. 4.6 the extent of removal due to adsorption varied depending on 
the pharmaceutical and it could be associated to each compound’s hydrophobicity. The 
highest adsorption observed was for CBZ which has the highest octanol/water partition 
coefficient (Log Kow=2.45) and the lowest water solubility (78 mg L-1) (Celiz et al., 2009; Pyka 
et al., 2006). Regarding to the antibiotics low sorption for AMX and SMX would be expected 
as judged from their corresponding partition coefficients and water solubility values: 0.87 
and 3400 mg L-1 for AMX and 0.89 and 610 mg L-1 for SMX (Suárez et al., 2008; Wang and 
Wang, 2016). In the case of CIP a Log Kow value of 0.28 but an extremely low solubility in 
water explains its high adsorption (Al-Omar, 2005; Takacs-Novak et al., 1992).  
Overall, the proportion of micropollutants removed by adsorption was practically the 
same for the four pharmaceuticals (30-50%). However, in presence of ABTS the adsorption 
of CIP and AMX was remarkably different in comparison to SYR/PCA control reactions (Fig. 
4.6c). If attention is paid to Fig. 4.6, ABTS seemed to reduce the proportion of 
micropollutants adsorbed on the support in comparison to the other mediators. 
Interestingly, this effect was mainly observed on antibiotic compounds. In a previous work, 
Parra Guardado et al. (2019) observed that the addition of ABTS, SYR or PCA in the absence 
of laccase had no effect in the transformation of target pharmaceuticals. Thus, results 
obtained in this investigation could have resulted from the interaction between inactivated 
enzyme and ABTS. Nevertheless, no explanation about the nature of the possible 
interactions occurring in the system can be provided; even when experiments were 
replicated the tendency of ABTS reducing the adsorption of pharmaceutical on the solid was 
corroborated. A deeper insight in the effect of mediator-protein-pollutant interactions 
would be needed in order to understand the adsorption mechanism of pharmaceuticals on 
the support, which is out of the scope of this investigation. 
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Although part of the observed elimination was caused by adsorption on the solid 
carrier, the action of immobilized enzyme-mediator system in the removal of the target 
pharmaceuticals was evident, especially for SMX and AMX. In presence of SYR complete 
transformation of the antibiotic SMX was achieved within 4 h of treatment (Fig. 4.6b). The 
use of ABTS and PCA also allowed removing 53% and 54% of SMX respectively in 30 minutes 
but afterwards the concentration remained practically constant until the end of the 
experiment. Regarding to AMX, the three mediators led to similar results with 
transformation yields in the range of 78-89% as observed in Fig. 4.6a. However, PCA was the 
mediator allowing the highest oxidation with only 11% of AMX remaining after 4 h. As with 
SMX, AMX oxidation occurred mainly during the first 60 minutes of reaction, after which the 
residual concentration remained almost constant regardless to the mediator used. According 
to Fig. 4.6c and 4.6d removal of CIP and CBZ occurred within the first 30 minutes of 
treatment. CBZ removal was entirely by adsorption as confirmed by control reactions with 
inactivated biocatalyst. Regarding to CIP, no effect of SYR and PCA mediators in the 
antibiotic’s removal was observed which was also attributed to adsorption on the support. 
However, in presence of ABTS as shown by the control, CIP transformation was caused by 
enzymatic biodegradation.  
Overall, results indicate that removal of these micropollutants by immobilized 
laccase-mediator system is both compound and mediator dependent. Marked difference in 
the removal of SMX, AMX and in some point of CIP and CBZ was observed. The main reason 
could be the difference in laccase-mediator oxidative capacity and the affinity of the 
pharmaceuticals for adsorption. Based on the global removal efficiency of the system, 
micropollutants clearly differentiate in two groups: the highly degradable pharmaceuticals 
and the recalcitrant pharmaceuticals. The latter group is formed by CBZ and CIP, compounds 
presenting high hydrophobicity and complex chemical structure that are very resistant to 
laccase oxidation even in presence of redox mediators (Hata et al., 2010). Belonging to the 
highly degradable group, AMX and SMX are antibiotics that possess functional groups prone 
to be attacked by laccase (hydroxyl and amine groups respectively). The highest oxidation 
rates of AMX and SMX were achieved when SYR or PCA were present in the reaction 
medium. Interestingly both mediators follow the hydrogen atom transfer mechanism of 
reaction in which after oxidation, phenoxyl radicals are produced to act as electron shuttle 
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between the laccase and substrate (Cañas and Camarero, 2010). Indeed, phenoxyl radicals 
formed were highly reactive and stable to carry out the simultaneous transformation of AMX 
and SMX.  
Nonetheless, it is important to note that the high removal obtained for AMX, for SMX 
specially and in some extent for CIP could not be totally attributed to laccase-catalysed 
oxidation but to a combined contribution of adsorption and degradation. As shown in Fig. 
4.6 adsorption of pharmaceuticals reached equilibrium 30 minutes after the start of the 
reaction, then laccase oxidation effects ongoing to be more evident. In other words, 
adsorption of micropollutant on immobilized enzyme could have help and in some extent 
enhance laccase degradation. Nguyen et al. observed similar behaviour for the removal of 
the recalcitrant CBZ and SMX with immobilized laccase on granular activated carbon (GAC) in 
a packed bed reactor. These authors suggested that enhancement in laccase degradation for 
both compounds could be possibly due to the improved electron transfer between laccase 
and substrate after adsorption on the support surface (Nguyen et al., 2016a). Such effect is 
especially evident for SMX when SYR acted as mediator leading to the complete 
transformation of the antibiotic in less than 4 h. 
Results obtained in this investigation are consistent with previous studies reporting 
the elimination of pharmaceutical micropollutants with immobilized laccase. For example, 
Becker et al. (2016) evaluated the simultaneous degradation of 38 antibiotics at 
environmentally relevant concentrations (10 µg L-1) in an enzymatic membrane reactor 
(EMR). After 24 h, 32 out of the 38 antibiotics were removed in a high extent (>50%) 
including 94% for AMX, 97% for SMX and 93% for CIP when SYR was present at a high 
concentration (1 mM). Cross-linked carbon nanotubes bio-catalytic membranes containing 
enzyme physically adsorbed were used for the treatment of a mixture of bisphenol-A, 
carbamazepine, diclofenac, clofibric acid and ibuprofen in an EMR obtaining removal yields 
from 40 to 90% depending on the compound (Ji et al., 2016a). Yang et al. used immobilized 
laccase in magnetic cross-linked enzyme aggregates combined with ABTS for the removal of 
different types of antibiotics including sulfamethoxazole (100 mg L-1) in batch reactions 
obtaining 30% degradation after 48 h (Yang et al., 2017). Similarly, De Cazes et al. (2014) 
reported that free and immobilized laccase degraded 56% and 30% respectively of 
tetracycline after 24 h.  
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In a previous work, the high affinity of free laccase-SYR system for AMX and SMX was 
also observed, although degradation yields obtained depended on the laccase used (MTL, 
TVL or PSL) (Parra Guardado et al., 2019). Free TVL (1.2 U mL-1) in presence of SYR reached 
50% removal for AMX in 3 h and complete elimination of SMX in 1.5 h. In the present 
investigation, considerably lower amounts of immobilized enzyme (0.5 U mL-1) achieved 
comparable or even higher removal yields for both micropollutants within the same period 
of time. These results suggest that the novel immobilization method proposed in this work 
positively influenced the stability of TVL which coupled with the adsorption capacity of the 
biocatalyst enhanced the removal of pharmaceutical pollutants. Therefore, the high removal 
yields obtained in this model study by the combined action of adsorption-degradation 
altogether with the enhanced stability of the enzyme highlights the potential of using this 
biocatalyst for the treatment of effluents containing similar type of recalcitrant compounds. 
 
4.3.4 Reusability of immobilized laccase 
The biocatalyst was reused in a total of 9 cycles (2 h each cycle) for the removal of 
selected micropollutants using SYR as redox mediator. At the end of each degradation cycle 
the biocatalyst was washed with buffer solution (see materials and methods, section 4.2.7) 
and added to a fresh solution containing the mixture of pharmaceuticals and mediator.  
As shown in Fig. 4.7 the percentage of removal varied depending on the 
micropollutant. The extent of degradation of AMX over the first four cycles was relatively 
constant (~60%). After, removals gradually decreased to reach 43% at the end of the ninth 
cycle (Fig. 4.7a). Moreover, it is important to note that levels of combined removal 
(degradation/adsorption) remained practically constant until the seventh cycle; afterwards 
no difference between degradation and adsorption was observed. In contrast, enzymatic 
oxidation of SMX occurred only during the first two cycles with high oxidation yields: 82% 
and 57% (Fig. 4.7b). Subsequent removal was entirely due to adsorption on the support 
(~40%). As expected CIP and CBZ removal was entirely by adsorption with average 
elimination of 30% and 50% for each compound (data not shown). 
The loss of efficiency observed for the degradation of AMX and SMX by immobilized 
enzyme has been extensively reported in different studies and is usually attributed to the 
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high molar mass products formed during the reaction that could inhibit or bury the active 
center of laccase leading to mass transfer resistance (Ji et al., 2016b; Xu et al., 2013). The 
possible inhibition of immobilized laccase could be explained by the loss in its capability to 
simultaneously transform both antibiotics. Whereas SMX was highly removed only in the 
first two cycles, AMX was continuously transformed during 7 cycles. There is the possibility 
that interactions between the active biocatalyst and the substrates/by-products formed 
during the first cycles caused conformational changes in the enzyme that narrowed its 
capacity to oxidize both compounds. Moreover, the preference for AMX transformation over 
SMX during the following cycles could be linked to its chemical structure and the presence of 
functional groups which make AMX more prone to laccase oxidation in comparison to SMX 
(Yang et al., 2013).  
 
 
Fig. 4.7. Removal of (a) AMX and (b) SMX in a mixture by immobilized laccase and SYR as 
redox mediator in consecutive cycles at 25°C and pH 7. Adsorption of each micropollutant on 
the support with inactivated laccase is represented by white bars. 
Chapter 4 
 
148 
 
4.3.5 Toxicity assessment  
The acute toxicity of the effluent after enzymatic treatment with the different 
mediators was evaluated by the Microtox® assay. This test is used to investigate the general 
toxicity of samples by monitoring the change in light emission of the bioluminescent bacteria 
Vibrio fischeri before and after sample addition. The obtained data was used to calculate the 
EC50, which is the percentage of sample dilution (v/v) that causes a 50% reduction in bacteria 
bioluminescence. Fig. 4.8 shows the results obtained for the untreated solutions at t=0 h 
(mix of pharmaceuticals + mediator) and samples after 4 h treatment with immobilized 
laccase -mediator systems (6 U, 0.52 mM respectively). According to Niemirycz et al. (2007), 
results from the EC50 values (15 minutes) can be classified as follow: Non-toxic samples: 
EC50>100%; low –toxic samples: 10<EC50≤100%; toxic samples 1%≤EC50≤10%; and, highly-
toxic samples EC50<1%.  
Results suggest that ABTS was the mediator showing the lowest toxic effect. Before 
treatment, the control samples containing only the mixture of the pharmaceuticals and ABTS 
showed an EC50 value of 103%, meaning that this solution was not toxic for the 
microorganisms. The analysis of the reaction by-products after 4 h of treatment with 
immobilized laccase and ABTS, showed a slightly increase in the toxicity with an EC50 value of 
95% which can be considered as a low-toxic sample. These results contrast to those reported 
by Kim and Nicell (2006) for the degradation of triclosan using ABTS as redox mediator. This 
authors observed that the addition of ABTS (20 µM) to the reaction increased the toxicity of 
the effluent by 120 times in contrast with the untreated sample. This was attributed to the 
generation of ABTS reactive radicals which may have attacked and damaged the bacteria. In 
this study, even with a considerably higher concentration of ABTS (520 µM) the increase in 
the toxicity was practically negligible. Probably, the radicals formed during the reaction after 
interacting with the mixture of pharmaceuticals were not reactive enough to cause damage 
to the bacteria.  
Regarding to PCA, no change in the toxicity of the samples was observed when 
comparing before (55%) and after laccase treatment (54%). However, it is important to note 
that, according to the untreated samples, the addition of PCA resulted more toxic to the 
bacteria than ABTS. Fillat et al. (2010) reported that the toxicity of laccase-PCA treated flax 
pulp effluent was below the emission limit stablished by the Spanish legislation; however, no 
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further explanation was given. A lack of information in literature about the toxicity 
assessment of PCA restricts giving any explanation about the behaviour of PCA. 
 
 
Fig. 4.8. Comparison of toxicity after the enzymatic treatment of pharmaceuticals in the 
presence of different redox mediators. 
 
 
The toxicity of the test media treated with laccase-SYR led to the most toxic effect on 
V. fischeri after 15 minutes of contact (EC50=11%). Even the untreated solution containing 
SYR reported the lowest EC50 (49%) from the three mediators evaluated. The higher toxicity 
of SYR has been previously reported in different investigations (Becker et al., 2016; Fillat et 
al., 2010; Nguyen et al., 2016b, 2014). For example, Fillat reported that the toxicity of 
laccase-SYR effluent was 10 times higher than that of laccase-HBT effluent from a flax pulp 
treatment process. The increase in toxicity of effluents treated with SYR has been related to 
the generation of intermediate species and/or the degradation products that are more toxic 
than the parent compounds (Fillat et al., 2010). According to Becker et al. (2016) oxidation of 
aromatic compounds such as quinolones and tetracyclines can lead to more toxic by-
products as is the case in this work. Moreover, the higher toxicity observed by SYR could be 
also related to its initial concentration in the reaction. SYR doses in the range of 10-50 µM 
significantly decreased the toxicity of the effluent from an enzymatic membrane reactor 
(EMR) containing several trace organic compounds in comparison to a 100 µM dose (Nguyen 
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et al., 2016b). In another work, Becker et al. (2016) reported that even at t=0 h the 
luminescence of bacteria was inhibited when SYR was added at a high concentration (1000 
µM). These authors attributed the toxicity of SYR in the luminescent bacteria to the 
antimicrobial activity of the mediator. Thus, the low EC50 values observed in the untreated 
samples for SYR and possibly for PCA could be also related to the antimicrobial effect of 
these compounds. Further research on this matter as well as on the optimal dose for SYR 
leading to lower toxicity would be necessary for the successful use of this mediator, however 
this is beyond the scope of this study.  
 
 
4.4. Conclusions 
In this study, Trametes versicolor laccase was covalently immobilized onto 
commercial silica gel particles through a novel immobilization method involving the 
activation of the support with glutaraldehyde in vapour phase. This is the first work 
reporting the use of this activation technique for the immobilization of laccase on solid 
supports for bioremediation applications. An experimental design was proposed in order to 
identify the most important factors involved in the immobilization process. According to the 
model generated the most important factor affecting immobilization was the pH. The 
immobilization conditions found to maximize the activity showed by the biocatalyst were 18 
h of GLU activation time, enzyme concentration of 107 U, 2 h of contact time and pH 7. 
Overall, in comparison to free enzyme, immobilization improved enzyme stability over a 
range of pH and temperature conditions as well as for long storage.  
The potentiality of using the biocatalyst for the removal of pharmaceuticals was 
evaluated in osmosed water containing a mixture of four representative pharmaceutical 
micropollutants. High removal yields (40-100%) were achieved when redox mediators were 
present in the reaction medium. It was observed that redox mediators generating phenoxyl 
radicals were the most effective for the biotransformation of the pharmaceuticals, with SYR 
showing the best performance. However, the use of SYR considerably increased the toxicity 
of the effluent, whilst ABTS led to the lowest toxic treatment. The higher toxicity of SYR 
could be related to the high dose of the mediator used in the treatment that led to the 
generation of intermediate species and formation of more toxic by-products. Compared to 
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free laccase, immobilized enzyme removed the micropollutants more effectively due to the 
combined action of adsorption on the support and laccase catalysed oxidation. In addition, 
reusability of the biocatalyst was proved for the continuous removal of the pharmaceuticals 
during seven cycles. The results presented in this study show that the novel immobilization 
method proposed and the resulting biocatalyst are a promising tool to increase the 
application of enzymes in bioremediation processes.  
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5. Versatile inorganic supports for laccase immobilization and 
enhanced removal of pharmaceutical micropollutants in water 
 
 
Abstract 
In this work, several biocatalysts were developed based on the immobilization of Trametes 
versicolor laccase on different clay, silica and silica/clay nanocomposite supports. The 
highest yields of enzyme immobilization were obtained when laccase was covalently bonded 
to silica and silica/clay nanocomposites with specific activity values of 109 and 185 U g-1 
respectively. These biocatalysts were applied for the biotransformation of a mixture of the 
pharmaceuticals amoxicillin (AMX), ciprofloxacin (CIP), sulfamethoxazole (SMX) and 
carbamazepine (CBZ) in batch treatments and in the presence of syringaldehyde as redox 
mediator. Results showed all these pharmaceuticals were eliminated in a high extent (45-
100%) at a contact time of less than 180 minutes due to the complementary action of 
laccase degradation and adsorption on the two supports. In comparison to laccase 
immobilized onto silica nanoparticles (SiNPs), the immobilized nanocomposite showed 
higher oxidative capacity and selective sorption properties towards the target 
pharmaceutical compounds, thus demonstrating the advantages of using these type of 
supports for bio-catalytic and environmental applications. 
 
Keywords: Laccase, covalent immobilization, pharmaceutical micropollutants, 
biodegradation, water pollution 
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5.1. Introduction 
The use of enzymes for bio-catalytic conversion of pollutants in bioremediation 
processes is an environmental friendly technology that has gained a lot of attention in recent 
years. Enzymes display excellent properties (high activity, selectivity and specificity) which 
allow them to catalyse complex reactions under mild experimental conditions (Misra et al., 
2014). Particularly, laccases are high potential oxidative enzymes showing large substrate 
specificity towards aromatic compounds, amines, methoxy-substituted phenols and some 
inorganic compounds (Gasser et al., 2014). According to several reports, laccases are a 
promising candidate for the remediation and treatment of contaminated water and soil with 
recalcitrant pollutants such as dyes (Pezzella et al., 2014), phenolic compounds (Gianfreda 
and Bollag, 1994), endocrine disrupting contaminants (EDC) (Debaste et al., 2014), 
pharmaceutical products (Kumar and Cabana, 2016) and pesticides (Jin et al., 2016). 
The use of enzymes in their free form presents some major disadvantages that limit 
their application in large scale processes. The relatively low stability of laccases and their 
susceptibility to inactivation due to unfavourable environmental conditions (i.e. inhibitory 
agents, extreme values of pH and temperature) are perhaps the main drawbacks (Gasser et 
al., 2014). Moreover, free enzymes are difficult to separate from the medium which limits 
their reusability and increases operational costs. In order to overcome such limitations, 
immobilization of enzymes on different kinds of support materials has been investigated as 
an effective way to improve laccases properties (Sheldon and van Pelt, 2013). There are 
plenty reports highlighting the benefits of laccases immobilization including longer storage, 
stability, reusability and increased tolerance to extreme conditions (Cabana et al., 2009; Ji et 
al., 2017; Patel et al., 2014; Zheng et al., 2016). Nonetheless, in order to achieve such 
benefits a proper selection of the immobilization method and support material is 
determinant since they greatly influence the final properties of the biocatalyst (Zdarta et al., 
2018a). 
Conceptually, physical and chemical interactions are the two basic methods through 
which enzyme immobilization can be accomplished. Physical methods include the 
entrapment of enzyme within a tridimensional matrix, encapsulation in polymers or 
adsorption of the enzyme to the support by electrostatic interactions, whereas chemical 
techniques by means of covalent bonding assures the irreversible binding of the enzyme to 
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the solid matrix (Sheldon, 2007). Covalent immobilization is an interesting and widely used 
technique to insolubilize enzymes due to its simplicity and specificity. Immobilization by 
covalent binding is based on the reaction of functional groups of the support material with 
functional groups of the enzyme (mainly reactive amino acid residues such as –NH2, -SH and 
–OH) resulting in the formation of strong chemical bonds which significantly increases 
laccase stability and reduces its leakage (Datta et al., 2013). 
Immobilization of enzymes has been carried out on a broad variety of support 
materials from organic and inorganic origin. The most relevant developments in support 
materials for immobilization from a historical perspective were recently reviewed by Zdarta 
et al. (2018a). According to these authors, three factors are determinant for the selection of 
a support for immobilization of enzymes: (i) the presence of numerous functional groups, (ii) 
good sorption properties, and (iii) good thermal, chemical and mechanical resistance as well 
as operational stability. In this sense, inorganic supports such as silica and montmorillonites 
represent an excellent option for laccase immobilization. These supports show large specific 
surface area and many different functional groups (i.e hydroxyl, carboxyl, carbonyl) that 
facilitates enzyme attachment and support functionalization by using anchorage agents like 
glutaraldehyde (GLU) or 3-aminpropyltriethoxyxilane (APTES) which are both convenient for 
covalent immobilization (Zucca and Sanjust, 2014). Moreover, these inorganic materials are 
relatively cheap and abundant in nature which facilitates their use and their application as 
enzymatic supports. 
During the last decades, scientific attention has focused on the development of new 
type of supports for enzyme immobilization such as nanoparticles, hybrid and composite 
materials (Zdarta et al., 2018b). Composite materials represent a very interesting option for 
enzyme immobilization since they combine properties of two different precursors which 
maximize their advantages (Grigoras, 2017). In this way it is possible to obtain “tailor made” 
carriers for a given enzyme and process to be applied, thus facilitating the control of 
immobilization process (Zdarta et al., 2018a). As result, immobilized enzymes on this type of 
supports are considerably stabilized which favours the retention of high catalytic properties, 
enhances enzyme reusability and protects it from conformational changes (Yang et al., 
2012). Composites can be obtained by the conjugation of organic-organic, inorganic-
inorganic and inorganic-organic precursors. Therefore, different type of compounds 
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including silica and clays have been combined for the formation of composites and used for 
catalytic and environmental applications (Addy et al., 2012; Li et al., 2009). However, to the 
best of our knowledge, there is no previous investigation reporting the use of silica/clay 
composite as support for laccase immobilization. 
As the research of innovative materials and immobilization methodologies capable to 
maximize enzyme properties is essential to the development of enzymatic processes at 
industrial scale, the aim of this work was to perform the efficient immobilization of laccase 
on different type of silica, clay and nanocomposite supports. For this purpose, covalent 
immobilization was carried out according to a novel immobilization protocol proposed by 
Parra et al. (in preparation) which involved the use of GLU in vapour phase as the cross-
linking agent. The biocatalysts showing the highest activity were then evaluated in terms of 
the biotransformation potential of a mixture of pharmaceutical compounds in spiked 
osmosed water. 
 
 
5.2. Materials and methods 
5.2.1 Chemicals and enzymes 
The target pharmaceuticals (amoxicillin (AMX), sulfamethoxazole (SMX), ciprofloxacin 
(CIP) and carbamazepine (CBZ)), the bifunctional agent for enzyme immobilization 
(glutaraldehyde (25%) (GLU)), the redox mediator (syringaldehyde (SYR)), the substrate (2,2’-
azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS)) and all other chemical products 
were purchased from Sigma-Aldrich. Stock solutions of AMX and SMX were prepared in 
citrate-phosphate buffer (0.1 M, pH 7); whereas CIP was pre-dissolved in a diluted solution 
of hydrochloric acid (0.1 N) and then the stock solution was finally prepared in the same 
buffer pH 7. SYR and CBZ stock solution were prepared in pure ethanol. The structure and 
physicochemical properties of target pharmaceuticals are shown in Table 5.1. Laccase 
powder from Trametes versicolor (activity ≥1 U mg-1 and ≥10 U mg-1) (TVL) was provided 
from Sigma-Aldrich. 
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Table 5.1. Structure and physicochemical properties of selected pharmaceutical 
micropollutants 
Compound Molecular weight 
(g mol-1) 
Solubility in water 
(mg L-1) 
Log Kow Chemical structure 
AMX 365.4 3400 0.87 
 
 
 
SMX 253.3 610 0.89 
 
 
 
CIP 331.3 ~0 0.28 
 
 
 
CBZ 236.3 78 2.45 
 
 
 
 
 
5.2.2 Support materials for immobilization 
Six different materials were used as support for immobilization: silica nanoparticles 
(SiNPs and Si-30R50), clay particles (Y and SWy-3) and nanocomposites (50/50 and 95/5). 
These materials were developed in the frame of the ANR project POLPHARMA (ANR-15-
CE04-0007) by different French research laboratories (LCMP-UPMC, BRGM, CEREGE); their 
characteristics are summarized in Table 5.2. 
 
Table 5.2. Characteristics of the different supports 
Type of material Supplier BET specific 
surface area 
(m2g-1) 
Size Material kind 
Silica nanoparticles 
   SiNPs LCMCP-UPMC 229 37 nm Silica nanoparticles 
   Si-30R501 BRGM 45 84 nm Klebosol 30R50 
Clay particles 
   Y 
BRGM 
99 1.3 µm 
Montmorillonite 
Nador, Morocco (98%) 
   SWy-3 44 1.5 µm 
Montmorillonite 
Wyoming (97%) 
Nanocomposites 
50/50 
CEREGE/BRGM 
73 51 µm 50% Y / 50% Si-30R50 
95/5 67 92 µm 95% Y / 5% Si-30R50 
1: (Bizi, 2012) 
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5.2.3 Determination of laccase activity and protein assay 
Laccase activity was determined by measuring the oxidation of 1 mM ABTS to its 
cation radical (ABTS+) at a wavelength of 420 nm in buffer citrate-phosphate (pH 4) and 25 
°C. One unit (U) of enzyme activity was defied as the amount of enzyme that oxidized 1 μmol 
of ABTS per min. Activity of immobilized laccase was assayed by incubating the biocatalyst in 
50 mL solution of ABTS (1 mM) prepared in citrate-phosphate buffer (pH 4) at 25 °C with 
continuous stirring. The absorbance at 420 nm was monitored every minute for a period of 
10 minutes. Immobilized laccase activity was expressed in Ug-1 solid. 
Protein assays were performed on supernatants and washing buffers according to the 
method of Lowry using bovine serum albumin as a standard (Lowry et al., 1951). All 
spectrophotometric measurements were carried out with a Shimadzu UV-2401PC 
spectrophotometer. 
 
5.2.4 Laccase immobilization 
Laccase was immobilized onto the different supports by the method described by 
Parra et al. (in preparation). First, activation of the support with GLU in vapour phase was 
carried out by dispersing 100 mg of each carrier on the bottom of an aluminium plate (35 
mL). The plate was placed inside a glass vessel (100 mL) containing approximately 15 mL of 
25% (v/v) GLU solution. The vessel was closed and kept at 30°C during 18 h. Enzyme 
immobilization was performed by incubating the GLU-modified particles in 5 mL solution 
containing 107 U of laccase in buffer citrate-phosphate (0.1 M) pH 7 at room temperature 
under continuous stirring for 2 h. The resulting biocatalyst was then washed four times with 
buffer citrate-phosphate pH 4 and stored at 4 °C. 
The enzymatic activity of all biocatalysts as well as the protein content of both 
supernatants and washing solutions were measured to determine the enzyme load and 
bound protein yield. 
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5.2.5 Biotransformation of pharmaceuticals by immobilized laccase onto SiNPs and 
nanocomposite 50/50  
The oxidation of a mixture of four pharmaceuticals by immobilized laccase was 
investigated in 5.5 mL reaction medium containing AMX, SMX, CIP (20 mg L-1) and CBZ (10 
mg L-1) dissolved in citrate-phosphate buffer (0.1 M, pH7) and SYR as redox mediator (520 
µM) in 25 mL glass vials at 25°C under continuous stirring to ensure O2 saturation of the 
reaction medium and dark conditions to avoid light oxidation. Reactions started when 7 U of 
immobilized laccase onto SiNPs or nanocomposite 50/50 were added to the reaction 
medium. Samples were withdrawn at specific time intervals for 3 h to monitor the removal 
process. After centrifugation at high speed for five minutes, sample supernatants were 
decanted, filtered with CHROMAFIL Xtra H-PTFE-20/30 filters and immediately analysed by 
HPLC-MS. 
In parallel, experiments with raw SiNPs and nanocomposite 50/50 with and without 
mediator, as well as controls with immobilized laccase previously inactivated were also 
carried out to assess the role of adsorption on the removal of the pharmaceuticals. All 
experiments were carried out by duplicate and results are reported as means with 
corresponding standard deviations. 
 
5.2.6 HPLC-MS analysis 
The concentration of pharmaceutical micropollutants was determined by high-
performance liquid chromatography (HPLC) on an Alliance – Waters e2695 separations 
module HPLC coupled to a MS Micromass Quatro API (triquadropole) detector and a 150 x 
2.1 mm Raptor C-18 column (5 µm). A 5 µL sample volume was injected into the column. 
Elution was performed at a flow rate of 0.25 mL min-1 with a gradient of (A) 95% water - 5% 
methanol and (B) 100% methanol. The gradient program was set as follows: 0-3 min, 100% 
(A); 3-8 min, 100% (B) and 8-15 min, 100% (A). 
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5.3. Results and discussion 
5.3.1 Immobilization of laccase onto different types of supports 
Inorganic materials are widely used as supports for immobilization of enzymes for 
environmental applications due to their exceptional properties (Zdarta et al., 2018a). In this 
investigation, five novel supports belonging to different classes of inorganic compounds 
(silica, clay and silica/clay nanocomposite) were used for the covalent immobilization of 
laccase (Table 5.2). Immobilization was performed according to a novel protocol proposed 
by Parra et al. (in preparation) which involved the activation of each support previously 
functionalized with APTES with GLU in vapour phase. This step allowed easier handling of 
micro/nanoparticles as it is performed in dry conditions, avoiding - agglomeration of the 
particles that may occur when activation is performed in a liquid solution. After 
immobilization, measurements of enzymatic activity of the different biocatalysts as well as 
protein determination of the supernatants were carried out in order to determine enzyme 
load and protein immobilization yield. Table 5.3 shows the results obtained for all supports. 
A comparative analysis of the different parameters in Table 5.3 will allow identifying the best 
biocatalysts to be further used. 
The various supports showed different laccase immobilization capability. Clay carriers 
allowed moderate enzyme loading and bound protein values. Both clay materials presented 
similar protein immobilization yields (32-38%) but Y-clay displayed higher specific activity 
with 57.4 U g-1 of support. According to Shen et al. (2002), interactions between clays and 
enzymes during immobilization can be influenced by the material properties such as clay 
type, surface area and cation exchange capacity. The higher specific activity obtained for Y 
clay could be related to its specific surface area (99 m2 g-1) which is considerable larger than 
those of SWy-3 clay (44 m2 g-1). For example, Ahn et al. (2002) compared montmorillonite 
and kaolinite as supports for laccase immobilization. These authors reported that 
montmorillonite capacity for enzyme immobilization was 12 times higher in comparison to 
kaolinite, which was attributed to its higher surface area. The specific area is an important 
parameter since it determines the enzyme loading capacity of a carrier. Typically, the best 
support would be that one showing the highest loading capacity, because in this way it is 
possible to immobilize larger amounts of enzyme with a lower volume of support (dos 
Santos et al., 2015). However, a higher loading capacity may not always ensure the resulting 
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biocatalyst will also show high enzyme activity as observed with SWy-3 clay. The Swy-3 clay 
allowed immobilizing 38% of protein, whereas Y-clay with a twice larger specific surface area 
attained similar protein immobilization yield (32%). There is the possibility that the higher 
immobilization capacity of SWy-3 led to an oversaturation of the support with laccase which 
reflected in low activity. According to literature, this could be due to the steric hindrance of 
laccase on the surface of clay particles. Steric hindrance occurs when an excessive 
concentration of enzyme is loaded on the support which leads to undesired protein 
interactions and flexibility inhibition of enzyme conformation (Fortes et al., 2017). Similar 
observation was also reported on previous studies dealing with the immobilization of 
laccases and lipases on magnetic nano and microparticles (Fortes et al., 2017; Guo et al., 
2003; Jiang et al., 2009). 
 
Table 5.3. Activity recovery, bound protein and enzyme loading obtained for laccase 
immobilization on different supports 
Type of material Bound protein 
(%) 
Activity 
(U g-1 biocatalyst) 
Silica particles  
   SiNPs 
48 ± 8 109 ± 10 
Clay particles 
     Y  33 ± 5 57 ± 7 
   SWy-3 38 ± 6 40 ± 5 
Nanocomposite 
     50/50 30 ± 10 185 ± 2 
   95/5 29 ± 7 24 ± 1 
 
 
Covalent attachment of TVL on SiNPs allowed high retention of protein which also 
showed high laccase activity. Actually, this nano-biocatalyst yielded to the greatest protein 
immobilization yield obtained in the study with an average of 48.2%, as well as the second 
highest enzyme loading with 108.7 U g-1. The overall good performance of SiNPs for laccase 
immobilization may be also attributed to the material properties. Moreira et al. (2017) 
observed that immobilization of TVL onto different types of silica nanoparticles previously 
modified with APTES and GLU led to high activity yields and improved enzyme stability. It 
was suggested that immobilization of enzymes onto silica supports could lead to high affinity 
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for model substrates such as ABTS which directly reflected in high activity yields. Probably, 
such affinity is the result of an effective enzyme immobilization and reduced diffusional 
limitations provided by the high surface area and porous structure of silica nanocarriers 
(Zdarta et al., 2018b). 
The use of composite materials as supports for enzyme immobilization represent a 
very interesting option since they combine the characteristics of different precursors which 
results in materials showing enhanced properties (Grigoras, 2017). Table 5.2 shows the 
characteristics of each nanocomposite. The two nanocomposites 50/50 and 95/5 present 
different particle size, 51 and 92 µm respectively; however, in terms of specific surface area 
both values are similar. Results show both nanocomposites attained the same protein 
immobilization yield (~30%) which is not surprising given that the nanocomposites 
presented almost the same specific surface area. However, these immobilization yields were 
the lowest from the five materials evaluated. The quantity of protein attached to the 
nanocomposites was 18% lower in comparison to SiNPs but nearly the same (3% lower) than 
the observed with Y-clay beads (one of their precursors). The latter observation is interesting 
since the specific area of both nanocomposites was reduced by 30% average in comparison 
to Y-clay (Table 5.2). Even when the specific surface area of nanocomposites was reduced, 
comparable capacity to Y-clay in terms of enzyme loading was observed.  
On the other hand, contrasting results were observed when the specific activity was 
evaluated. The nanocomposite 50/50 showed the maximum enzyme load in the study with 
185.2 U g-1, whereas nanocomposite 95/5 reported the lowest activity with barely 23.7 U g-1. 
The different ratio of silica/clay of each nanocomposite could be the cause for the different 
activity showed by each material. Nanocomposite 50/50 presented equal concentration of 
both Y-clay and Si 30R50, whilst composite 95/5 structure was 95% Y-clay and 5% Si 30R50. 
Probably, the highest concentration of Si 30R50 in composite 50/50 provided a more 
suitable environment for TVL which reflected in a considerable higher activity. Therefore, the 
outstanding results obtained with the nanocomposite 50/50 could be the result of Y-clay 
allowing the attachment of relatively high quantities of laccase and the highest 
concentration of silica in the support providing a stable microenvironment for the enzyme. 
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Considering the best results of bounded protein and enzyme load the SiNPs and 
nanocomposite 50/50 were selected for the following experiments of biotransformation of 
pharmaceutical micropollutants.  
 
5.3.2 Biotransformation of pharmaceuticals by immobilized laccase on SiNPs and 
nanocomposite 50/50 particles 
The capacity of immobilized TVL onto SiNPs and nanocomposite 50/50 to transform 
pharmaceutical micropollutants was assessed in batch reactions. The reaction medium was 
composed by a mixture of the antibiotics AMX, CIP, and SMX (20 mg L-1); the antiepileptic 
CBZ (10 mg L-1) and SYR (520 µM) as redox mediator. Enzymatic transformation of each 
micropollutant for both biocatalysts tested is presented in Fig. 5.1, along with the 
adsorption-based removals observed in the control experiments.  
Results show both biocatalysts yielded to high removal efficiencies ranging from 45 to 
100% and 49 to 100% with SiNPs and nanocomposite 50/50 respectively. Nonetheless, the 
elimination extent depended on the pharmaceutical and biocatalyst used, since removals 
observed were the outcome of a combined process of adsorption and enzymatic 
degradation. As shown in Fig. 5.1, the two materials showed different adsorption capacities 
as demonstrated by control experiments prepared with previously inactivated laccase. The 
nanocomposite 50/50 exhibited outstanding affinity for CIP that was completely eliminated 
via adsorption on this support, whereas CBZ was moderately adsorbed (up to 49%) and AMX 
and SMX removal was negligible (<10%). On the other hand, SiNPs controls showed similar 
capacity of adsorption for all the compounds with slightly high values in the range from 44 to 
65%. Moreover, it is important to mention that neither the modification of the carriers nor 
the presence of SYR modified the sorption capacity of both supports as observed in their 
corresponding controls carried out with the pristine materials. 
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Fig. 5.1. Removal of (a) AMX, (b) SMX, (c) CIP and (d) CBZ in mixture with TVL immobilized 
onto SiNPs particles ( ), and onto nanocomposite 50/50 ( ) over 3 h at pH 7 and with SYR as 
redox mediator. The open symbols represent the removal by adsorption on the support with 
inactivated laccase (standard deviation is indicated as error bars). 
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The different capability of the two carriers to adsorb the micropollutants can be 
related to each material properties. For example, the presence of various functional groups, 
good sorption properties and high stability of silica carriers make them an excellent option 
for the immobilization of oxidative enzymes as well as for the selective sorption of pollutants 
such as dyes and phenolic compounds (Champagne and Ramsay, 2007; Kim et al., 2011). In a 
previous work Parra et al. (in preparation) observed comparable sorption removals (30-50%) 
for a mixture of pharmaceutical micropollutants by inactivated TVL immobilized on 
commercial silica gel particles. In contrast, the high and selective adsorption of the 
micropollutants showed by nanocomposite 50/50 probably was the result of the combined 
characteristics of its inorganic precursors, silica and clay, which are characterized for 
presenting high surface area and sorption capacity. It is known that montmorillonite clay 
materials can provide extra adsorption due to their two dimensional layered structure (An et 
al., 2015). 
However, adsorption observed for the pharmaceuticals in this study cannot be only 
associated to the properties of the solid supports but also to the physicochemical 
characteristics of each micropollutant. In general, hazardous compounds can be attached to 
the surface of sorbent materials by means of different mechanisms such as surface 
adsorption, ion exchange, complexation, chelation or micro-precipitation (Crini, 2006; 
Michael et al., 2013). Nevertheless, it has been recognized that the efficiency and selectivity 
of adsorption for pharmaceutical compounds are mostly due to hydrophobic or ion 
exchange interactions. The affinity of compounds to adsorb and accumulate to solids due to 
hydrophobic interactions can be evaluated by the octanol-water partition coefficient (Kow). 
Typically, neutral charged compounds with a log Kow<2.5 are considered to show low 
sorption potential (Michael et al., 2013). Nonetheless, it is important to know that this 
assumption cannot be applied to polar or charged molecules since their prediction often 
leads to underestimations. In the present investigation even when the studied 
pharmaceuticals showed log Kow values below 2.5 (Table 5.1), the compounds were indeed 
adsorbed onto the supports. The relatively low Log Kow values of AMX and SMX (0.89 and 
0.87 respectively) and the hydrophilic nature of both antibiotics could explain their low 
adsorption observed on nanocomposite 50/50. The high adsorption of CIP can be attributed 
to its particular sorption mechanism, which appears to occur by a combination of 
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hydrophobic forces and electrostatic interactions, being the latter one the most 
predominant mechanism (Golet et al., 2003). Regarding to CBZ, the removal yields observed 
by both supports can be related to its Log Kow value of 2.45 which is in the limit between low 
and moderate adsorption potential as well to its low solubility in water (78 mg L-1). In 
addition, it is worth noting that elimination of CIP and CBZ was entirely by adsorption as 
shown in Fig. 5.1c and 5.1d. Fast and complete removal of CIP was obtained by composite 
50/50 in only 30 minutes. Whilst in presence of SiNPs residual concentration of CIP 
decreased constantly to reach 56% at the end of 3 h. According to Fig. 5.1d CBZ removal 
occurred mainly during the first 30 minutes of treatment with average elimination of 50% for 
both SiNPs and nanocomposite immobilized biocatalysts.  
Even if part of the elimination was associated with the adsorption of the 
micropollutants to the supports, enzymatic degradation was observed as the major 
contribution in the removal process for the antibiotics AMX and SMX. The biotransformation 
of AMX by both immobilized biocatalysts followed almost identical profiles, reaching 91% 
removal at the end of 3 h (Fig. 5.1a). In the case of SMX, a rapid and complete degradation 
was observed with laccase immobilized onto SiNPs after 1 h of reaction (see Fig. 5.1b). 
Similarly, laccase immobilized on composite 50/50 allowed 100% removal of SMX but 2 h 
were necessary to achieve such transformation. These results confirmed that the solid 
support played a relevant role in the degradation of these compounds. 
According to the results obtained, faster removal of the antibiotics was obtained 
when TVL was immobilized onto SiNPs, as this carrier was capable of moderately adsorbing 
AMX and SMX. This observation suggests that adsorption of micropollutants onto active 
SiNPs may have facilitated the degradation of pharmaceuticals by laccase. Similar effect was 
reported by various research groups for the removal of dyes and pharmaceutical 
micropollutants when enzyme was immobilized onto different supports such as granular 
activated carbon (GAC), alumina and chitosan-Fe membranes (Nguyen et al., 2016; Wen et 
al., 2015; Zille et al., 2003). According to these authors, the interaction between pollutants 
and the active sites of immobilized laccase was improved after adsorption resulting in an 
enhanced removal performance. In this way, the combined action of adsorption and 
biodegradation allowed to TVL immobilized on SiNPs to achieve high and fast removal yields 
for both antibiotics which was especially evident for SMX. 
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Although no adsorption of AMX and SMX was observed on nanocomposite 50/50, 
however, this activated solid yielded to the same high removal percentages obtained by 
SiNPs. Nonetheless, longer contact times were necessary to achieve such comparable 
results. The use of composite/hybrid materials for the covalent immobilization of enzymes 
have been demonstrated to significantly improve enzyme stability (Aydemir and Güler, 2015; 
Sathishkumar et al., 2012). Aydemir and Güler (2015) observed that covalent immobilization 
of TVL on magnetic chitosan-clay composite beads considerably enhanced enzyme stability 
allowing complete removal of phenol under the optimum conditions. The longer time 
needed for nanocomposite 50/50 catalysed reactions could be related to diffusional 
limitations in the transport of substrate created by the multipoint attachment of laccase on 
the nanocarrier. Nonetheless, even considering these diffusional constraints, immobilized 
TVL onto composite 50/50 was able to achieve high removal yields.  
The high degradation yields observed for AMX and SMX can be related to the 
presence of functional groups in their structure susceptible for laccase oxidation. The 
presence of hydroxyl and amino groups directly attached to a benzene ring, in AMX and SMX 
respectively, make them putative laccase substrates. However, the presence of SYR in the 
reaction media acting as electron shuttle between immobilized TVL and substrates could be 
considered as the determinant factor that favoured the transformation of AMX and SMX as 
reported by (Parra Guardado et al., 2019). In contrast, CIP and CBZ showed recalcitrance to 
laccase biotransformation. Neither the presence of SYR nor the immobilization of laccase 
allowed the enzymatic transformation of the pharmaceuticals. Resistance of CBZ and CIP is 
associated to the presence of strong electron withdrawing functional groups (amide and 
halogen, respectively) which generates electron deficiency making the compounds less 
prone to laccase action (Yang et al., 2013). 
 
 
5.4. Conclusions 
In recent years, the simultaneous use of a material for enzyme immobilization and for 
adsorption has become subject of study to many research groups with the objective to 
develop advanced technologies able to achieve high removal efficiency of environmental 
pollutants. Different materials of organic, inorganic and hybrid/composite origin have been 
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tested for their potential to simultaneously immobilize enzyme and adsorb pharmaceutical 
micropollutants and results seem encouraging (Cabana et al., 2009; García-Delgado et al., 
2018; Ji et al., 2016; Naghdi et al., 2017; Nguyen et al., 2016; Shao et al., 2019). In this 
regard, results described in the present work highlight the important role of the carrier 
material properties in the immobilization process of laccase as well as in the performance of 
the immobilized biocatalyst for the removal of environmental micropollutants.  
The five materials evaluated in the present study showed different capability to 
immobilize laccase. Results revealed that the immobilization process was influenced by both 
the specific surface area of each carrier and the type of material and its composition. It was 
found that silica materials had a positive effect in the immobilization of laccase as observed 
with the composite silica/clay nanoparticles where a higher concentration of silica yielded to 
the most active biocatalyst. Therefore, composite 50/50 and SiNPs resulted as the best 
supports in terms of high specific activity (185 U mg-1) and protein immobilization yield 
(48%), respectively.  
The two biocatalysts were then used for the removal of a mixture of pharmaceutical 
micropollutants in the presence of SYR as redox mediator. Overall, both SiNPs and 
nanocomposite 50/50 biocatalysts achieved high removal yields for all the pharmaceuticals 
as the result of increased laccase stability after immobilization and the remarkable sorption 
capacity of the carriers. High removal of the antibiotics AMX (91%) and SMX (100%) was 
mainly due to the oxidative action of immobilized laccase, whilst the elimination of CIP (56-
100%) and CBZ (50%) was due to adsorption on the carriers. Although both biocatalysts 
showed similar performance for the removal of the target micropollutants, it was observed 
that they followed different pathways. High and fast degradation efficiency of 
micropollutants by immobilized laccase on SiNPs was possibly due to the moderate sorption 
capacity showed by the support, allowing a better interaction between laccase and 
pharmaceuticals after the compounds were adsorbed on the silica surface. In contrast, the 
high removals obtained by the active nanocomposite were the result of an increased 
stability of the enzyme and a remarkable selective sorption capacity only towards CIP and 
CBZ. From the best of our knowledge this is the first report of the use of silica/clay 
nanocomposites as laccase carriers for the removal of environmental micropollutants. The 
conception of treatment systems using materials showing properties for immobilization of 
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enzymes and adsorption could be a promising option for the effective biotransformation of 
toxic mixtures of pollutants at mild conditions to obtain cleaner effluents in one step 
treatment. In this sense, the biocatalysts herein proposed represent a valuable addition to 
the current knowledge for the future development of this type of processes in different 
configurations of enzymatic bioreactors for example. 
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6. Conclusions and perspectives 
 
 
The objective of this thesis was to evaluate the removal of four model pharmaceutical 
micropollutants in water (amoxicillin (AMX), ciprofloxacin (CIP), sulfamethoxazole (SMX) and 
the antiepileptic carbamazepine (CBZ)) by different laccase-based treatments. For this 
purpose, two different approaches were followed: the enzymatic treatment by means of 
free laccase systems and the use of immobilized enzymes onto different solid supports. For 
the free laccase systems, the oxidative potential of a crude extract from a native strain from 
Pycnoporus sanguineus (PSL) white rot fungus was compared to that of the commercially 
available Myceliophthora thermophila (MTL) and Trametes versicolor (TVL) purified enzymes. 
As described in chapter 3, enzymatic treatment resulted ineffective for the 
biotransformation of the pharmaceutical compounds. Only the antibiotic AMX was partially 
eliminated, but the extent depended on the laccase used and the reactions conditions 
assayed which was observed to increase at slightly acidic conditions (pH 5-6). The poor 
removals observed were attributed to the physicochemical properties of the 
pharmaceuticals which make them resistant to laccase attack. In an attempt to expand the 
substrate spectrum of laccases, redox mediators were added to the reaction. Results 
demonstrated the positive effect of the addition of the natural mediators syringaldehyde 
(SYR), p-coumaric acid (PCA) and the synthetic compound 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid (ABTS). However, the performance of the laccase-
mediator systems was observed to be mediator dependent. ABTS and SYR yielded to the 
highest removal efficiencies. In particular, ABTS was observed to enhance the degradation of 
phenolic compounds. However, SYR was the best redox mediator allowing the highest 
degradation yields, especially for non-phenolic molecules, as result of the highly reactive and 
stable radicals formed after its oxidation by laccase. In this sense, commercial laccases 
showed better performance than the crude extract from P. sanguineus. Overall, laccase 
oxidative potential was increased by the addition of mediators, however it was not possible 
to find a broad spectrum mediator since CBZ was not transformed by any laccase-mediator 
system tested. Anyhow, the potential of free laccase-mediator systems for the treatment of 
recalcitrant pharmaceuticals was demonstrated. 
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In the fourth chapter, we have presented the work carried out for the immobilization 
of the laccases. A new methodology was developed for the covalent binding of laccases onto 
commercial amino-functionalized silica gel micro-particles. The novel method involved the 
activation of the silica beads with glutaraldehyde (GLU) in vapour phase in order to facilitate 
the handling of the small particles during this step. This is the first time this activation 
technique is used for the immobilization of laccase on solid supports for bioremediation 
applications. In order to stablish the best immobilization conditions, a 23 full experimental 
design was generated to study the effect of different parameters in the process. According 
to the resulting model, the conditions leading to the highest laccase activity (14±2 U g-1 of 
beads) and protein immobilization yield (35%) were: 18 h of GLU activation time, 107 U of 
enzyme, 2 h of contact time and pH 7. The covalent immobilization of laccase onto the silica 
beads allowed to enhance its stability over a range of pH and temperature values as well as 
to improve its long term storage in comparison to the free form. Even if the stability of 
laccase was increased after immobilization, the resulting biocatalyst was still unable to 
catalyze the oxidation of the target pharmaceuticals. However, similarly to free enzyme, the 
addition of redox mediators significantly increased the transformation of the 
pharmaceuticals reaching high removal yields (40-100%) within 3 h of reaction. It was 
observed that removal of pharmaceuticals occurred by the combined action of degradation 
and adsorption on the support, and the occurrence of one or the other mechanism was 
compound dependent. AMX and SMX elimination was due to biodegradation, although it 
was also observed that adsorption may have played an important role in the process by 
enhancing the electron transfer between laccase and substrates. In the case of CIP and CBZ, 
the removal was completely by adsorption which was attributed to their high affinity to 
adsorb on solids. Overall, redox mediators generating phenoxyl radicals were the most 
effective for the biotransformation of the pharmaceuticals, with SYR showing the best 
performance. Nonetheless, the use of SYR considerably increased the toxicity of the effluent 
as suggested by the Microtox® assay; whilst ABTS led to the lowest toxic treatment. Finally, 
the reusability of the biocatalyst showed that immobilize enzyme could be effectively reused 
for the degradation of pharmaceuticals for seven consecutive cycles with SYR as mediator. In 
this sense, a balance between effective removal of the micropollutants and less toxic 
effluents needs to be found for the successful implementation of the treatment. 
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The fifth chapter of this thesis was devoted to study the immobilization of laccase 
onto different inorganic support materials. Silica (SiNPs), clays (Y-clay and SWy-3) and 
silica/clay (95/5 and 50/50) nanocomposites showing different characteristics in terms of 
chemical composition, size and specific surface area were used to carry out the covalent 
immobilization of TVL using the new method developed in chapter 3. Results showed the 
five supports presented different capability to immobilize laccase and it was mainly 
influenced by the specific surface area of each carrier as well as by the type and composition 
of the material. It was observed that silica materials had a positive impact in the 
immobilization of laccase by allowing binding large quantities of highly active protein. This 
was especially evident with the nanocomposites, where a higher concentration of silica in 
the composite (5% vs 50%) yielded to the most active biocatalyst. Thus, nanocomposite 
50/50 and SiNPs resulted as the best supports in terms of high specific activity (185 U mg-1) 
and protein immobilization yield (48%), respectively. The performance of both biocatalysts 
was compared for the degradation of pharmaceutical micropollutants with SYR as mediator 
in batch reactions. Both biocatalysts reached high removal yields (50-100%) for the four 
pharmaceuticals studied due to the synergistic action of laccase catalyzed oxidation and 
remarkable sorption capacity of the carriers. Interestingly, even when the two biocatalysts 
showed similar removal yields the mechanism they follow to achieve such results was 
certainly different. Laccase immobilized onto SiNPs showed high and fast degradation 
efficiency due to the moderate sorption capacity of the support for the pharmaceuticals, 
which possibly enhanced the interaction between laccase and pharmaceuticals once the 
compounds were adsorbed on the support surface. In contrast, even when nanocomposite 
50/50 showed remarkable sorption capacity, it was not observed to increase the 
biotransformation of the micropollutants. In other words, the degradation and adsorption of 
the pharmaceuticals were carried out by independent processes. In this work, this is the first 
time that silica/clay composite materials are used as laccase carriers for the treatment of 
pharmaceutical pollutants and results seem encouraging. The results presented here, 
highlight the important role of the carrier material properties in the immobilization process 
as well as in the performance of the resulting biocatalyst for the removal of environmental 
pollutants. In this sense, we have demonstrated the benefit of using versatile materials 
showing properties to both immobilize enzymes and adsorb hazardous compounds which 
could potentially lead to greener and simpler “one step” treatment processes. 
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The work done here demonstrate the potential of using laccases for the enzymatic 
treatment of pharmaceutical micropollutants in water, however is important to consider 
some aspects for the future develop of this research. The performance of laccases in this 
thesis was investigated mainly using synthetic wastewater. It is important to evaluate the 
performance of both free and immobilized systems in real wastewater conditions. In this 
sense, tests with enzymes-mediator systems in real wastewater at the very low 
concentration of micropollutants, as they are usually encountered in such waters, should be 
fundamental to assess the impact of real conditions on the effectiveness of the treatment. 
Another important aspect to consider would be scaling up the treatment, since all the 
experiments carried out in this work were at laboratory scale. In this sense, the design of a 
reactor (e.g. enzymatic membrane bioreactor, packed bed) would be the best option as it 
would also allow to evaluate the effectiveness of the treatment in continuous operation.  
Immobilization of laccase allowed to increase the stability and reusability of the 
enzyme which is crucial for large scale applications. Therefore, the immobilization method 
proposed should be optimized in order to maximize the immobilization yields and the 
activity load on the carriers to make the process more cost effective. Additionally, further 
tests should be done with SiNPs and nanocomposite 50/50 to fully characterize these 
biocatalysts and evaluate their possible reusability. 
In this study, the addition of redox mediators has been demonstrated to improve the 
degradation and also to expand the spectrum of compounds degraded by laccase. However, 
the continuous addition of these compounds to the reaction leads to increased costs and 
higher toxicity of the treated effluent. It is recommended to study the effect of mediator 
type and concentration on both degradation yields and acute toxicity in order to truly 
develop an efficient and effective treatment process. Moreover, at the end of the thesis a 
new approach for the reusability of SYR was investigated by immobilizing the mediator onto 
solid supports. Since the preliminary results seemed promising, we think it is worth to study 
in deep this technology. 
  
  
 
Résumé 
Ce travail concerne l'étude de la dégradation enzymatique de micropolluants 
pharmaceutiques récalcitrants présents dans l'eau. Tout d’abord, les efficacités de trois 
laccases différentes issues respectivement de : Pycnoporus sanguineus CS43, Trametes 
versicolor (Tv) et Myceliophtora thermophila ont été comparés lors d’essais de dépollution 
de solutions modèles renfermant trois antibiotiques (amoxicilline, ciprofloxacine et 
sulfaméthoxazole) et un antiépileptique (carbamazépine). Les essais ont été réalisés avec les 
laccases libres en présence ou non de médiateurs redox. L'impact de plusieurs paramètres 
opératoires sur les performances des enzymes a également été étudié. Puis, une nouvelle 
méthode d’immobilisation des laccases impliquant l’activation du support (microparticules à 
base de silice commerciales) par du glutaraldéhyde en phase vapeur a été mise au point et 
optimisée en utilisant la méthodologie de plans d’expériences. Après immobilisation, la 
laccase Tv s’est avérée être la plus active. Des essais de dégradation en présence de 
médiateurs redox ont confirmé l’efficacité de l’enzyme immobilisée et sa possible 
réutilisation lors de cycles successifs. La toxicité des solutions après traitement a été évaluée 
par des tests Microtox®. La laccase Tv a également été immobilisée sur des nanoparticules 
non commerciales à base de silice ou d’argile ainsi que sur des composites à base de silice et 
d’argile. La laccase Tv immobilisée sur les supports composites riches en silice a montré une 
plus grande réactivité et de meilleures performances pour l'élimination des composés cibles.  
Mots-clés :  Laccase, Enzymes immobilisées, Médiateurs redox, Micropolluants 
pharmaceutiques, Biodégradation. 
 
Abstract 
This work is focused on the study of the enzymatic depletion of recalcitrant pharmaceutical 
micropollutants in water. The potential degradation of three antibiotics (amoxicillin, 
ciprofloxacin and sulfamethoxazole) and one anti-epileptic (carbamazepine) was studied 
with three laccases: Pycnoporus sanguineus CS43, Trametes versicolor (Tv) and 
Myceliophtora thermophila. Free laccase systems were evaluated for pharmaceuticals 
depletion on model solutions in the presence or absence of redox mediators and the impact 
of several parameters on the performance of laccases for degradation were studied. The 
enzymes were then immobilized on different solid supports: commercial silica, laboratory 
synthetized nano-silica and clay based composite nanomaterials and used for degradation 
tests. A novel methodology for the covalent binding of laccases onto carriers was developed 
by using glutaraldehyde in vapour phase and the best immobilization conditions were 
determined through a 23 full factorial design. The immobilized Tv shown the highest activity 
and was tested in presence of redox mediators. Moreover, the reusability was evaluated in 
several degradation cycles and the toxicity of the solutions after treatment was assessed 
with the Microtox® test. In comparison to laccase immobilized on commercial silica, the Tv 
supported on laboratory synthetized materials showed higher activity and a better 
performance for the removal of target compounds. 
Keywords: Laccase, Enzyme immobilization, Redox mediators, Pharmaceutical 
micropollutants, Biodegradation. 
